Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution
3017446	s-testo	nmol/l (nmol/l)	35353	76427	0.03%
3017446	s-testo	— (—)	7366	13077	100.00%	Distribution not available
3017446	s-testo	nmol/l____ (nmol/l)	566	1138	0.00%
3017446	s-testoms	nmol/l (nmol/l)	481	697	0.00%
3017446	s-hstesto	nmol/l (nmol/l)	418	613	0.00%
3017446	s-testosteroni	nmol/l (nmol/l)	418	611	0.00%
3017446	testosteroni	nmol/l (nmol/l)	154	247	0.00%
3017446	s-tesmsvl	pmol/l (nmol/l)	105	114	0.00%
3017446	s-testosteroni	nmol/l____ (nmol/l)	78	97	0.00%
3017446	s-hstesto	— (—)	22	25	100.00%	Distribution not available
3017446	s-testo	pmol/l (nmol/l)	20	25	0.00%
3017446	s-testoms	nmol/l____ (nmol/l)	11	16	0.00%

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Other antidepressants

8125

25165

1.74

307.65

2.7

2.2

12.84

13.08

nmol/l

1.69

7196

23164

Polycystic ovarian syndrome, consortium definition

1747

2349

4.40

307.65

1.5

1.4

1.45

1.89

nmol/l

4.52

1541

1999

Irregular menses

1132

2251

3.89

307.65

1.4

1.35

1.91

nmol/l

6.36

991

1917

Polycystic ovarian syndrome

690

626

14.46

307.65

1.5

1.3

1.62

1.66

nmol/l

0.12

633

546

Ovarian dysfunction

735

770

11.68

307.65

1.5

1.3

1.59

1.60

nmol/l

0.04

674

661

Abnormal serum enzyme levels

3855

16376

2.72

307.65

2.3

10.25

13.68

nmol/l

90.93

3357

14649

malignant neoplasm of male genital organs

4870

11315

3.35

307.65

2.5

2.3

8.99

15.42

nmol/l

307.65

4235

10345

L02BX Other hormone antagonists and related agents

1323

2763

10.72

307.65

2.9

2.1

3.00

13.42

nmol/l

294.24

1056

2406

Disorders of other endocrine glands

4995

14338

4.04

307.65

4.9

1.9

10.42

12.89

nmol/l

67.71

4652

13010

Polycystic ovarian syndrome, broad definition

970

1101

10.48

307.65

1.4

1.3

1.47

1.58

nmol/l

0.59

893

932

malignant neoplasm of male genital organs, including Hilmo

4935

11702

3.26

307.65

2.5

2.3

9.19

15.41

nmol/l

307.65

4297

10720

Malignant neoplasm of prostate

4600

10414

3.36

307.65

2.4

2.3

8.63

15.38

nmol/l

307.65

3967

9490

Abnormal findings on examination of blood, without diagnosis

4679

20928

2.26

307.65

2.4

2.3

10.55

13.52

nmol/l

87.11

4105

18840

Female infertility

911

968

5.92

307.65

1.3

1.4

1.28

2.25

nmol/l

8.90

841

810

Hypogonadotropic hypogonadism

1107

2428

29.50

307.65

8.0

2.3

11.38

14.95

nmol/l

47.05

1060

2275

Female infertility, associated with anovulation

623

564

12.88

307.65

1.3

1.4

1.37

2.04

nmol/l

3.92

585

468

Hypertrichosis

360

187

30.56

307.65

1.8

1.5

1.55

3.49

nmol/l

4.76

327

172

Hypopituitarism

1751

3685

9.31

307.65

7.2

2.1

11.73

14.42

nmol/l

34.49

1664

3417

L02BB Anti-androgens

1884

3906

8.23

307.65

2.9

2.1

4.13

13.33

nmol/l

265.70

1552

3386

Malignant neoplasm of prostate, including Hilmo

4648

10729

3.27

307.65

2.4

2.3

8.82

15.38

nmol/l

307.65

4004

9791

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

2770

9832

3.16

307.65

5.5

2.1

11.68

12.72

nmol/l

8.95

2595

8892

Testicular dysfunction

1494

3184

31.73

307.65

6.7

2.1

13.33

14.94

nmol/l

11.78

1445

2973

Hirsutism in women

335

146

38.04

307.65

1.8

1.3

1.51

1.65

nmol/l

0.30

306

135

Sleep disorders (combined)

7826

25012

1.71

307.65

2.7

2.1

12.31

12.99

nmol/l

9.81

7030

22817

Testicular hypofunction

1347

2827

39.26

307.65

6.8

2.1

13.26

15.00

nmol/l

12.07

1298

2642

Benign neoplasm: Pituitary gland, craniopharyngeal duct

771

1686

6.55

307.65

6.0

2.3

12.29

13.14

nmol/l

2.02

745

1535

Exclusions for E4_PCOS_BROAD

2509

6457

5.12

307.65

5.9

2.1

11.18

13.19

nmol/l

26.90

2356

5890

Amenorrhoea

407

442

10.34

307.65

1.5

1.4

1.30

2.32

nmol/l

4.12

359

365

Sleep apnoea, including avohilmo

7577

26434

1.83

307.65

2.8

2.1

12.42

13.50

nmol/l

25.51

6814

24093

Sleep apnoea

7380

26555

1.86

307.65

2.9

2.2

12.27

13.66

nmol/l

41.55

6629

24227

Depression or dysthymia

5168

16468

1.81

276.57

2.7

2.1

13.39

13.15

nmol/l

1.13

4621

15173

Diseases of male genital organs

6840

22431

1.69

254.04

2.8

2.3

14.44

14.17

nmol/l

2.05

6298

20752

Selective serotonin reuptake inhibitors

7438

25297

1.59

248.53

2.7

2.2

12.92

13.06

nmol/l

0.70

6616

23286

Secondary malignant neoplasm of other and unspecified sites, including Hilmo

1714

7189

2.54

241.85

2.5

2.2

4.68

15.06

nmol/l

307.65

1412

6474

Endocrine, nutritional and metabolic diseases

6198

19880

1.65

233.98

3.0

1.8

11.27

14.24

nmol/l

129.17

5642

18403

Benign neoplasm of other and unspecified endocrine glands

1144

4230

3.12

230.32

4.7

2.2

11.63

13.26

nmol/l

9.71

1070

3820

Recurrent or chronic depression

2970

11061

1.98

219.89

2.9

2.1

12.65

13.62

nmol/l

8.17

2677

10416

Female infertility, cervical, vaginal, other or unspecified origin

627

908

4.57

216.89

1.3

1.4

1.28

2.17

nmol/l

4.72

581

761

Exclusions for E4_PCOS_CONSORTIUM

3186

10904

1.89

209.54

5.1

2.0

10.31

11.25

nmol/l

7.48

2933

9921

Depression medications

2589

6616

2.11

209.35

2.8

1.9

12.97

14.68

nmol/l

18.84

2371

6359

Abnormal spermatozoa

1600

7528

2.64

205.04

2.4

2.3

11.03

13.40

nmol/l

19.04

1447

6696

Behavioural syndromes associated with physiological disturbances and physical factors

6493

29627

1.54

198.00

2.8

2.3

13.15

12.96

nmol/l

1.04

5922

27157

Medical observation and evaluation for suspected diseases and conditions

5031

16282

1.65

193.57

2.8

2.1

12.61

13.39

nmol/l

8.11

4448

15002

Hypothyroidism and >3 levothyroxin purchases

2139

5928

2.17

191.49

3.5

1.8

11.70

14.48

nmol/l

39.11

1964

5690

Hypothyroidism, levothyroxine purchases

2139

5928

2.17

191.49

3.5

1.8

11.70

14.48

nmol/l

39.11

1964

5690

Impotence

935

3617

3.61

190.96

3.2

2.2

14.05

13.90

nmol/l

0.23

855

3283

Hypothyroidism (congenital or acquired)

2148

5971

2.16

190.17

3.5

1.8

11.71

14.48

nmol/l

39.23

1971

5733

Codeine

6415

23325

1.54

188.91

2.7

2.1

12.35

13.17

nmol/l

11.43

5781

21468

Tramadol

5343

21094

1.58

180.44

2.8

2.2

12.68

13.51

nmol/l

9.98

4737

19372

Sleep disorders

6095

28643

1.52

175.61

2.7

2.3

13.11

12.96

nmol/l

0.68

5558

26282

Gender identity disorders

272

448

10.26

175.42

2.6

2.0

9.87

12.25

nmol/l

2.56

252

418

Panhypopituitarism

337

707

8.47

172.27

7.3

2.3

13.62

13.54

nmol/l

0.06

316

646

Episodal and paroxysmal disorders

7127

25259

1.48

169.97

2.7

2.1

11.92

13.08

nmol/l

25.58

6442

23083

Codeine or tramadol medication

7554

29080

1.46

169.74

2.6

2.2

12.43

12.93

nmol/l

5.30

6787

26527

Genitourinary diseases

5641

19055

1.57

168.35

2.7

2.3

13.61

14.11

nmol/l

4.48

5192

17719

Neoplasms

5917

21170

1.52

163.38

2.8

2.2

12.52

13.72

nmol/l

22.03

5434

19660

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

3867

23799

1.65

163.08

2.7

2.3

13.53

13.22

nmol/l

1.48

3496

21728

Opioids

6594

23720

1.48

160.88

2.6

2.1

12.18

13.16

nmol/l

15.71

5920

21833

Oligomenorrhoea

165

154

11.84

155.57

1.5

1.36

2.46

nmol/l

2.64

147

131

Coxibs

1962

5294

2.06

153.47

2.5

2.0

12.64

12.55

nmol/l

0.15

1773

4791

Insomnia

5828

28162

1.49

153.29

2.7

2.3

13.04

12.93

nmol/l

0.43

5316

25866

Noninflammatory disorders of female genital tract

754

1217

3.18

147.78

1.4

1.5

1.44

2.51

nmol/l

8.24

672

1030

Hyperfunction of pituitary gland

409

1064

4.52

145.06

5.2

1.9

9.80

12.41

nmol/l

7.78

384

970

Symptoms and signs involving the urinary system

5020

26000

1.51

142.77

2.6

2.3

11.97

13.31

nmol/l

22.29

4427

23709

Exposure to unspecified factor

6757

33312

1.42

138.99

2.5

2.3

13.28

12.71

nmol/l

5.99

6053

30393

Exposure to other specified factors

5526

33459

1.47

138.92

2.6

2.3

13.47

12.82

nmol/l

6.84

5061

30536

Use of hypnotics and sedatives

7098

29519

1.42

138.57

2.8

2.3

13.11

13.00

nmol/l

0.48

6317

26966

Hyperprolactinaemia

285

603

5.63

131.55

5.4

1.9

9.05

11.58

nmol/l

5.17

269

562

Other dorsopathies, not elsewhere classified

6794

25714

1.41

128.75

2.5

2.2

12.58

12.81

nmol/l

1.44

6091

23573

Injuries to the wrist and hand

6614

32322

1.40

122.16

2.4

2.3

13.24

12.68

nmol/l

5.67

5982

29425

Any death

1873

22316

0.56

121.79

2.2

2.3

9.22

13.80

nmol/l

88.30

1568

20260

General examination and investigation of persons without complaint and reported diagnosis

4558

16275

1.51

120.10

2.6

2.1

12.71

13.40

nmol/l

6.14

4152

14997

Dislocation, sprain and strain of joints and ligaments of knee

4358

27416

1.49

119.74

2.5

2.3

13.76

13.09

nmol/l

6.62

4041

25217

Abnormalities of breathing

5896

24369

1.42

119.68

2.8

2.2

12.41

12.92

nmol/l

4.79

5328

22367

Dorsalgia

6585

25618

1.40

119.52

2.5

2.2

12.49

12.80

nmol/l

2.24

5898

23481

Acute upper respiratory infections of multiple and unspecified sites

4814

24681

1.47

119.37

2.4

2.2

12.81

12.76

nmol/l

0.17

4375

22504

Anxiety (asthma-related co-morbidities)

4038

20922

1.52

119.35

2.7

2.3

11.93

13.35

nmol/l

21.17

3598

19565

Pain in throat and chest

5657

24088

1.43

118.87

2.5

2.2

12.81

13.05

nmol/l

1.38

5129

22119

Hyperplasia of prostate

3933

15119

1.58

118.41

2.6

2.3

13.96

13.61

nmol/l

1.81

3557

13792

Neurological diseases

5613

20151

1.44

117.95

2.6

2.1

12.13

13.11

nmol/l

13.96

5064

18564

Other diseases of upper respiratory tract

6972

26954

1.38

117.56

2.4

2.2

12.94

12.69

nmol/l

1.55

6265

24487

Used for control exclusion in common control thyroid runs

7513

28462

1.37

116.85

3.0

2.1

12.64

13.02

nmol/l

3.34

6829

25958

All anxiety disorders

4107

22118

1.49

110.97

2.7

2.3

11.83

13.26

nmol/l

21.50

3658

20598

Hyperkinetic disorders, excluding more controls

1041

4707

2.24

110.95

2.7

2.0

11.60

12.18

nmol/l

1.17

934

4446

Acetic acid derivatives and related substances

1779

5119

1.88

109.02

2.5

2.0

12.79

12.50

nmol/l

0.61

1590

4626

Injuries to the shoulder and upper arm

5783

32937

1.40

108.99

2.5

2.3

13.62

13.09

nmol/l

5.45

5282

29963

Mood [affective] disorders

6560

31539

1.37

106.86

2.8

2.2

12.36

13.16

nmol/l

11.64

5834

29006

Mood disorders

6566

31552

1.37

106.02

2.8

2.2

12.35

13.16

nmol/l

11.76

5840

29015

Mood disorders, excluding more controls

6108

26689

1.38

104.61

2.8

2.2

12.50

13.21

nmol/l

8.75

5429

24577

Parasetamol

5461

20103

1.42

104.10

2.6

2.1

12.31

13.69

nmol/l

26.86

4965

18628

Oxicams

1425

4301

1.98

103.32

2.6

2.0

12.89

12.48

nmol/l

0.92

1259

3856

Hernia

5836

28793

1.38

102.86

2.5

2.3

13.59

13.22

nmol/l

2.83

5337

26297

Depression

6097

30573

1.37

100.68

2.8

2.2

12.30

13.21

nmol/l

13.95

5439

28198

Solid cancers

4912

20806

1.42

100.19

2.5

2.3

11.76

14.32

nmol/l

77.91

4434

19227

Other special examinations and investigations of persons without complaint or reported diagnosis

4530

16285

1.45

100.10

2.6

2.1

13.08

13.39

nmol/l

1.60

4136

15003

Male infertility

794

3838

2.72

99.94

3.5

2.4

15.20

14.99

nmol/l

0.36

753

3639

Other joint disorders

6047

23574

1.37

97.79

2.5

2.2

12.67

12.81

nmol/l

0.63

5453

21599

Malignant neoplasm

5048

21586

1.41

96.69

2.6

2.4

11.97

14.27

nmol/l

66.49

4573

19961

Inflammatory diseases of prostate (prostatitis)

1444

8391

1.95

96.48

2.6

2.3

14.29

13.68

nmol/l

2.34

1303

7661

Neurotic, stress-related and somatoform disorders

5579

28655

1.38

96.27

2.8

2.3

12.32

13.24

nmol/l

12.62

4990

26536

Malignant neoplasm

5049

21617

1.41

96.01

2.6

2.4

11.97

14.28

nmol/l

66.76

4576

19988

Soft tissue disorders

6699

26082

1.35

95.84

2.5

2.2

12.73

12.74

nmol/l

0.03

6075

23806

Nonorganic sleeping disorders, excluding more controls

1361

7597

1.90

95.72

3.0

2.1

12.65

12.89

nmol/l

0.46

1233

7035

Symptoms and signs involving the circulatory and respiratory systems

6477

24550

1.35

95.46

2.6

2.2

12.46

12.94

nmol/l

4.53

5863

22540

Deviated nasal septum

2796

18849

1.58

94.73

2.7

2.3

13.92

13.70

nmol/l

0.70

2548

17274

Malignant neoplasm, wide definition

5199

22295

1.39

94.05

2.6

2.4

12.12

14.24

nmol/l

58.39

4727

20629

Solid cancers, including Hilmo

5062

21639

1.40

94.00

2.6

2.4

11.98

14.27

nmol/l

64.93

4590

20014

Anxiety disorders

5614

28846

1.37

93.93

2.7

2.3

12.35

13.24

nmol/l

11.84

5023

26695

Malignant neoplasm, including Hilmo

5193

22287

1.39

93.82

2.6

2.4

12.12

14.24

nmol/l

58.00

4722

20619

Neurological diseases, wide definition

2147

6619

1.70

93.10

2.6

1.9

12.14

13.49

nmol/l

9.87

1964

6199

Other diseases of intestines

6906

29578

1.33

92.60

2.6

2.3

12.60

12.88

nmol/l

1.93

6254

27085

Dorsopathies

6682

25837

1.34

92.42

2.5

2.2

12.63

12.80

nmol/l

0.87

6000

23685

Malignant neoplasm of testis

325

1084

4.96

90.80

4.7

2.5

13.26

15.50

nmol/l

6.98

314

1014

Malignant neoplasm of testis, including Hilmo

343

1171

4.57

90.72

4.7

2.5

13.27

15.48

nmol/l

7.17

331

1095

Other soft tissue disorders, not elsewhere classified

5966

25662

1.36

90.43

2.6

2.2

12.07

12.69

nmol/l

6.36

5323

23415

Other anxiety disorders

2955

17115

1.52

89.58

2.7

2.3

11.40

13.06

nmol/l

20.22

2640

15959

Osteoporosis

901

4054

2.12

89.47

2.3

2.2

12.81

12.45

nmol/l

0.56

771

3594

Any event in cancer register

5326

23194

1.37

88.87

2.6

2.3

11.79

13.77

nmol/l

51.50

4817

21391

Anxiety disorders, excluding more controls

5189

24765

1.38

87.46

2.8

2.2

12.55

13.34

nmol/l

8.99

4634

22975

Benign neoplasms

6921

29244

1.32

86.42

2.8

2.2

12.71

12.94

nmol/l

1.43

6296

26736

Transport accidents

3121

17995

1.49

86.25

2.4

2.2

13.32

12.68

nmol/l

3.97

2829

16591

Excessive, frequent and irregular menstruation

586

1213

2.62

85.09

1.4

1.5

1.27

2.50

nmol/l

14.09

510

1027

Oter anti-inflammatory and antirheumatic agents, non-steroids

1222

3606

1.95

84.99

2.5

2.0

12.63

12.61

nmol/l

0.02

1080

3203

General symptoms and signs

6939

27000

1.32

84.45

2.6

2.2

12.32

13.20

nmol/l

14.11

6256

24822

Special screening examination for infectious and parasitic diseases

2135

10047

1.63

83.24

2.4

2.1

13.79

13.74

nmol/l

0.08

1921

9455

Mouth breathing

3018

21148

1.50

82.85

2.9

2.3

13.33

13.57

nmol/l

0.88

2772

19346

Persons encountering health services in other circumstances, wide

7393

29905

1.30

81.59

2.5

2.3

12.28

13.24

nmol/l

17.90

6683

27284

Shoulder lesions

4723

21036

1.38

81.58

2.7

2.3

13.52

13.16

nmol/l

2.20

4317

19137

GASTRO-related operations

4972

18571

1.38

81.30

2.4

2.2

12.33

13.28

nmol/l

11.45

4483

17298

Any gastric operation

4972

18571

1.38

81.30

2.4

2.2

12.33

13.28

nmol/l

11.45

4483

17298

Other intervertebral disc disorders

5154

23150

1.36

81.05

2.6

2.3

13.02

13.07

nmol/l

0.20

4642

21193

Chronic rhinitis, nasopharyngitis and pharyngitis

1819

11496

1.65

79.58

2.7

2.2

13.24

12.76

nmol/l

1.74

1647

10509

Obesity related asthma

2125

13951

1.59

79.48

3.0

2.3

11.51

13.16

nmol/l

18.89

1900

12714

Pain (limb, back, neck, head abdominally)

5014

18861

1.37

78.42

2.5

2.2

13.13

13.26

nmol/l

0.45

4514

17309

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

2647

8937

1.54

77.10

2.6

2.1

13.15

13.97

nmol/l

5.44

2447

8426

Disorders of skin appendages

2960

20738

1.47

76.65

2.5

2.3

10.83

12.76

nmol/l

24.03

2681

18956

Disturbance of activity and attention

1018

5461

1.96

76.26

2.7

2.2

11.46

11.65

nmol/l

0.25

912

5089

Medical treatment for female infertility

480

1922

2.54

75.86

1.3

1.4

1.29

1.50

nmol/l

1.88

444

1632

Intracranial trauma

3647

17849

1.42

75.22

2.4

2.1

12.91

13.20

nmol/l

1.15

3270

16512

Rotator cuff syndrome

3808

19166

1.41

75.21

2.7

2.3

13.45

13.24

nmol/l

0.82

3480

17405

Abdominal and pelvic pain

6892

27289

1.30

74.97

2.5

2.3

12.95

13.15

nmol/l

1.20

6242

24998

Disease of hard tissues of teeth, NOS

3465

12961

1.45

74.64

2.5

2.2

13.08

13.61

nmol/l

3.06

3086

11939

Liquid cancers, including Hilmo

1872

10655

1.61

73.21

2.6

2.3

10.82

14.88

nmol/l

71.29

1672

9685

Mycoses, including avohilmo

5736

34034

1.31

73.18

2.4

2.3

12.81

12.85

nmol/l

0.15

5195

30995

Acute sinusitis

3116

20259

1.44

72.76

2.6

2.3

13.06

12.85

nmol/l

0.72

2847

18623

Nonorganic sleeping disorders

1361

8223

1.75

72.49

3.0

2.3

12.65

12.50

nmol/l

0.26

1233

7525

Persons encountering health services for other counselling and medical advice, not elsewhere classified

7069

29858

1.28

72.28

2.5

2.3

12.24

13.25

nmol/l

18.34

6455

27248

Propionic acid derivatives

1773

5581

1.66

70.93

2.3

2.0

12.87

12.39

nmol/l

1.30

1607

5061

Other headache syndromes

1892

12304

1.58

70.77

2.6

2.1

11.89

12.62

nmol/l

3.40

1703

11241

First line medication for Crohn's disease

7051

30227

1.28

70.70

2.7

2.2

12.16

13.09

nmol/l

16.75

6385

27663

Artrosis, including avohilmo

5349

22584

1.33

70.40

2.7

2.3

13.10

13.35

nmol/l

1.40

4870

20623

Persons encountering health services for examination and investigation

4343

16285

1.37

69.75

2.5

2.1

13.16

13.39

nmol/l

1.00

3933

15003

Lumbar disc prolapse

3995

22100

1.38

69.45

2.7

2.3

13.06

13.22

nmol/l

0.62

3610

20256

Spondylopathies

4695

21119

1.35

68.91

2.6

2.3

12.93

13.22

nmol/l

1.52

4171

19298

Use of cabergoline

174

435

5.40

68.35

7.0

2.4

11.11

13.13

nmol/l

2.80

168

405

Secondary and unspecified malignant neoplasm of lymph nodes, including Hilmo

917

5068

1.93

67.24

2.5

2.3

9.01

14.92

nmol/l

66.06

818

4588

Hyperkinetic disorders

1052

5919

1.85

67.01

2.7

2.2

11.49

11.69

nmol/l

0.28

944

5505

Diseases of the musculoskeletal system and connective tissue

3663

13458

1.40

66.97

2.5

2.1

12.75

12.78

nmol/l

0.09

3341

12426

Pain and other conditions associated with female genital organs and menstrual cycle

371

1155

2.74

66.36

1.3

1.5

1.55

2.58

nmol/l

3.80

313

979

Testicular dysfunction, other/unspecified

151

394

11.61

66.03

6.4

2.2

13.48

15.41

nmol/l

2.63

151

374

Psychiatric diseases

6072

24013

1.29

65.02

2.6

2.2

12.82

13.15

nmol/l

2.18

5423

22091

Concussion

3131

17683

1.41

64.04

2.4

2.1

12.76

13.22

nmol/l

2.24

2798

16355

Sexual dysfunction

281

1026

3.74

63.48

3.6

2.3

13.95

13.81

nmol/l

0.10

267

952

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

2113

11105

1.51

63.38

2.2

2.0

9.20

10.28

nmol/l

5.74

1905

9794

Arthropathies

5918

23627

1.29

63.26

2.5

2.2

12.79

12.80

nmol/l

0.04

5367

21647

Oxycodone

2271

13452

1.49

63.10

2.6

2.2

8.71

13.67

nmol/l

118.00

1920

12197

Obesity due to excess calories

2639

18860

1.44

63.01

3.1

2.2

8.98

12.80

nmol/l

124.50

2338

17226

Other disorders of adrenal gland

297

1067

3.11

62.66

3.5

2.1

10.59

12.97

nmol/l

3.99

260

964

Hypertrophy of breast in women and men

611

2983

2.12

62.28

2.7

2.1

11.04

10.64

nmol/l

0.49

543

2665

Other specific joint derangements/joint disorders

4744

22878

1.32

62.27

2.6

2.2

12.74

12.80

nmol/l

0.16

4287

20976

Anti-inflammatory and antirheumatic products, non-steroids

1729

5582

1.61

62.25

2.4

2.0

12.97

12.39

nmol/l

1.77

1574

5062

Symptoms and signs involving the digestive system and abdomen

6764

27289

1.27

61.61

2.5

2.3

13.04

13.15

nmol/l

0.48

6104

24998

Obesity and other hyperalimentation

3549

25032

1.37

61.55

3.0

2.2

8.98

12.95

nmol/l

173.21

3165

22877

Obesity

3532

24944

1.37

61.35

3.0

2.2

8.97

12.94

nmol/l

172.98

3153

22798

Polyuria

1448

9294

1.64

60.86

2.6

2.2

13.24

13.07

nmol/l

0.30

1254

8309

Diarrhoea and gastroenteritis of presumed infectious origin, including avohilmo

6138

31548

1.27

60.29

2.5

2.3

12.73

12.85

nmol/l

0.50

5620

28642

Chronic sinusitis

2278

15962

1.47

60.16

2.6

2.2

13.20

12.88

nmol/l

1.17

2067

14580

Other diseases of hard tissues of teeth

3424

13102

1.39

59.96

2.4

2.2

12.77

13.54

nmol/l

5.69

3052

12049

L02BG Aromatase inhibitors

289

1002

2.89

59.86

3.6

1.8

8.68

6.39

nmol/l

2.99

273

856

Other disorders of penis

1087

6667

1.83

59.53

2.8

2.3

14.57

13.96

nmol/l

1.71

975

6127

Other and unspecified tonsillitis

2791

16925

1.43

59.35

2.6

2.3

12.97

13.25

nmol/l

1.13

2626

15795

Paracetamol or NSAID medication

1126

3306

1.79

59.27

2.4

2.0

12.97

13.00

nmol/l

0.04

1042

3043

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

1529

8665

1.61

59.24

2.7

2.2

11.31

11.77

nmol/l

1.12

1362

8074

Metabolic disorders

5717

27332

1.28

58.55

2.8

2.3

12.37

13.43

nmol/l

18.37

5161

25023

Injuries to the head

6758

32550

1.25

58.25

2.4

2.3

13.06

12.71

nmol/l

2.59

6003

29763

Generalized anxiety disorder

955

5549

1.80

58.05

2.8

2.1

11.01

11.55

nmol/l

1.09

862

5158

Pain in joint

3931

18420

1.35

57.56

2.6

2.2

12.78

13.32

nmol/l

3.76

3540

16940

Arthrosis

4429

18755

1.32

57.43

2.7

2.3

12.99

13.42

nmol/l

2.86

4026

17138

Other symptoms and signs involving the urinary system

787

4402

1.94

57.01

2.9

2.3

11.75

13.48

nmol/l

6.19

701

3957

Other nutritional deficiencies

3733

26087

1.34

56.19

3.0

2.2

9.15

12.96

nmol/l

146.64

3340

23825

Diseases of the eye and adnexa

5507

21942

1.29

56.08

2.5

2.3

13.06

12.90

nmol/l

0.66

5015

20266

142

4711

0.27

55.82

2.4

2.3

12.59

13.48

nmol/l

0.84

111

4223

Obesity, other/unspecified

1673

11257

1.53

54.90

2.9

2.2

8.62

12.73

nmol/l

85.67

1509

10268

Other medical care

2619

15985

1.41

54.85

2.4

2.2

8.34

13.31

nmol/l

136.40

2257

14269

Dermatophytosis, including avohilmo

4267

32754

1.31

54.81

2.4

2.3

13.25

13.12

nmol/l

0.48

3884

29855

Injuries to the knee and lower leg

7077

31381

1.24

54.38

2.4

2.3

13.00

12.68

nmol/l

2.40

6419

28517

Examination and observation for other reasons

3749

16170

1.34

53.02

2.6

2.1

12.60

13.39

nmol/l

6.74

3373

14898

Postprocedural endocrine and metabolic disorders, not elsewhere classified

484

2310

2.19

53.01

4.0

2.2

11.49

12.45

nmol/l

1.61

450

2100

Factors influencing health status and contact with health services

2452

8802

1.45

52.88

2.5

2.1

13.69

14.54

nmol/l

5.50

2244

8215

Acute upper respiratory infections

5741

27731

1.26

52.76

2.4

2.2

12.58

12.61

nmol/l

0.08

5165

25056

Disorders of adult personality and behaviour

1801

12471

1.50

52.22

2.9

2.3

11.26

12.77

nmol/l

9.89

1600

11551

Bronchitis

6295

30779

1.25

52.21

2.4

2.3

12.61

12.69

nmol/l

0.30

5688

27928

Unspecified haematuria

2791

16903

1.39

51.66

2.4

2.3

11.38

13.35

nmol/l

22.52

2410

15209

Low back pain

4620

24655

1.29

51.64

2.6

2.2

12.19

12.74

nmol/l

4.49

4132

22578

Gonarthrosis

3770

16383

1.33

50.95

2.6

2.2

12.72

13.42

nmol/l

6.28

3395

14901

Meniscus derangement

3456

17522

1.34

50.89

2.5

2.3

13.45

13.56

nmol/l

0.37

3138

16000

Diseases of the ear and mastoid process

7010

28955

1.23

50.77

2.5

2.3

12.84

12.89

nmol/l

0.15

6358

26512

Myalgia

1145

7215

1.64

50.61

2.6

2.1

11.65

12.31

nmol/l

1.79

1007

6556

Malignant neoplasm of skin, including Hilmo

2456

11915

1.41

50.52

2.2

2.3

12.99

14.91

nmol/l

23.17

2209

10865

Diseases of the skin and subcutaneous tissue

6179

25251

1.25

50.40

2.5

2.3

12.59

13.11

nmol/l

4.81

5596

23083

Artificial joint operation, meniscal resection

5402

27952

1.26

49.24

2.5

2.3

13.31

13.41

nmol/l

0.43

4893

25384

Adrenocortical insufficiency

235

850

3.10

49.17

3.7

2.1

11.74

13.37

nmol/l

1.79

207

765

Acne, including avohilmo

1342

7115

1.59

49.06

2.4

2.2

9.72

11.43

nmol/l

8.63

1209

6567

Antihypertensive medication - note that there are other indications

3846

15547

1.32

49.02

2.6

2.1

11.42

13.44

nmol/l

39.10

3519

14483

Irritable bowel syndrome

1193

7644

1.61

48.82

2.9

2.1

12.01

12.14

nmol/l

0.19

1076

6958

Other metabolic disorders

534

2734

2.04

48.35

3.9

2.2

11.82

12.61

nmol/l

1.23

495

2490

Gastro-oesophageal reflux disease

3918

25980

1.30

47.58

2.6

2.3

13.11

12.97

nmol/l

0.49

3483

23638

Thyrotropin deficiency

113

265

5.43

47.39

5.7

2.3

11.20

12.84

nmol/l

1.20

104

253

Other reaction to severe stress, and adjustment disorders

1935

13761

1.45

47.29

2.7

2.2

12.06

12.83

nmol/l

3.33

1731

12792

Malignant neoplasm of skin

2271

11121

1.41

47.11

2.2

2.3

12.93

14.93

nmol/l

23.71

2032

10114

Other endocrine disorders

316

1289

2.57

46.73

3.2

2.0

9.99

12.36

nmol/l

4.37

281

1161

Pain, not elsewhere classified

1516

10343

1.51

46.70

2.7

2.2

11.93

12.93

nmol/l

4.96

1367

9455

Intestinal infectious diseases

5602

34075

1.24

46.62

2.5

2.3

12.70

12.80

nmol/l

0.36

5083

30991

Visual disturbances

2464

18312

1.38

46.18

2.7

2.2

12.42

12.49

nmol/l

0.15

2226

16514

Visual disturbances and blindness

2626

19674

1.37

46.17

2.7

2.2

12.39

12.48

nmol/l

0.21

2359

17714

Abnormalities of heart beat

1775

12095

1.46

46.13

2.5

2.1

12.22

12.36

nmol/l

0.25

1576

10897

Basal cell carcinoma, including Hilmo

1982

9521

1.44

46.04

2.2

2.3

13.16

15.00

nmol/l

16.68

1762

8603

Diarrhoea and gastroenteritis of presumed infectious origin

4275

30470

1.28

45.96

2.6

2.3

12.91

12.83

nmol/l

0.26

3902

27832

Other diseases of anus and rectum

1555

10658

1.50

45.80

2.4

2.2

11.07

12.78

nmol/l

11.49

1356

9585

Basal cell carcinoma

1874

8991

1.46

45.58

2.2

12.98

15.05

nmol/l

20.14

1657

8106

Panic disorder

846

5103

1.74

45.30

2.7

2.1

10.94

12.10

nmol/l

3.57

760

4743

Vasomotor and allergic rhinitis

2023

14280

1.42

45.17

2.6

2.2

12.66

12.62

nmol/l

0.07

1874

13153

Lower back pain or/and sciatica

6351

32732

1.23

44.92

2.6

2.3

12.38

12.85

nmol/l

4.58

5679

29838

ILD medications

6926

31165

1.22

44.52

2.5

2.3

12.27

13.00

nmol/l

10.81

6273

28477

ILD medications: prednisolone, methylprednisolone, prednisone

6598

30534

1.22

43.96

2.6

2.3

12.16

13.01

nmol/l

13.56

5943

27888

Monoamine oxidase A inhibitors

616

3440

1.89

43.59

2.9

2.1

13.16

13.41

nmol/l

0.32

549

3142

Diseases of oral cavity, salivary glands and jaws

3313

13152

1.33

43.35

2.4

2.2

12.58

13.50

nmol/l

7.48

2955

12089

Restless leg syndrome

670

3840

1.83

43.07

3.0

2.3

12.82

12.84

nmol/l

0.02

611

3463

Inguinal hernia

4913

26673

1.26

42.81

2.3

2.4

14.18

13.74

nmol/l

3.37

4477

24442

Temporomandibular joint disorders, including avohilmo

1804

12460

1.43

42.71

2.4

2.1

11.43

11.22

nmol/l

0.45

1636

11316

Osteopathies and chondropathies

2795

19535

1.34

42.27

2.5

2.3

12.33

12.92

nmol/l

3.18

2478

17792

Gastrointestinal diseases

3604

14110

1.31

42.20

2.4

2.1

12.56

12.80

nmol/l

0.90

3284

13029

Schizophrenia

467

8562

0.52

41.93

2.2

2.4

11.22

14.30

nmol/l

14.80

401

7975

Pure hypercholesterolaemia

4516

23160

1.26

41.91

2.6

2.3

12.50

13.74

nmol/l

20.61

4050

21169

Procreative management

2218

13560

1.39

41.81

2.6

2.4

12.88

13.77

nmol/l

5.78

2112

12570

Malaise and fatigue

2819

16973

1.34

41.77

2.6

2.2

11.41

12.87

nmol/l

15.60

2467

15370

Internal derangement of knee

2302

17052

1.38

41.75

2.6

2.2

13.36

13.30

nmol/l

0.13

2058

15600

Migraine

2073

11761

1.40

41.58

2.3

2.0

10.67

12.16

nmol/l

10.03

1892

10811

Phobic anxiety disorders

853

5282

1.69

41.18

2.8

2.2

11.28

12.59

nmol/l

4.39

754

4950

Medicines for HER+ breast cancer

342

1441

2.23

41.14

3.6

1.8

9.27

6.69

nmol/l

4.24

321

1230

Disorders of lipoprotein metabolism and other lipidaemias

4965

24671

1.25

40.88

2.7

2.3

12.55

13.75

nmol/l

21.46

4482

22590

Redundant prepuce, phimosis and paraphimosis

2252

16797

1.40

40.82

2.7

2.4

13.95

14.40

nmol/l

2.04

2055

15632

Other disorders of male genital organs

489

2690

2.14

40.73

3.1

2.3

14.37

14.51

nmol/l

0.16

460

2495

Other malignant neoplasms of skin (=non-melanoma skin cancer), including Hilmo

2049

10096

1.40

40.20

2.2

2.3

13.19

15.01

nmol/l

17.26

1833

9150

Pain in limb

4733

24507

1.25

40.07

2.6

2.2

11.90

12.58

nmol/l

6.37

4225

22327

Sulfonylureas

857

10712

0.62

40.06

2.5

2.1

9.75

13.15

nmol/l

31.01

697

9400

Intestinal infectious diseases, including avohilmo, including avohilmo

6685

31296

1.21

39.99

2.5

2.3

12.68

12.84

nmol/l

0.83

6077

28409

Injury of muscle and tendon at shoulder and upper arm level

2531

19406

1.35

39.97

2.6

2.3

13.68

13.55

nmol/l

0.39

2340

17618

Benzodiazepine use

5849

32911

1.22

39.63

2.8

2.2

12.27

12.89

nmol/l

6.45

5085

30112

Personality disorders, excluding more controls

1519

10701

1.47

39.43

2.9

2.2

11.14

13.10

nmol/l

14.52

1334

10022

Other malignant neoplasms of skin (=non-melanoma skin cancer)

1923

9464

1.41

39.40

2.2

2.3

13.16

15.00

nmol/l

17.08

1715

8550

Any operation in hilmo

385

919

2.29

39.38

2.4

1.7

14.33

15.80

nmol/l

2.81

367

893

Gingivitis and periodontal diseases

5860

25155

1.22

39.34

2.4

2.3

12.41

13.18

nmol/l

9.54

5213

23058

Disorders of puberty

132

396

3.94

38.73

3.7

1.8

7.06

12.64

nmol/l

10.34

124

368

Disorders of puberty, all

156

521

3.55

38.71

3.7

2.0

7.26

11.08

nmol/l

6.08

144

484

Infections with a predominantly sexual mode of transmission, including avohilmo

2117

14436

1.38

38.55

2.4

2.2

12.73

12.20

nmol/l

1.91

1906

13353

Malignant melanoma, including Hilmo

792

4893

1.68

38.42

2.2

2.3

11.87

14.88

nmol/l

18.75

706

4389

Other disorders of lacrimal gland

1390

9674

1.47

38.08

2.7

2.2

12.82

12.34

nmol/l

1.20

1225

8714

Malignant melanoma

720

4355

1.73

38.06

2.2

2.3

11.71

14.85

nmol/l

18.56

640

3913

Fever of other and unknown origin

3263

22354

1.29

37.94

2.5

2.2

11.55

13.10

nmol/l

20.75

2898

20430

Other sleep disorders

707

4288

1.74

37.74

2.9

2.0

12.20

13.55

nmol/l

4.38

641

3885

COPD, early/later onset

1460

17154

0.69

37.74

2.3

11.82

12.84

nmol/l

4.52

1197

15195

Dental operations

3567

14531

1.29

37.72

2.4

2.2

12.53

13.58

nmol/l

10.62

3198

13303

Spondylosis

2932

17868

1.31

37.72

2.7

2.3

13.19

13.29

nmol/l

0.27

2596

16264

Fall on same level

6962

31483

1.20

37.38

2.4

2.3

12.74

12.85

nmol/l

0.49

6218

28863

Diseases of oesophagus, stomach and duodenum

6181

30698

1.21

37.17

2.6

2.3

12.99

12.89

nmol/l

0.45

5532

28032

All-cause Heart Failure

1999

18550

0.73

37.09

2.4

2.3

10.91

13.27

nmol/l

28.70

1690

16559

COPD related to multimorbidity

1206

14699

0.67

37.05

2.4

2.2

11.38

12.63

nmol/l

5.59

973

12938

COPD, hospital admissions 1, only main diagnosis

958

12405

0.64

36.98

2.3

2.2

11.85

12.49

nmol/l

1.39

782

10891

Migraine without aura

746

4563

1.68

36.91

2.4

1.9

9.85

10.37

nmol/l

0.83

672

4167

Heart failure, strict

2051

18920

0.74

36.72

2.4

2.3

10.92

13.29

nmol/l

29.66

1736

16911

Hyperhidrosis

191

721

2.90

36.55

2.4

2.1

10.73

11.81

nmol/l

0.92

164

662

Any mental disorder

6404

27042

1.20

36.52

2.6

2.2

12.53

13.15

nmol/l

6.84

5679

24853

COPD, hospital admissions

1448

17002

0.70

36.48

2.3

11.79

12.83

nmol/l

4.57

1189

15052

Social phobias

597

3496

1.82

36.47

2.8

2.2

11.82

12.83

nmol/l

2.05

532

3283

Status post-ami

845

9858

0.63

36.40

2.4

2.2

11.32

13.07

nmol/l

7.40

704

8703

Erectile dysfunction

688

4254

1.79

36.38

2.5

2.3

12.60

13.05

nmol/l

0.56

596

3743

Disorders of lacrimal system

1668

11875

1.41

36.36

2.7

2.2

12.80

12.21

nmol/l

1.97

1473

10674

Enthesopathies of lower limb, excluding foot

1187

8130

1.51

36.14

2.6

2.3

13.59

13.29

nmol/l

0.52

1075

7521

COPD, hospital admission 2, with asthma infections

935

12118

0.64

36.08

2.4

2.3

11.70

12.57

nmol/l

2.19

756

10703

Other arthrosis

3077

16238

1.30

35.97

2.7

2.2

13.37

13.53

nmol/l

0.55

2794

14796

Asthma, excluding more controls

4424

18529

1.25

35.88

2.6

2.2

12.36

13.26

nmol/l

10.37

4013

17154

Haemorrhoids and perianal venous thrombosis

1702

12353

1.40

35.54

2.5

2.2

13.23

12.88

nmol/l

0.95

1526

11133

Migraine with aura

901

5829

1.58

35.13

2.3

1.9

10.94

10.89

nmol/l

0.05

834

5312

Other extrapyramidal and movement disorders in other diseases

1143

7812

1.51

35.13

2.9

2.2

12.83

12.75

nmol/l

0.11

1017

6978

Other functional intestinal disorders

2129

14608

1.35

35.07

2.5

2.2

11.65

12.27

nmol/l

2.53

1899

13101

Gonarthrosis [arthrosis of knee](FG)

4323

20351

1.24

34.93

2.6

2.3

12.70

13.52

nmol/l

9.61

3889

18515

Squamous cell neoplasms and carcinomas of the skin, including Hilmo

466

2520

1.90

34.65

2.4

2.2

11.84

15.13

nmol/l

11.81

412

2190

COPD, hospital admissions 3, with asthma pneumonia sepsis

724

9768

0.61

34.50

2.3

2.2

11.53

12.36

nmol/l

1.61

576

8579

Heart failure,strict

1935

17887

0.74

34.39

2.4

2.3

10.96

13.57

nmol/l

34.20

1647

16114

Benign neoplasm of colon, rectum, anus and anal canal

3280

22201

1.27

34.31

2.5

2.3

12.43

13.14

nmol/l

4.71

2872

19952

Certain infectious and parasitic diseases, including avohilmo

4131

16832

1.25

34.24

2.4

2.2

12.82

13.06

nmol/l

1.01

3751

15402

Asthma

4526

19185

1.24

34.17

2.6

2.2

12.38

13.20

nmol/l

8.73

4096

17720

Tinnitus

1237

8644

1.48

34.17

2.5

2.3

13.58

13.25

nmol/l

0.76

1120

7826

Other sex chromosome abnormalities, male phenotype, not elsewhere classified

239

8.92

34.10

6.5

2.6

13.27

15.86

nmol/l

2.78

232

Continuous positive airway pressure

1330

7845

1.48

34.00

3.0

2.1

12.35

14.67

nmol/l

24.20

1160

7349

Complications associated with artificial fertilization

6.75

33.27

1.5

1.3

1.43

1.93

nmol/l

0.63

Sciatica+with lumbago

2804

19605

1.29

33.20

2.6

2.2

12.41

13.07

nmol/l

4.12

2502

17975

Somatoform disorder

731

4590

1.65

33.18

2.7

2.2

11.85

12.71

nmol/l

1.82

653

4202

Persistent mood disorders

934

6206

1.56

33.06

2.8

2.2

12.07

13.10

nmol/l

3.05

828

5679

Malignant melanoma of skin, including Hilmo

667

4107

1.69

32.98

2.2

2.3

11.88

14.80

nmol/l

14.64

599

3692

Cardiovascular diseases

3846

16581

1.25

32.91

2.5

2.1

12.28

13.12

nmol/l

7.56

3540

15455

Seborrhoeic keratosis

1101

7569

1.50

32.76

2.4

2.2

13.99

12.79

nmol/l

5.02

1022

6697

Symptoms and signs involving the skin and subcutaneous tissue

3688

28456

1.24

32.18

2.4

2.3

12.46

12.58

nmol/l

0.38

3314

25690

Atherosclerosis, excluding cerebral and coronary sclerosis

1245

13696

0.70

32.01

2.1

2.3

11.22

12.67

nmol/l

6.94

1008

12050

Voice disturbances

1038

7077

1.51

32.00

2.4

2.2

12.53

12.34

nmol/l

0.30

926

6301

Excessive attrition of teeth

3383

27175

1.26

31.98

2.5

2.3

12.43

12.77

nmol/l

1.58

3021

24895

KRA_PSY_EATING, excluding more controls

310

1504

2.12

31.80

1.9

1.6

6.37

6.55

nmol/l

0.11

266

1371

2377

18393

1.31

31.64

2.7

2.3

12.04

12.83

nmol/l

4.86

2158

16853

Statin medication

3862

17763

1.25

31.51

2.6

2.2

12.56

13.90

nmol/l

20.30

3544

16397

Asthma (mode)

4441

19304

1.23

31.45

2.6

2.2

12.35

13.20

nmol/l

9.19

4020

17824

Other/unspecified dorsalgia

1787

13256

1.36

31.16

2.6

2.2

12.23

12.63

nmol/l

1.22

1581

12146

Bipolar affective disorders

1055

7297

1.50

30.91

3.0

2.2

11.46

13.00

nmol/l

8.09

935

6759

Disturbances of skin sensation

1323

9518

1.43

30.68

2.5

2.3

12.21

12.53

nmol/l

0.72

1189

8653

Liquid cancers

1307

8865

1.43

30.61

2.6

2.3

12.39

14.87

nmol/l

22.95

1180

8041

Other external causes of accidental injury

4468

18569

1.22

30.45

2.3

2.2

12.64

12.57

nmol/l

0.23

3993

17053

Myocardial infarction, unclassifiable

470

7121

0.57

30.42

2.2

10.57

12.10

nmol/l

3.64

395

6184

Inflammatory bowel disease treatment related agents

6745

32212

1.18

30.37

2.5

2.3

12.23

12.98

nmol/l

10.82

6084

29405

Heart failure and coronary heart disease

1438

13668

0.72

30.27

2.4

2.3

11.09

13.36

nmol/l

20.05

1219

12169

Chronic diseases of tonsils and adenoids

4427

23258

1.22

30.23

2.5

2.3

12.93

12.99

nmol/l

0.18

4085

21411

Subjective visual disturbances

1142

8030

1.46

30.15

2.6

2.2

12.38

12.56

nmol/l

0.32

1027

7231

Acne

682

4311

1.65

30.12

2.6

2.2

10.42

11.85

nmol/l

3.61

619

3988

Fissure and fistula of anal and rectal regions

1383

10082

1.42

30.05

2.5

2.2

13.07

13.31

nmol/l

0.51

1242

9204

Peripheral artery disease

1399

15025

0.72

29.96

2.2

2.3

11.35

12.84

nmol/l

8.28

1153

13282

Certain infectious and parasitic diseases

5573

23666

1.20

29.87

2.4

2.2

12.35

12.97

nmol/l

5.95

5056

21693

Other disorders of prostate

315

1638

2.17

29.85

2.6

2.2

12.41

13.27

nmol/l

0.57

272

1454

Other disorders of ear

5032

27436

1.20

29.79

2.5

2.3

13.02

12.98

nmol/l

0.12

4539

24952

Spinal stenosis

2551

14832

1.29

29.75

2.6

2.2

12.50

13.11

nmol/l

3.34

2234

13370

Squamous cell neoplasms and carcinomas of the skin

365

1942

1.95

29.64

2.2

11.76

15.07

nmol/l

9.71

322

1678

Accidents

4454

18569

1.22

29.39

2.3

2.2

12.58

12.57

nmol/l

0.03

3975

17053

Malignant melanoma of skin

561

3416

1.72

29.15

2.1

2.3

11.75

14.82

nmol/l

13.41

500

3069

Adenomyosis (Endometriosis of uterus)

106

318

3.37

29.01

1.5

1.4

1.16

1.57

nmol/l

1.26

263

Diseases of external ear

1934

14893

1.33

28.86

2.5

2.3

12.42

12.76

nmol/l

0.96

1679

13483

Short stature, not elsewhere classified

138

462

3.09

28.65

2.8

1.9

8.27

11.19

nmol/l

3.26

131

420

Other chronic obstructive pulmonary disease

1445

15881

0.73

28.64

2.3

11.89

12.90

nmol/l

4.36

1188

14155

Diverticular disease of intestine

3787

19449

1.23

28.57

2.5

2.3

12.58

13.39

nmol/l

7.92

3374

17649

Persons encountering health services for specific procedures and health care

6194

31445

1.18

28.52

2.6

2.3

11.53

13.22

nmol/l

45.86

5572

28772

Hernia of abdominal wall, postoperative

1067

7460

1.47

28.35

2.8

2.2

12.26

14.08

nmol/l

11.47

958

6878

Anaemias

1204

5477

1.45

28.17

2.7

1.8

11.63

14.44

nmol/l

25.51

1110

5249

Any reimbursement code in KELA

3647

15014

1.24

27.84

2.6

2.0

11.90

14.22

nmol/l

50.11

3326

14146

Other disorders of patella

875

5958

1.52

27.70

2.6

2.2

13.03

13.17

nmol/l

0.16

793

5528

Corticotropin deficiency

232

4.47

27.69

4.2

2.4

12.52

13.52

nmol/l

0.44

218

Symptoms and signs involving speech and voice

1334

9766

1.40

27.62

2.4

2.2

12.64

12.37

nmol/l

0.53

1178

8697

Disorders of refraction and accommodation

1469

10907

1.38

27.45

2.4

2.3

12.63

12.47

nmol/l

0.30

1333

9990

Viral hepatitis, IBD co-morbidity

429

2495

1.85

27.43

2.9

2.0

13.39

15.18

nmol/l

3.79

366

2362

Melanocytic naevi

1477

11014

1.37

27.42

2.4

2.2

12.77

12.35

nmol/l

1.13

1382

9951

Symptoms and signs involving the nervous and musculoskeletal systems

2850

23086

1.26

27.39

2.7

2.3

12.08

12.55

nmol/l

2.38

2552

20755

Stroke, including SAH

2255

20429

0.78

27.38

2.3

12.27

13.23

nmol/l

5.78

1927

18386

Pain in thoracic spine

714

4670

1.58

27.26

2.6

2.2

12.66

13.19

nmol/l

1.02

658

4297

Diabetes insipidus

229

4.36

27.15

4.9

2.1

13.92

14.02

nmol/l

0.03

214

Infections with a predominantly sexual mode of transmission

1446

10738

1.38

27.11

2.4

2.3

12.77

12.08

nmol/l

2.22

1288

9893

Nerve, nerve root and plexus disorders

6010

31122

1.17

26.96

2.6

2.3

12.51

13.00

nmol/l

4.69

5360

28335

Disorders of ocular muscles, binocular movement, accommodation and refraction

2481

19670

1.27

26.87

2.4

2.3

12.47

12.52

nmol/l

0.10

2240

17962

6022

26268

1.18

26.77

2.4

2.2

12.42

12.67

nmol/l

1.34

5400

23783

Stroke, excluding SAH

2106

19287

0.77

26.76

2.3

12.18

13.17

nmol/l

5.83

1796

17298

Cervical disc disorders

1873

14506

1.32

26.69

2.6

2.3

13.44

13.35

nmol/l

0.19

1685

13246

Viral warts, including avohilmo

1257

9208

1.41

26.64

2.5

2.3

13.25

12.77

nmol/l

1.30

1167

8433

Cervicalgia

928

6427

1.49

26.64

2.8

2.2

12.74

13.06

nmol/l

0.55

833

5886

Cough

1926

13929

1.31

26.62

2.6

2.1

12.52

12.57

nmol/l

0.09

1728

12607

Headache

3622

23215

1.22

26.57

2.6

2.2

11.93

13.05

nmol/l

12.84

3253

21361

Other inflammation of eyelid, including avohilmo

2139

16834

1.29

26.48

2.4

2.3

13.04

12.26

nmol/l

4.25

1951

15400

Spermatocele

661

4358

1.64

26.39

2.4

2.2

14.21

13.56

nmol/l

1.46

610

3931

Mental and behavioural disorders due to opioids

354

1994

1.99

26.32

3.9

2.5

12.21

14.40

nmol/l

4.44

302

1885

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

2195

16579

1.29

26.18

2.6

2.3

12.50

12.23

nmol/l

0.76

2006

15205

Myocardial infarction, strict

1858

16862

0.76

26.17

2.3

12.39

13.70

nmol/l

10.29

1642

15262

Finngen Rheumatological endpoints

5711

27898

1.18

26.12

2.5

2.3

12.64

12.94

nmol/l

2.00

5166

25512

Post-traumatic stress disorder

391

2220

1.84

26.08

2.6

1.9

9.41

10.00

nmol/l

0.63

349

2044

Other pulmonary diagnosis

4589

19410

1.20

26.04

2.5

2.2

12.90

13.21

nmol/l

1.62

4152

17929

Allergic conjunctivitis

2301

17578

1.28

25.95

2.6

2.3

12.53

12.23

nmol/l

0.94

2101

16100

Use of pramipexole

898

6216

1.49

25.92

2.8

2.2

12.93

13.00

nmol/l

0.07

796

5536

COPD

1546

16455

0.75

25.79

2.3

11.97

12.95

nmol/l

4.24

1271

14699

Impingement syndrome of shoulder

1263

9320

1.40

25.54

2.6

2.2

14.03

13.46

nmol/l

1.65

1134

8490

Blepharochalasis

951

6663

1.46

25.34

2.4

2.2

12.91

12.44

nmol/l

0.98

828

5882

Persons with potential health hazards related to communicable diseases

2067

16169

1.30

25.31

2.4

2.3

12.58

12.32

nmol/l

0.73

1881

14898

Benign neoplasm: Colon

2695

20545

1.25

25.26

2.5

2.3

12.27

13.08

nmol/l

5.46

2354

18358

Later onset COPD

684

8195

0.65

25.05

1.9

2.1

10.88

11.55

nmol/l

1.01

526

6975

Fibromyalgia

224

1061

2.17

25.02

2.2

1.9

8.50

9.53

nmol/l

0.95

188

942

Persons encountering health services in other circumstances

2165

17021

1.28

24.90

2.6

2.2

11.49

12.82

nmol/l

10.20

1876

15488

Acne vulgaris

544

3431

1.67

24.89

2.6

2.2

10.58

12.17

nmol/l

3.49

492

3188

Gonarthrosis,primary

4607

23614

1.19

24.87

2.6

2.3

12.54

13.31

nmol/l

8.99

4111

21324

Skin changes due to chronic exposure to nonionizing radiation

1541

10588

1.34

24.79

2.3

2.2

12.86

12.02

nmol/l

2.98

1338

9112

Migraine without aura and triptan purchases

551

3473

1.63

24.37

2.4

2.0

9.53

9.44

nmol/l

0.08

490

3131

Personality disorders

1519

11607

1.35

24.23

2.9

2.3

11.14

12.80

nmol/l

10.77

1334

10747

Dentofacial anomalies [including malocclusion]

3516

22975

1.21

24.08

2.5

2.3

12.51

12.89

nmol/l

1.66

3203

21173

Injuries to the abdomen, lower back, lumbar spine and pelvis

2139

16803

1.28

24.05

2.4

2.3

12.74

12.79

nmol/l

0.09

1875

15259

Diaphragmatic hernia

1470

11164

1.34

23.96

2.6

2.3

12.73

12.79

nmol/l

0.11

1313

9981

Chronic apical periodontitis

6337

31004

1.16

23.95

2.5

2.3

12.44

12.90

nmol/l

3.86

5557

28443

Myocardial infarction

1988

17484

0.78

23.92

2.3

12.43

13.72

nmol/l

10.98

1755

15856

Constipation

4546

26292

1.19

23.61

2.6

2.3

12.04

12.80

nmol/l

6.79

3933

23816

Actinic keratosis

1498

10376

1.34

23.60

2.3

2.2

12.86

12.01

nmol/l

2.97

1300

8917

Dysphagia

1183

8732

1.39

23.57

2.5

2.2

12.83

12.66

nmol/l

0.28

1024

7830

Diseases of pulp and periapical tissues, including avohilmo

5874

26396

1.16

23.24

2.4

2.2

12.01

12.89

nmol/l

11.48

5194

24230

Ischaemic Stroke, excluding all haemorrhages

1937

17958

0.78

23.21

2.3

12.18

13.07

nmol/l

4.44

1642

16036

Contact with and exposure to communicable diseases

1604

12346

1.32

23.17

2.4

2.3

12.47

11.93

nmol/l

1.74

1459

11369

Primary amenorrhea

5.93

23.03

1.4

1.22

1.85

nmol/l

1.22

661

4417

1.55

22.98

2.5

2.2

11.27

12.81

nmol/l

5.08

591

4044

Falls/tendency to fall

6274

27451

1.16

22.96

2.3

12.55

12.84

nmol/l

1.78

5606

25222

Heart failure and bmi 25plus

1186

10588

0.73

22.91

2.5

2.4

10.43

12.63

nmol/l

15.86

1003

9443

Excluding asthma or asthma-COPD overlap

4542

19410

1.19

22.87

2.5

2.2

12.90

13.21

nmol/l

1.61

4100

17929

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2865

23192

1.23

22.85

2.6

2.2

11.82

12.66

nmol/l

6.33

2560

20793

Follow-up examination after treatment for malignant neoplasms

388

2286

1.76

22.65

2.4

2.0

9.66

12.40

nmol/l

7.01

327

2034

Anogenital herpesviral [herpes simplex] infection, including avohilmo

519

3301

1.63

22.62

2.5

2.1

12.20

10.56

nmol/l

3.30

456

3021

COPD differential diagnosis

4515

19314

1.19

22.49

2.5

2.2

12.89

13.20

nmol/l

1.63

4082

17832

Other enthesopathies

1341

10148

1.35

22.46

2.8

2.2

13.03

13.16

nmol/l

0.25

1222

9290

ILD differential diagnosis

4512

19304

1.19

22.41

2.5

2.2

12.89

13.20

nmol/l

1.57

4078

17824

Premenstrual syndrome

6.02

22.21

1.3

1.4

1.16

2.28

nmol/l

1.62

Asthma-related infections

3008

24407

1.22

22.09

2.6

2.3

11.99

12.69

nmol/l

4.78

2704

22173

Asthma, hospital admission 2, infections

3008

24407

1.22

22.09

2.6

2.3

11.99

12.69

nmol/l

4.78

2704

22173

Specific personality disorders

1253

9440

1.36

22.09

2.9

2.3

11.05

12.58

nmol/l

7.39

1106

8716

Excessive earwax

3477

26572

1.20

22.08

2.4

2.3

13.05

13.03

nmol/l

0.05

3139

23981

1621

11345

1.31

21.73

2.3

2.2

12.88

12.10

nmol/l

2.86

1412

9804

Infections, IBD-co-morbidities

839

4131

1.47

21.73

2.5

1.9

12.57

14.08

nmol/l

5.44

760

3848

Other symptoms and signs involving the digestive system and abdomen

491

3094

1.62

21.71

2.8

2.2

11.73

nmol/l

0.00

431

2797

Orchitis and epididymitis

815

5828

1.49

21.47

2.7

2.3

13.32

13.92

nmol/l

1.50

729

5323

Hypertension, essential

4442

21536

1.18

21.46

2.8

2.3

12.19

14.15

nmol/l

52.30

4035

19899

Diseases of pulp and periapical tissues and dental caries

3550

15300

1.21

21.39

2.4

2.2

12.48

13.25

nmol/l

5.72

3160

14098

Allergic rhinitis

1540

11823

1.31

21.27

2.6

2.3

12.49

12.40

nmol/l

0.17

1424

10861

Emotionally unstable personality disorder

584

3873

1.56

21.17

2.6

2.2

9.63

11.29

nmol/l

4.04

511

3569

Deforming dorsopathies

1200

9014

1.36

21.14

2.7

2.2

12.76

12.74

nmol/l

0.02

1057

8284

Pain associated with micturition

497

3178

1.62

21.13

2.4

2.2

12.23

12.61

nmol/l

0.42

425

2852

Cardiac arrhythmias

3349

18035

1.21

21.12

2.6

2.2

13.00

13.80

nmol/l

7.00

3039

16802

Other chronic obstructive pulmonary disease, including avohilmo

1988

20229

0.79

20.97

2.4

2.3

12.13

13.07

nmol/l

5.12

1646

18126

Other symptoms and signs involving the nervous and musculoskeletal systems

1940

15540

1.27

20.88

2.7

2.3

12.04

12.55

nmol/l

2.08

1771

14053

Retention of urine

2061

13435

1.27

20.86

2.4

2.2

10.61

13.06

nmol/l

27.42

1738

11950

Sleep disorders, other/unspecified

213

1082

2.12

20.74

2.9

2.1

13.01

12.56

nmol/l

0.28

190

1002

Colonic or urogenital fistula

1430

11078

1.33

20.71

2.5

2.3

12.97

13.23

nmol/l

0.59

1283

10061

Influenza and pneumonia

5992

32505

1.15

20.59

2.5

2.3

12.32

12.99

nmol/l

7.98

5391

29773

Other predominantly sexually transmitted diseases, not elsewhere classified, including avohilmo

1002

7386

1.39

20.31

2.4

2.2

12.84

11.85

nmol/l

2.94

906

6819

Diseases of appendix

4251

32794

1.17

20.27

2.4

2.3

13.16

13.06

nmol/l

0.36

3931

29876

Dental caries, including avohilmo

3953

17250

1.19

20.22

2.4

2.2

12.53

13.25

nmol/l

5.70

3504

15870

Other disorders of bladder

717

5029

1.49

20.14

2.5

2.2

13.10

13.07

nmol/l

0.03

600

4488

Appendicitis, broad definition

4228

32739

1.17

20.14

2.4

2.3

13.16

13.06

nmol/l

0.35

3909

29827

Any dementia

891

8467

0.72

19.99

2.0

2.2

11.04

11.68

nmol/l

1.24

738

7229

Secondary polycythaemia

203

1048

2.19

19.87

5.2

2.4

14.11

13.70

nmol/l

0.26

186

960

Chronic laryngitis and laryngotracheitis

599

4045

1.53

19.85

2.4

2.2

13.20

12.77

nmol/l

0.60

495

3624

Functional dyspepsia

1067

7956

1.37

19.81

2.4

2.2

12.22

12.54

nmol/l

0.61

957

7208

Migraine with aura and triptan purchases

511

3326

1.57

19.76

2.2

2.0

9.77

9.19

nmol/l

0.73

475

2993

Ovarian hyperstimulation (induction)

127

4.33

19.71

1.5

1.4

1.46

1.61

nmol/l

0.20

114

Haemorrhage from respiratory passages

1846

13100

1.27

19.59

2.5

2.2

12.49

13.09

nmol/l

2.21

1602

11805

Unspecified/other endometriosis

122

483

2.51

19.58

1.3

1.4

1.21

2.17

nmol/l

4.58

403

Major coronary heart disease event excluding revascularizations

2477

19702

0.82

19.50

2.4

2.3

12.59

13.72

nmol/l

10.45

2200

17884

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

1951

15823

1.27

19.49

2.6

2.4

14.03

13.71

nmol/l

0.96

1784

14551

Other and unspecified disorders of vitreous body

1556

11958

1.29

19.48

2.4

2.2

13.57

12.74

nmol/l

3.64

1385

10622

Endometriosis

298

951

1.83

19.33

1.4

1.24

2.30

nmol/l

7.32

252

794

Obsessive-compulsive disorder

394

2449

1.69

19.26

2.8

2.1

10.24

12.12

nmol/l

4.06

358

2291

Candidiasis, including avohilmo

1129

8524

1.35

19.20

2.5

2.2

10.75

11.43

nmol/l

1.81

995

7641

Soft tissue disorders related to use, overuse and pressure

1295

9991

1.32

19.10

2.6

2.2

13.62

13.20

nmol/l

0.90

1167

9119

Other problems related to primary support group, including family circumstances

489

3101

1.59

19.08

2.7

2.2

9.46

10.99

nmol/l

3.06

438

2849

Cardiovascular diseases (excluding rheumatic etc)

3784

18516

1.19

19.04

2.6

2.2

12.28

13.36

nmol/l

12.77

3486

17251

Any dementia, excluding more controls

842

7947

0.71

19.00

2.1

11.24

11.87

nmol/l

1.16

698

6841

Open wound of wrist and hand

3297

27195

1.20

18.92

2.4

13.34

13.39

nmol/l

0.15

2977

25022

Acute appendicitis

4002

32097

1.17

18.86

2.4

2.3

13.14

13.10

nmol/l

0.13

3708

29264

Caries of dentine, including avohilmo

4242

18690

1.17

18.85

2.4

2.2

12.41

13.17

nmol/l

6.69

3766

17195

Hypertensive diseases (excluding secondary)

3089

15144

1.21

18.77

2.8

2.2

12.18

14.21

nmol/l

40.06

2836

14143

Routine general health check-up of defined subpopulation

100

382

2.80

18.73

2.8

1.9

13.43

12.49

nmol/l

0.50

356

Menorrhagia

260

767

1.90

18.70

1.5

1.4

1.11

1.90

nmol/l

5.90

214

637

Chronic periodontitis, including avohilmo

5537

31122

1.15

18.70

2.4

2.3

12.57

13.26

nmol/l

7.60

4856

28496

Osteoporosis with pathological fracture (FG)

338

2.80

18.60

2.3

9.31

11.43

nmol/l

1.50

294

Other adrenocortical overactivity

5.40

18.59

3.2

1.9

4.41

8.97

nmol/l

2.60

Retinal breaks without detachment

772

5546

1.44

18.59

2.3

13.52

13.32

nmol/l

0.28

710

4989

Non-selective monoamine reuptake inhibitors

1379

10302

1.30

18.53

2.9

2.1

12.43

13.03

nmol/l

2.01

1196

9385

Dysplasia of cervi uteri

231

847

1.93

18.35

1.4

1.48

2.08

nmol/l

2.56

207

706

Conductive and sensorineural hearing loss

4016

23010

1.17

18.31

2.4

2.3

12.93

13.07

nmol/l

0.46

3582

20832

Emotional disorders starting during childhood or adolecense, excluding more controls

244

1303

1.91

18.30

2.6

1.9

8.59

10.28

nmol/l

1.89

211

1214

Vocal cord dysfunction

678

4178

1.47

18.30

2.5

2.0

12.28

14.10

nmol/l

6.13

579

3889

Wide developmental disorders, excluding more controls

232

1239

1.97

18.29

2.4

2.1

10.42

13.34

nmol/l

4.28

201

1178

Viral infections characterized by skin and mucous membrane lesions, including avohilmo

5024

34349

1.15

18.24

2.5

2.3

12.94

12.77

nmol/l

0.72

4573

31242

Endocrine disorders, other/unspecified

110

452

2.68

18.16

4.6

2.2

11.83

13.52

nmol/l

1.29

424

Cervicocranial syndrome

411

2606

1.63

18.11

2.7

2.2

12.11

12.66

nmol/l

0.68

375

2381

Complications of medical and surgical care

3494

26909

1.18

18.07

2.6

2.3

11.82

12.67

nmol/l

6.86

3107

24239

Early onset COPD

782

10665

0.71

18.06

2.7

2.3

12.48

13.49

nmol/l

3.07

675

9664

Osteonecrosis due to drugs

105

428

2.80

18.04

3.1

2.5

4.44

13.57

nmol/l

19.00

383

Psychotic depression

282

1630

1.81

18.00

2.8

2.0

11.65

13.04

nmol/l

1.78

248

1503

Umbilical hernia

1855

15120

1.26

17.94

2.8

2.3

12.54

13.42

nmol/l

5.50

1680

13816

Asthma, including avohilmo

6771

33282

1.13

17.94

2.5

2.3

12.42

12.89

nmol/l

4.79

6144

30282

Implicit viral Sepsis, including avohilmo

1503

11889

1.29

17.93

2.7

2.2

11.83

12.78

nmol/l

3.98

1325

10673

Lyme disease

1511

11986

1.29

17.92

2.3

13.74

13.03

nmol/l

2.71

1350

10852

Lyme disease, including avohilmo

1511

11986

1.29

17.92

2.3

13.74

13.03

nmol/l

2.71

1350

10852

Injuries to the ankle and foot

4130

30643

1.17

17.91

2.4

2.3

12.57

12.97

nmol/l

2.41

3772

28169

Periodontitis

5532

31153

1.14

17.83

2.4

2.3

12.57

13.25

nmol/l

7.62

4850

28529

Oral corticosteroids

5950

30931

1.14

17.83

2.5

2.3

11.91

13.02

nmol/l

20.57

5317

28206

Dental pulpitis, including avohilmo

5455

30863

1.14

17.76

2.5

2.3

12.44

13.15

nmol/l

8.30

4903

28408

Colitis due to radiation

316

3.16

17.74

2.6

2.3

8.03

12.33

nmol/l

3.59

265

Other spirochaetal diseases, including avohilmo

1547

12323

1.28

17.71

2.3

13.72

13.00

nmol/l

2.89

1383

11163

Oedema, not elsewhere classified

1478

11423

1.29

17.68

2.6

2.2

10.88

12.87

nmol/l

12.67

1264

10289

Heart failure, not strict

3034

23946

0.84

17.67

2.6

2.3

11.13

13.63

nmol/l

51.95

2613

21828

Other heart diseases, wide

5203

27726

1.15

17.57

2.6

2.3

12.99

13.13

nmol/l

0.57

4689

25568

Other noninflammatory disorders of vulva and perineum

371

2.65

17.54

1.4

1.5

1.23

2.10

nmol/l

3.47

306

Cervicobrachial syndrome

904

6704

1.38

17.52

2.7

2.2

12.11

13.14

nmol/l

3.65

823

6177

Sensorineural hearing loss

3757

21592

1.17

17.41

2.4

2.3

12.89

13.08

nmol/l

0.69

3333

19495

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2573

21546

1.21

17.38

2.5

2.3

11.81

12.62

nmol/l

5.41

2287

19289

Spirochaetal infections, other/unspecified, including avohilmo

1518

12093

1.28

17.37

2.3

13.72

13.02

nmol/l

2.69

1356

10952

Other spirochaetal diseases

1522

12132

1.28

17.33

2.3

13.73

13.01

nmol/l

2.81

1360

10984

Eating disorder

310

1849

1.73

17.26

1.9

1.8

6.37

6.35

nmol/l

0.01

266

1667

Other diseases of lip and oral mucosa

1856

15120

1.25

17.24

2.6

2.3

12.43

12.80

nmol/l

1.09

1627

13751

Anomalies of dental arch relationship, including avohilmo

961

6524

1.37

17.16

2.6

2.2

12.25

12.05

nmol/l

0.27

867

5985

Herpesviral [herpes simplex] infections, including avohilmo

996

7514

1.35

17.15

2.6

2.2

12.36

11.68

nmol/l

1.60

894

6815

Spondylolisthesis/Spondylolysis

765

5550

1.41

17.15

2.8

2.2

13.13

13.56

nmol/l

0.76

675

5108

Achilles tendinitis

560

3861

1.51

17.12

2.8

2.3

13.44

13.86

nmol/l

0.61

505

3550

Other and unspecified nerve root and plexus disorders, also in other diseases

1131

8727

1.33

17.05

2.7

2.3

12.85

13.69

nmol/l

3.15

1017

8015

Dislocation, sprain and strain of joints and ligaments at neck level

811

5962

1.40

17.04

2.7

2.3

12.45

12.60

nmol/l

0.19

731

5476

Drug-induced osteoporosis with pathological fracture

283

3.06

16.98

2.5

2.4

10.75

13.27

nmol/l

1.88

257

Mental and behavioural disorders due to sedatives or hypnotics

459

3065

1.59

16.96

3.3

2.5

12.59

14.07

nmol/l

2.80

389

2863

Dental caries

1529

11556

1.28

16.84

2.7

2.2

12.02

13.92

nmol/l

13.96

1350

10738

Ovarian cyst

318

1063

1.72

16.74

1.3

1.4

1.50

2.35

nmol/l

2.57

271

896

Coronary artery bypass grafting

1039

10005

0.75

16.71

2.1

2.2

11.65

13.04

nmol/l

6.21

873

8807

Nasal polyp

1157

8999

1.33

16.65

2.4

2.3

13.70

13.36

nmol/l

0.81

1055

8208

Polyp of the female genital tract

181

498

2.07

16.60

1.3

1.4

1.28

1.58

nmol/l

0.73

160

412

Hypertension

4474

22075

1.16

16.60

2.8

2.3

12.17

14.07

nmol/l

50.00

4073

20404

Organic, including symptomatic, mental disorders

1626

14152

0.80

16.59

2.3

2.2

11.86

12.65

nmol/l

2.90

1376

12431

Bilateral cryptorchidism (undescended testicles)

108

6.89

16.54

5.7

2.3

11.10

12.81

nmol/l

0.51

100

Other disorders of eyelid

1627

12358

1.26

16.53

2.4

2.2

12.33

12.32

nmol/l

0.01

1413

10876

Persons encountering health services in circumstances related to reproduction

3729

21682

1.17

16.43

2.6

2.4

13.82

13.90

nmol/l

0.25

3535

20193

Constitutional tall stature

5.01

16.40

2.3

1.9

7.45

11.24

nmol/l

1.36

Allergic asthma (mode)

1132

8548

1.32

16.29

2.4

2.1

12.84

12.76

nmol/l

0.13

1059

7932

Extrapyramidal and movement disorders

1664

13486

1.25

16.28

2.6

2.2

12.78

12.59

nmol/l

0.40

1468

11978

Triptan medication for migraine, min. 3 purchases

2032

12486

1.23

16.27

2.4

2.2

10.78

11.54

nmol/l

3.59

1867

11455

Hypertensive diseases

4470

22091

1.15

16.24

2.8

2.3

12.17

14.07

nmol/l

49.72

4070

20419

Other viral diseases, including avohilmo

2113

17402

1.22

16.13

2.6

2.3

12.69

nmol/l

0.01

1961

16012

Drug-induced adrenocortical insufficiency

102

429

2.61

16.06

2.9

2.3

11.30

13.11

nmol/l

1.21

400

Disorders of mineral metabolism

418

2750

1.58

16.06

2.6

2.2

13.06

13.73

nmol/l

0.84

371

2504

Other and unspecified mood [affective] disorders

375

2409

1.62

16.02

2.7

2.2

11.08

12.37

nmol/l

1.98

331

2242

Non-ischemic cardiomyopathy

996

10267

0.75

15.82

2.3

10.81

13.30

nmol/l

15.49

838

9155

Molar incisor enamel hypoplasia, with caries

225

3.41

15.79

3.5

2.2

8.60

8.47

nmol/l

0.04

199

Dementia

1134

9951

0.77

15.77

2.2

11.57

11.99

nmol/l

0.78

947

8558

Schizophrenia or delusion

1263

15879

0.78

15.71

2.5

2.4

11.54

13.77

nmol/l

16.30

1092

14739

Schizophrenia, schizotypal and delusional disorders

1265

15900

0.78

15.70

2.5

2.4

11.55

13.76

nmol/l

16.19

1094

14755

Other follicular disorders

434

2905

1.57

15.60

2.7

2.3

11.76

13.29

nmol/l

2.93

387

2668

Lung cancer and mesothelioma

541

6519

0.69

15.57

2.0

2.1

10.21

12.68

nmol/l

9.61

452

5801

Other disorders starting during childhood or adolecense, excluding more controls

257

1444

1.78

15.43

2.6

1.9

10.62

12.03

nmol/l

1.61

234

1358

External causes of morbidity and mortality

3428

14798

1.17

15.38

2.3

2.2

12.46

12.51

nmol/l

0.11

3078

13594

Cardiac arrest

201

2976

0.55

15.38

2.0

2.1

12.12

14.23

nmol/l

2.86

174

2704

Other noninflammatory disorders of uterus, except cervix

248

2.60

15.36

1.5

1.3

1.33

1.35

nmol/l

0.04

204

Cerebrovascular diseases

2922

23591

0.85

15.33

2.3

12.52

13.28

nmol/l

5.02

2541

21330

385

2.59

15.33

2.2

2.1

9.86

9.40

nmol/l

0.20

346

Degenerative diseases of the nervous system

839

8025

0.74

15.29

2.1

2.2

11.37

11.70

nmol/l

0.47

690

6889

Disorders of puberty, other/unspecified

5.93

15.29

2.5

1.9

6.32

10.38

nmol/l

1.33

Allergic asthma (mode), excluding more controls

1132

8621

1.31

15.28

2.4

2.1

12.84

12.78

nmol/l

0.09

1059

8001

Melanocytic naevi of trunk

616

4412

1.44

15.28

2.5

2.3

12.79

12.77

nmol/l

0.01

574

3983

Autoimmune diseases

6764

30919

1.12

15.25

2.4

2.3

12.76

12.91

nmol/l

0.68

6072

28260

Congenital malformations of genital organs

281

1680

1.71

15.24

2.9

2.1

9.00

9.32

nmol/l

0.25

261

1518

Fracture of lumbar spine and pelvis

904

6839

1.35

15.15

2.1

2.3

12.37

12.81

nmol/l

0.77

756

6116

Personal history of malignant neoplasm

165

844

2.00

15.14

3.8

2.1

12.03

11.09

nmol/l

0.82

157

750

Other menopausal disorders

142

362

2.20

15.12

1.6

1.3

1.28

1.48

nmol/l

0.28

119

299

Speech and linguistic disorders, excluding more controls

464

2964

1.53

15.01

2.8

2.0

11.26

13.25

nmol/l

5.03

431

2780

Macular pucker

665

4832

1.42

15.00

2.4

2.2

12.62

12.36

nmol/l

0.32

583

4226

Disorders of thyroid, IBD co-morbidities

771

3880

1.39

14.97

2.4

1.9

11.53

12.75

nmol/l

3.09

695

3593

Infections of the skin and subcutaneous tissue

3651

31420

1.16

14.94

2.7

2.3

12.38

13.25

nmol/l

8.09

3296

28814

Diseases of the respiratory system

3259

14047

1.18

14.92

2.4

2.1

12.65

12.78

nmol/l

0.38

2942

12851

Gestational diabetes (for exclusion)

582

2795

1.44

14.83

1.3

1.4

1.23

1.71

nmol/l

8.88

505

2428

Varicose veins of other sites

490

3420

1.52

14.83

2.8

2.4

15.06

14.44

nmol/l

1.05

455

3177

Erosion of teeth , including avohilmo

1415

11415

1.27

14.74

2.5

2.3

12.44

12.74

nmol/l

0.67

1256

10471

Other shoulder lesions

464

3180

1.51

14.59

2.7

2.2

13.27

13.31

nmol/l

0.03

413

2896

Autism spe, excluding more controls

176

951

2.00

14.56

2.3

2.1

10.62

13.66

nmol/l

3.66

150

908

Other bacterial diseases, including avohilmo

5616

31384

1.13

14.54

2.6

2.3

11.80

13.34

nmol/l

35.96

5025

28756

Other predominantly sexually transmitted diseases, not elsewhere classified

733

5431

1.38

14.52

2.4

2.3

12.56

11.96

nmol/l

1.07

655

5019

Benign neoplasm: Adrenal gland

357

2325

1.60

14.47

2.4

2.3

9.97

13.32

nmol/l

11.86

312

2091

Asthma (only as main-diagnosis), excluding more controls

3835

18529

1.16

14.44

2.5

2.2

12.51

13.26

nmol/l

6.43

3455

17154

Other and unspecified polyneuropathies, also in other diseases

1030

8039

1.32

14.43

2.7

2.3

12.51

13.13

nmol/l

1.67

905

7187

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

3221

24305

1.17

14.41

2.5

2.3

12.32

13.00

nmol/l

4.63

2821

21897

Asthma and allergy

592

4183

1.43

14.40

2.4

2.1

12.23

12.29

nmol/l

0.05

561

3896

Viral infections characterized by skin and mucous membrane lesions

2262

19127

1.20

14.31

2.6

2.3

13.27

12.99

nmol/l

0.96

2052

17518

Insulin, combination of fast acting with intermediate-acting or long-acting

2830

29702

0.85

14.25

2.5

2.3

11.58

13.34

nmol/l

25.25

2446

26999

Acute appendicitis, no complications

3185

27527

1.17

14.19

2.4

13.28

13.21

nmol/l

0.20

2956

25259

Varicose veins

1579

14566

0.81

14.16

2.3

2.2

12.27

12.44

nmol/l

0.34

1375

12903

Endometriosis of ovary

119

516

2.19

14.12

1.3

1.4

1.26

1.79

nmol/l

1.70

105

432

Injuries to the neck

1268

10162

1.28

14.12

2.6

2.3

12.48

12.84

nmol/l

0.87

1151

9296

Anankastic personality disorder

204

1162

1.86

14.06

3.3

2.2

11.72

12.61

nmol/l

0.80

185

1074

Symptoms and signs concerning food and fluid intake

502

3507

1.47

14.06

2.6

2.1

12.65

12.80

nmol/l

0.14

444

3160

Disorders of tooth development and eruption

858

5305

1.35

14.01

2.3

2.2

13.19

13.87

nmol/l

1.53

782

4949

Polyneuropathies and other disorders of the peripheral nervous system

1173

9335

1.29

14.00

2.7

2.3

12.49

13.13

nmol/l

1.96

1035

8360

Disorders of vitreous body

2000

15931

1.21

13.91

2.4

2.3

13.40

12.90

nmol/l

1.99

1779

14207

Chromosomal abnormalities, not elsewhere classified

140

713

2.15

13.90

5.3

2.4

11.95

12.23

nmol/l

0.15

132

669

Agoraphobia

183

1014

1.92

13.86

3.1

2.1

10.97

12.58

nmol/l

1.61

161

952

Mixed and other personality disorders

456

3162

1.51

13.81

3.2

2.4

11.48

13.53

nmol/l

5.53

390

2953

4481

23197

1.14

13.77

2.5

2.2

12.03

12.85

nmol/l

8.11

3991

21132

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

4481

23197

1.14

13.77

2.5

2.2

12.03

12.85

nmol/l

8.11

3991

21132

Sequelae of cerebrovascular disease

1188

12684

0.79

13.75

2.4

2.3

12.18

12.74

nmol/l

1.54

1005

11199

All pneumoniae

5645

32959

1.12

13.73

2.5

2.3

12.28

13.07

nmol/l

10.04

5050

30206

Peripheral artery operations in Hilmo

335

5055

0.64

13.68

2.2

2.3

11.34

12.86

nmol/l

3.00

276

4483

Retinal detachments and breaks

1679

13891

1.23

13.65

2.4

2.3

13.32

12.93

nmol/l

1.11

1496

12423

Other eating disorders

186

1032

1.87

13.60

2.0

1.7

7.69

6.91

nmol/l

0.42

158

945

Asthma and allergy, excluding more controls

592

4232

1.41

13.51

2.4

2.1

12.23

12.32

nmol/l

0.09

561

3940

Substance abuse, excluding more controls

3589

26361

1.15

13.47

2.6

2.2

13.12

13.40

nmol/l

1.09

3094

24263

Other sexually transmitted chlamydial diseases, including avohilmo

621

4561

1.41

13.41

2.5

2.2

13.11

11.71

nmol/l

3.17

560

4244

Coxarthrosis

2537

13985

1.19

13.40

2.5

2.2

12.46

13.35

nmol/l

6.48

2254

12646

Eating disorders

385

2574

1.53

13.37

1.9

8.07

8.39

nmol/l

0.25

332

2327

Complications of procedures, not elsewhere classified

4128

29448

1.14

13.37

2.5

2.3

12.12

12.91

nmol/l

7.57

3694

26705

Inflammatory diseases of female pelvic organs

677

3378

1.38

13.36

1.4

1.31

1.76

nmol/l

5.39

572

2922

Malignant neoplasm of endocrine gland, including Hilmo

273

1694

1.66

13.31

2.6

2.2

10.71

13.64

nmol/l

6.25

249

1546

Other and unspecified visual disturbances

444

3070

1.49

13.30

2.4

2.3

12.16

12.72

nmol/l

0.71

400

2768

Tonsillectomy and adenotomy

3117

18853

1.16

13.29

2.4

12.35

12.90

nmol/l

3.07

2890

17480

Malignant neoplasm of bladder, including Hilmo

512

3586

1.45

13.27

2.2

10.12

15.33

nmol/l

37.17

448

3178

Disorders of continuity of bone

455

3169

1.48

13.18

2.6

2.3

12.45

13.23

nmol/l

1.08

418

2905

Conjunctivitis (acute, non atopic)

1350

10916

1.25

13.15

2.4

2.3

12.65

12.57

nmol/l

0.12

1214

9976

Pneumonias (Asthma/COPD co-morbidities)

5601

32946

1.12

13.12

2.5

2.3

12.24

13.08

nmol/l

11.07

5003

30195

Special screening examination for neoplasms

380

2568

1.55

13.09

2.2

2.1

12.98

13.64

nmol/l

0.81

329

2358

Caries of dentine

1357

10660

1.26

13.02

2.7

2.2

11.92

13.94

nmol/l

13.93

1197

9922

Other inflammation of eyelid

569

4125

1.41

12.98

2.4

2.3

13.47

12.67

nmol/l

1.29

503

3706

Amputation

248

3940

0.61

12.97

2.4

2.3

11.34

12.97

nmol/l

2.39

207

3476

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

1663

13831

1.23

12.96

2.5

2.3

13.62

13.12

nmol/l

1.62

1517

12772

Fibroblastic disorders

1120

8933

1.28

12.92

2.3

2.2

13.08

12.80

nmol/l

0.50

1000

7956

Other noninfective gastroenteritis and colitis

1076

8533

1.28

12.85

2.4

2.3

11.97

12.62

nmol/l

1.68

968

7705

Alcoholic liver disease

376

5437

0.66

12.85

2.1

2.3

13.75

13.78

nmol/l

0.02

320

4930

Hallux rigidus

485

3425

1.45

12.82

2.4

2.1

13.56

13.29

nmol/l

0.30

418

3077

Provisional assignment of new diseases of uncertain etiology

2626

22482

1.17

12.79

2.4

2.3

11.58

12.42

nmol/l

4.91

2357

20227

Other benign neoplasms of skin

1484

12195

1.23

12.79

2.6

2.2

12.49

12.54

nmol/l

0.07

1309

10909

Injury of muscle and tendon at lower leg level

1036

8245

1.30

12.78

2.4

14.28

13.83

nmol/l

1.14

963

7560

Asthma (only as main-diagnosis)

3890

19185

1.14

12.77

2.5

2.2

12.47

13.20

nmol/l

6.15

3499

17720

Other arrhythmias

3258

21273

1.16

12.76

2.6

2.3

12.87

13.08

nmol/l

0.75

2916

19491

Dementia, including avohilmo

1267

10675

0.80

12.75

2.2

11.60

12.07

nmol/l

0.99

1061

9210

Congenital malformations, deformations and chromosomal abnormalities, including avohilmo

3402

27233

1.15

12.74

2.6

2.3

12.56

12.88

nmol/l

1.41

3102

25064

Bulimia nervosa (incl. atypical)

107

501

2.22

12.74

1.8

1.6

4.79

5.23

nmol/l

0.20

454

Pollen allergy

906

6955

1.31

12.71

2.6

2.3

12.25

11.99

nmol/l

0.40

831

6427

Codes for special purposes

2627

22503

1.17

12.69

2.4

2.3

11.58

12.42

nmol/l

4.89

2357

20246

Other disorders of eye and adnexa

571

4158

1.41

12.69

2.3

12.55

12.43

nmol/l

0.11

514

3772

Disorders of vitreous body and globe

2053

16439

1.20

12.61

2.4

2.3

13.44

12.88

nmol/l

2.35

1825

14661

Uterine polyps

152

452

1.97

12.55

1.3

1.4

1.34

1.59

nmol/l

0.49

133

375

Endometriosis of pelvic peritoneum

130

590

2.02

12.48

1.3

1.4

1.43

2.03

nmol/l

1.36

110

490

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

544

7378

0.71

12.46

2.2

2.4

13.43

13.65

nmol/l

0.24

471

6670

Other diseases of blood and blood-forming organs

360

2435

1.55

12.41

4.3

2.4

13.49

13.46

nmol/l

0.02

331

2200

Disorders of psychological development

728

5143

1.35

12.21

2.6

2.2

11.16

12.89

nmol/l

5.52

663

4759

Symptoms and signs involving cognition, perception, emotional state and behaviour

5158

31036

1.12

12.20

2.5

2.3

12.63

12.83

nmol/l

0.95

4575

28269

Other and unspecified follicular disorders

264

1683

1.67

12.20

3.0

2.4

12.84

13.63

nmol/l

0.73

237

1545

Urolithiasis

1902

16123

1.20

12.16

2.4

2.3

12.37

13.12

nmol/l

3.62

1697

14464

Hypothyroidism, drug reimbursement

529

2645

1.42

12.15

2.7

1.7

12.14

14.79

nmol/l

9.80

466

2516

Superficial injury of lower leg

1171

9448

1.26

12.13

2.5

2.3

12.54

12.65

nmol/l

0.17

1037

8595

Abrasion of teeth

1393

11443

1.23

12.07

2.3

13.34

12.83

nmol/l

1.37

1248

10389

Undetermined asthma

559

4087

1.40

12.06

2.7

2.2

12.38

12.81

nmol/l

0.62

488

3732

Other hearing loss

1116

8671

1.27

12.03

2.3

2.2

12.33

12.26

nmol/l

0.09

937

7624

Other abnormal uterine and vaginal bleeding

142

524

1.96

12.01

1.3

1.4

1.28

1.92

nmol/l

2.72

115

436

Thyroiditis, ILD-related definition

335

2228

1.54

12.00

3.1

2.1

10.19

11.15

nmol/l

1.28

299

1998

Striking against or struck by other objects

2335

20122

1.18

11.99

2.4

13.59

13.50

nmol/l

0.23

2115

18568

Injury, poisoning and certain other consequences of external causes

2688

11622

1.17

11.98

2.3

2.2

12.38

12.30

nmol/l

0.18

2423

10655

Viral and other specified intestinal infections, including avohilmo

1644

13240

1.22

11.90

2.6

2.3

11.95

12.65

nmol/l

2.71

1505

12228

Hypoparathyroidism

102

483

2.20

11.85

3.2

2.1

11.88

12.82

nmol/l

0.50

433

Other/unspecified enthesopathies of lower limb, excluding foot

310

2043

1.57

11.85

2.4

2.2

13.71

13.30

nmol/l

0.42

284

1901

Fenamates

497

2406

1.43

11.85

2.5

2.0

12.28

11.85

nmol/l

0.49

438

2177

Bacterial pneumoniae

1608

16846

0.83

11.84

2.6

2.3

11.87

13.10

nmol/l

7.21

1434

15173

Condition for Implicit Sepsis (Organ dysfunction codes), including avohilmo

4932

29968

1.12

11.80

2.5

2.3

12.56

13.09

nmol/l

4.18

4396

27445

Fitting and adjustment of other devices

1549

11331

1.22

11.79

2.3

2.2

11.80

13.21

nmol/l

9.01

1383

9963

Otitis externa

1110

8947

1.27

11.77

2.4

2.3

11.98

12.92

nmol/l

3.26

963

8132

Hypoplasia of dental enamel

259

2.87

11.75

3.6

2.3

8.06

8.53

nmol/l

0.16

230

Dyspnoea

4552

29474

1.12

11.68

2.7

2.3

11.86

12.83

nmol/l

12.36

3997

26741

Diabetic nephropathy, excluding more controls

473

5302

0.71

11.63

2.4

2.7

12.15

10.70

nmol/l

3.35

422

4727

Heartburn

521

3799

1.41

11.63

2.4

2.3

13.43

13.03

nmol/l

0.51

467

3472

Postprocedural disorders of nervous system

281

1820

1.60

11.60

2.6

2.2

12.13

11.88

nmol/l

0.18

258

1672

Covid-19 confirmed case

1780

15022

1.20

11.52

2.5

2.2

11.25

12.45

nmol/l

6.05

1574

13416

Diseases of middle ear and mastoid

3168

22780

1.15

11.49

2.4

2.3

12.25

12.76

nmol/l

2.73

2867

20911

Osteonecrosis

303

2009

1.58

11.48

2.8

2.4

10.20

13.52

nmol/l

8.49

259

1817

In situ neoplasms

1236

10076

1.24

11.42

2.2

2.1

10.97

10.96

nmol/l

0.01

1060

8760

Bacterial pneumonia, not elsewhere classified

1489

15654

0.82

11.40

2.6

2.3

11.78

13.06

nmol/l

7.24

1332

14083

Anogenital herpesviral [herpes simplex] infection

280

1824

1.59

11.35

2.5

2.2

13.36

11.38

nmol/l

2.76

239

1680

Disorders of iron metabolism

122

643

2.11

11.34

2.8

2.4

14.89

14.03

nmol/l

0.59

108

604

Malignant neoplasm of endocrine gland

234

1458

1.65

11.32

2.4

2.3

11.26

13.75

nmol/l

3.98

213

1338

Superficial injury of abdomen, lower back and pelvis

798

6220

1.31

11.30

2.4

2.3

12.31

12.89

nmol/l

1.08

713

5681

Ganglion

804

6255

1.31

11.28

2.4

2.2

12.67

12.61

nmol/l

0.06

735

5714

Non-Hodgkin lymphoma, all, including Hilmo

532

3916

1.39

11.19

2.5

2.3

12.58

14.99

nmol/l

9.87

487

3531

Other viral diseases, not elsewhere classified, including avohilmo

1371

11283

1.23

11.16

2.6

2.3

12.52

12.64

nmol/l

0.22

1281

10343

Other disorders of bone

981

7855

1.28

11.12

2.7

2.3

12.72

13.24

nmol/l

1.27

892

7226

Early lumbar disc prolapse, operated

645

4917

1.36

11.09

2.7

2.4

13.00

13.86

nmol/l

2.19

601

4666

Lateral epicondylitis

614

4629

1.36

11.07

2.8

2.2

13.05

13.83

nmol/l

1.86

568

4255

Disorders of sclera, cornea, iris and ciliary body

2840

24959

1.15

10.96

2.4

2.3

13.32

13.12

nmol/l

0.63

2556

22798

Urethral stricture

415

2977

1.47

10.91

2.5

2.3

12.48

13.34

nmol/l

1.14

364

2654

Pathological/recurrent dislocation and subluxation of joint, not elsewhere classified

425

3038

1.45

10.89

2.6

2.3

13.39

13.79

nmol/l

0.47

392

2838

Early onset COPD, excluding more controls

782

9920

0.77

10.86

2.7

2.2

12.48

13.57

nmol/l

3.49

675

9094

Other skin changes

817

6411

1.30

10.85

2.5

2.2

12.72

12.46

nmol/l

0.38

738

5691

Fracture of rib(s), sternum and thoracic spine

1768

15042

1.20

10.83

2.4

2.3

13.22

13.35

nmol/l

0.27

1547

13649

Brachial plexus disorders

370

2573

1.48

10.83

2.7

2.3

11.85

12.81

nmol/l

1.32

337

2371

Calculus of kidney and ureter

1742

14812

1.20

10.82

2.4

2.3

12.42

13.16

nmol/l

3.45

1557

13315

Undetermined asthma, excluding more controls

559

4161

1.37

10.82

2.7

2.2

12.38

12.84

nmol/l

0.67

488

3799

Trigger finger

568

4243

1.37

10.78

2.4

2.2

13.56

13.27

nmol/l

0.35

506

3844

Ethmoidectomy

678

5216

1.34

10.78

2.6

2.3

13.65

13.55

nmol/l

0.13

600

4784

Raynaud syndrome

337

2306

1.50

10.74

2.6

2.2

13.14

12.29

nmol/l

0.89

307

2090

Bacterial pneumonia (organism specified)

1707

18187

0.84

10.71

2.6

2.3

11.92

12.80

nmol/l

4.22

1523

16317

Impacted cerumen

515

3805

1.39

10.69

2.4

2.2

12.92

12.73

nmol/l

0.17

434

3385

Presbyopia

378

2655

1.48

10.68

2.7

2.4

14.15

13.64

nmol/l

0.67

347

2450

Benign neoplasm: Cerebral meninges

240

1524

1.61

10.65

2.9

2.3

11.10

12.38

nmol/l

1.52

206

1357

Hernia of abdominal wall

2572

22524

1.16

10.65

2.7

2.3

12.36

13.34

nmol/l

8.64

2326

20443

Other viral diseases

1601

13469

1.21

10.65

2.7

2.3

12.86

12.78

nmol/l

0.14

1481

12403

Zoster [herpes zoster], including avohilmo

2127

17690

1.17

10.61

2.5

2.2

12.60

12.54

nmol/l

0.12

1892

15803

Emotional disorders and disorders of social functioning with onset specific to childhood

265

1699

1.59

10.58

2.5

2.1

8.93

9.95

nmol/l

0.87

232

1573

Benign neoplasm of meninges

265

1724

1.57

10.58

2.9

2.3

10.85

12.38

nmol/l

2.21

230

1537

Other specified disorders of external ear

251

1643

1.64

10.57

2.7

2.4

13.15

13.36

nmol/l

0.14

216

1477

Benign neoplasm: Ascending colon

624

4754

1.35

10.55

2.7

2.3

11.95

13.05

nmol/l

2.91

542

4210

Cardiomyopathy (excluding other)

486

6529

0.72

10.55

2.6

2.3

12.32

13.39

nmol/l

1.92

429

5912

Sequelae of injuries, of poisoning and of other consequences of external causes

1362

11364

1.22

10.51

2.7

2.4

13.58

13.72

nmol/l

0.27

1244

10476

Mycoses

1321

10970

1.22

10.49

2.5

2.3

12.91

12.85

nmol/l

0.08

1199

9907

Dilated cardiomyopathy

424

5798

0.71

10.42

2.5

2.3

12.41

13.46

nmol/l

1.59

373

5200

Disorders of muscles

517

3841

1.39

10.41

2.8

2.2

12.86

13.48

nmol/l

1.03

471

3502

Fall on same level involving ice and snow

2755

24221

1.15

10.40

2.3

12.89

12.93

nmol/l

0.11

2460

22039

Atypical facial pain

162

939

1.78

10.36

2.6

2.3

11.03

12.09

nmol/l

0.74

144

854

Ocular pain

324

2218

1.50

10.31

2.3

12.14

12.18

nmol/l

0.02

288

2013

Abnormal involuntary movements

611

4655

1.35

10.30

2.8

2.3

12.22

13.05

nmol/l

1.59

544

4193

Rheumatism, unspecified

216

1344

1.63

10.28

2.2

2.1

11.01

11.48

nmol/l

0.35

177

1183

FESS (DNB20)

650

5007

1.34

10.26

2.6

2.4

13.64

13.53

nmol/l

0.15

574

4589

Urticaria and erythema

1415

11831

1.21

10.24

2.5

2.2

11.29

12.18

nmol/l

3.77

1264

10725

Benign lipomatous neoplasm

1299

10798

1.22

10.21

2.6

2.3

13.05

13.27

nmol/l

0.37

1168

9777

Congenital malformations, deformations and chromosomal abnormalities

3057

25683

1.14

10.20

2.6

2.3

12.56

12.87

nmol/l

1.28

2801

23651

Type 2 diabetes

5212

27420

1.11

10.20

2.7

2.2

10.05

13.66

nmol/l

197.47

4654

25162

Viral Sepsis

1001

8111

1.26

10.18

2.7

2.2

11.85

12.92

nmol/l

3.45

888

7269

Cluster headache, wide

207

1297

1.68

10.16

2.5

2.1

13.33

13.98

nmol/l

0.53

192

1219

Implicit viral Sepsis

999

8096

1.26

10.14

2.7

2.2

11.84

12.92

nmol/l

3.46

886

7255

Cardiomyopathy

674

8623

0.76

10.12

2.6

2.3

12.86

13.38

nmol/l

0.79

597

7795

Use of biperiden

106

1959

0.52

10.12

2.5

12.01

13.75

nmol/l

1.23

1798

Diabetes mellitus in pregnancy

522

2431

1.37

10.12

1.4

1.33

1.82

nmol/l

6.63

455

2111

Hyperaldosteronism

144

822

1.87

10.09

2.9

2.2

11.98

13.30

nmol/l

0.44

127

741

Other general symptoms and signs

214

1334

1.64

10.06

2.9

2.1

11.34

12.17

nmol/l

0.62

189

1212

Wide developmental disorders

233

1506

1.63

10.04

2.4

2.3

10.42

12.63

nmol/l

2.71

201

1414

Abnormal results of function studies

443

3235

1.42

10.03

2.7

2.3

12.05

13.29

nmol/l

2.18

392

2966

Disorders of adrenal gland, other and/or unspecified

108

3.72

10.01

4.5

2.4

10.87

13.09

nmol/l

0.58

102

Transient global amnesia

310

2119

1.50

9.96

2.4

2.3

13.54

12.80

nmol/l

0.82

285

1875

Acute alcohol intoxication

1280

15278

0.82

9.95

2.4

2.3

13.05

13.44

nmol/l

0.88

1086

14039

Seborrhoeic dermatitis

566

4302

1.36

9.95

2.6

2.3

13.16

13.31

nmol/l

0.16

507

3895

Unspecific neurodegenerative disorder

1063

8908

0.81

9.88

2.1

2.2

11.50

11.69

nmol/l

0.26

875

7579

Assault

983

8023

1.26

9.84

2.6

2.4

13.95

14.07

nmol/l

0.17

872

7505

Cluster headache, strict

197

1231

1.69

9.82

2.5

2.1

13.38

14.05

nmol/l

0.53

183

1161

Disorders of parathyroid gland

481

3501

1.38

9.81

2.5

2.0

11.72

12.80

nmol/l

2.28

425

3101

Diseases of salivary glands

1334

11151

1.21

9.80

2.4

2.3

12.15

12.77

nmol/l

1.98

1203

10130

Other diseases of blood and blood-forming organs, wide

957

7754

1.26

9.75

3.2

2.3

12.29

13.12

nmol/l

2.26

870

6966

Faecal incontinence

169

1003

1.71

9.74

2.7

2.2

10.77

11.61

nmol/l

0.58

142

894

Other enthesopathy of foot (+metatarsalgia)

338

2355

1.47

9.72

2.6

2.1

12.98

12.76

nmol/l

0.21

307

2115

Primary adrenocortical insufficiency

264

2.58

9.71

4.2

2.5

11.72

13.22

nmol/l

0.68

249

Myocardial infarction, with ST-elevation

599

7746

0.76

9.70

2.2

2.3

11.96

12.93

nmol/l

1.91

510

6870

Examination and encounter for administrative purposes

474

3527

1.39

9.66

2.4

2.1

13.24

13.36

nmol/l

0.11

442

3199

Other and unspecified dermatitis

2301

20102

1.16

9.64

2.6

2.3

12.40

12.54

nmol/l

0.35

2044

18179

Appendectomy

3267

27766

1.13

9.62

2.4

2.3

12.94

13.05

nmol/l

0.33

3017

25455

Other sexually transmitted chlamydial diseases

387

2790

1.44

9.62

2.4

2.3

12.91

12.38

nmol/l

0.53

347

2597

Localized swelling, mass and lump of skin and subcutaneous tissue

1429

12048

1.20

9.60

2.4

2.3

12.57

12.78

nmol/l

0.44

1280

10882

Motorcycle rider injured in other and unspecified transport accidents

489

3690

1.40

9.58

2.5

13.63

14.28

nmol/l

1.13

454

3453

COPD (mode)

1133

10673

0.81

9.57

2.3

2.2

11.90

13.35

nmol/l

6.73

932

9693

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

1038

8381

1.24

9.57

2.5

2.1

9.97

10.68

nmol/l

1.64

910

7598

Lichen ruber planus, wide definition including periferal and oral lichen planus

777

6153

1.28

9.56

2.4

2.3

12.71

13.21

nmol/l

0.94

697

5534

Other heart diseases

2733

15666

1.15

9.54

2.6

2.2

13.30

14.05

nmol/l

5.33

2482

14615

Ptosis of eyelid

423

3085

1.41

9.50

2.5

2.3

12.83

12.66

nmol/l

0.15

378

2727

COPD/asthma related infections

5088

23197

1.11

9.43

2.4

2.2

12.20

12.85

nmol/l

6.05

4577

21132

COPD/asthma/ILD related infections

5088

23197

1.11

9.43

2.4

2.2

12.20

12.85

nmol/l

6.05

4577

21132

Cervical polyps

189

2.66

9.43

1.3

1.4

1.15

1.41

nmol/l

0.50

156

Injury of muscle and tendon at hip and thigh level

581

4470

1.34

9.40

2.8

2.3

13.58

13.68

nmol/l

0.12

524

4098

Alcohol withdrawal state with delirium

286

4076

0.67

9.39

2.2

2.4

13.48

14.09

nmol/l

0.64

238

3740

Pneumonia, organism unspecified

4984

31160

1.10

9.39

2.6

2.3

12.21

13.19

nmol/l

13.13

4422

28523

Injuries to the thorax

2695

23855

1.14

9.38

2.4

2.3

13.18

13.31

nmol/l

0.37

2372

21689

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

5403

32916

1.10

9.38

2.5

2.3

12.23

13.10

nmol/l

11.60

4817

30161

Disorders of vestibular function (Vertigo)

1693

14109

1.18

9.31

2.5

2.3

12.53

12.61

nmol/l

0.16

1494

12635

Dementia in Alzheimer disease

284

3456

0.68

9.31

1.8

2.1

10.18

10.60

nmol/l

0.36

231

2884

Other superficial mycoses, including avohilmo

581

4469

1.34

9.31

2.3

13.16

13.08

nmol/l

0.08

523

4110

Insulin medication

2830

26391

0.88

9.29

2.5

2.3

11.58

13.91

nmol/l

42.45

2446

24204

Weight loss

421

3083

1.40

9.29

2.5

2.3

13.18

12.55

nmol/l

0.74

366

2741

Keratitis

1831

15806

1.17

9.28

2.5

2.3

13.34

13.23

nmol/l

0.23

1655

14471

Secondary uncertain malignant neoplasm

518

3910

1.35

9.28

2.2

2.3

10.64

14.89

nmol/l

23.43

470

3525

Substance use, excluding alcohol

1259

10566

1.22

9.27

2.9

2.4

12.78

13.91

nmol/l

4.25

1073

9858

Type 2 diabetes, definitions combined, including avohilmo

4965

26155

1.11

9.26

2.7

2.2

9.73

13.70

nmol/l

240.42

4441

24000

Benign paroxysmal vertigo

933

7565

1.25

9.26

2.5

2.2

12.61

12.62

nmol/l

0.01

820

6763

Postviral fatigue syndrome

185

2.85

9.22

3.2

2.1

13.58

12.74

nmol/l

0.26

177

Anorexia (incl.atypical)

216

1394

1.59

9.10

1.7

1.9

9.01

9.16

nmol/l

0.07

187

1266

Dissociative [conversion] disorders

138

796

1.80

9.08

2.3

2.0

7.06

11.00

nmol/l

6.94

119

742

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

263

1761

1.51

9.05

1.4

1.49

1.72

nmol/l

0.75

227

1513

Cardiomyopathies, Primary/intrinsic

473

6234

0.74

9.05

2.5

2.3

12.39

13.42

nmol/l

1.72

417

5633

Myocardial infarction, without ST-elevation

1550

16337

0.84

9.04

2.2

2.3

11.71

12.94

nmol/l

7.85

1350

14428

Diplopia

580

4472

1.33

9.03

2.6

2.3

12.36

12.98

nmol/l

1.06

524

4015

Brain meningioma

121

670

1.86

9.02

2.5

2.4

11.31

14.14

nmol/l

2.92

100

611

Otalgia

287

1971

1.49

9.00

2.6

2.2

12.21

11.74

nmol/l

0.40

254

1776

Benign neoplasm: Testis

234

2.95

9.00

3.3

2.6

12.91

14.27

nmol/l

0.55

215

Other disorders of the musculoskeletal system and connective tissue

629

4903

1.31

8.99

2.7

2.3

13.10

13.27

nmol/l

0.19

561

4428

Motor disorders, excluding more controls

417

2.14

8.96

2.8

1.9

10.02

12.29

nmol/l

1.16

389

Acute pharyngitis

984

8011

1.25

8.95

2.4

2.3

12.58

12.94

nmol/l

0.57

912

7437

Other bacterial intestinal infections, including avohilmo

1014

8341

1.24

8.91

2.4

2.3

12.22

12.86

nmol/l

1.56

910

7514

Plantar fascial fibromatosis

325

2288

1.45

8.90

2.5

2.2

12.14

13.10

nmol/l

1.23

293

2070

Caries of enamel

5315

31882

1.10

8.85

2.5

2.3

12.80

13.17

nmol/l

2.66

4779

29262

Ehlers-Danlos syndrome, including avohilmo

158

2.88

8.85

2.3

2.0

4.64

8.91

nmol/l

2.64

148

Unstable angina pectoris

1434

13225

0.84

8.84

2.4

2.3

11.73

13.32

nmol/l

10.92

1248

11748

Hydrocele

839

6817

1.27

8.83

2.3

2.2

13.75

13.38

nmol/l

0.74

755

6169

Malignant neoplasm of urinary organs, including Hilmo

486

3668

1.36

8.83

2.4

2.3

11.78

15.19

nmol/l

14.90

424

3303

Disturbances of smell and taste

160

971

1.71

8.83

2.6

2.3

12.76

12.98

nmol/l

0.12

145

877

Brain meningioma, including Hilmo

125

704

1.82

8.82

2.5

2.4

11.23

14.09

nmol/l

3.13

104

642

Diabetic nephropathy

480

6225

0.74

8.81

2.4

2.6

12.10

10.64

nmol/l

3.47

427

5446

Degeneration of macula and posterior pole

1842

12274

1.17

8.81

2.4

2.2

12.41

12.33

nmol/l

0.14

1565

10740

Metatarsalgia

302

2101

1.47

8.81

2.7

2.2

12.98

12.60

nmol/l

0.36

272

1888

Autism

181

1145

1.68

8.79

2.3

10.64

13.13

nmol/l

2.75

155

1075

Single spontaneous delivery

240

1906

0.66

8.77

1.3

1.5

1.32

2.22

nmol/l

9.46

219

1642

Recurrent dislocation and subluxation of joint

370

2687

1.43

8.77

2.7

2.3

13.60

13.81

nmol/l

0.21

341

2518

Other congenital malformations, including avohilmo

526

4014

1.34

8.75

2.6

2.2

11.86

12.01

nmol/l

0.15

474

3653

Viral hepatitis, including avohilmo

493

3758

1.37

8.74

2.9

2.5

13.58

13.90

nmol/l

0.34

423

3518

Complications of surgical and medical care, not elsewhere classified

5143

31431

1.10

8.72

2.5

2.3

12.11

12.93

nmol/l

9.86

4589

28561

Female infertility, tubal origin

146

2.84

8.71

1.2

1.4

1.23

1.59

nmol/l

0.86

121

Secondary and unspecified malignant neoplasm of lymph nodes

360

2601

1.43

8.69

2.3

12.04

14.91

nmol/l

9.06

336

2357

Cholelithiasis, broad definition with cholecystitis

3127

23227

0.89

8.68

2.4

2.2

11.34

12.54

nmol/l

13.14

2725

20859

Other specified and unspecified personality disorders

451

3383

1.37

8.68

2.9

2.4

11.40

13.26

nmol/l

4.08

399

3129

Alcohol dependence

1447

16875

0.84

8.67

2.6

2.4

13.53

13.76

nmol/l

0.47

1206

15539

Iron deficiency

103

551

1.94

8.66

2.9

1.9

10.42

8.92

nmol/l

0.34

498

Hypermetropia

317

2240

1.46

8.66

2.5

2.3

12.02

12.18

nmol/l

0.11

286

2023

Urticaria

1131

9421

1.22

8.64

2.5

2.2

10.99

12.05

nmol/l

4.26

1005

8553

Rare circulating lymphoid malignancy, including Hilmo

141

837

1.78

8.61

3.4

2.3

11.30

14.49

nmol/l

4.69

136

760

Other viral hepatitis, including avohilmo

451

3407

1.38

8.59

2.9

2.5

13.49

13.95

nmol/l

0.50

384

3202

Diabetes, varying definitions

5452

29035

1.10

8.55

2.6

2.2

10.43

13.57

nmol/l

148.49

4870

26665

Fracture at wrist and hand level

2223

19533

1.15

8.53

2.5

2.4

13.97

13.63

nmol/l

1.05

2042

18094

Mental and behavioural disorders due to alcohol, excluding acute intoxication

2616

29047

0.88

8.53

2.5

2.4

13.33

13.62

nmol/l

1.00

2241

26669

Monoclonal gammopathy of undetermined significance (MGUS), including Hilmo

172

1074

1.66

8.47

2.4

2.2

12.43

15.01

nmol/l

3.16

145

963

Implicit fungal Sepsis, including avohilmo

279

1935

1.48

8.44

2.7

2.2

11.02

13.01

nmol/l

3.25

246

1730

Other congenital malformations

350

2526

1.42

8.44

2.6

2.3

11.54

11.82

nmol/l

0.24

320

2302

Care involving use of rehabilitation procedures

3206

25906

1.12

8.44

2.7

2.3

11.66

13.46

nmol/l

31.12

2930

23586

Other systemic involvement of connective tissue (FG)

711

5543

1.27

8.43

2.2

2.1

11.63

11.79

nmol/l

0.20

622

4936

Primary hyperparathyroidism

250

1690

1.51

8.41

2.5

2.3

11.77

12.39

nmol/l

0.62

223

1502

Transplanted organ and tissue status

582

4556

1.32

8.38

3.1

2.4

13.87

13.99

nmol/l

0.14

557

4188

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

588

4591

1.31

8.37

2.6

2.3

12.92

13.45

nmol/l

0.84

536

4185

Alcohol use disorder, ICD-based

2403

27018

0.88

8.33

2.6

2.4

13.25

13.66

nmol/l

1.59

2050

24815

Other disorders of veins

1369

11439

1.19

8.33

2.5

2.3

12.76

12.66

nmol/l

0.16

1199

10295

Abnormal weight loss

391

2884

1.39

8.32

2.5

2.3

13.55

12.63

nmol/l

1.25

342

2563

Other and unspecified disorders of skin and subcutaneous tissue

237

1597

1.53

8.32

2.7

2.3

11.48

12.82

nmol/l

1.48

203

1443

Poisoning by drugs, medicaments and biological substances

1203

10141

1.21

8.29

2.8

2.3

11.62

13.02

nmol/l

5.99

1017

9398

Hydronephrosis

527

4065

1.33

8.25

2.6

2.2

7.95

12.89

nmol/l

27.33

447

3630

Cluster headache, wide,, including avohilmo

272

1895

1.49

8.24

2.5

2.4

13.25

13.31

nmol/l

0.04

255

1762

Certain disorders involving the immune mechanism

892

7318

1.24

8.24

2.8

2.4

12.86

13.52

nmol/l

1.93

803

6667

Dermatitis

2931

25679

1.13

8.24

2.5

2.3

12.45

12.66

nmol/l

0.72

2612

23196

Diabetes mellitus

5467

29052

1.09

8.23

2.6

2.2

10.41

13.57

nmol/l

151.01

4882

26683

Hypothyroidism, other/unspecified

3954

23581

1.11

8.22

3.0

2.2

11.05

12.17

nmol/l

12.88

3521

21189

Need for other prophylactic measures

307

2190

1.46

8.22

2.7

2.4

13.27

13.81

nmol/l

0.49

280

2006

Noninfective enteritis and colitis

2351

20799

1.14

8.15

2.4

2.3

12.64

13.01

nmol/l

1.39

2154

18982

Autism spe

176

1128

1.66

8.15

2.3

10.62

13.19

nmol/l

2.82

150

1062

Enlarged lymph nodes

765

6179

1.26

8.14

2.6

2.2

12.50

13.43

nmol/l

2.38

705

5638

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

1247

10410

1.20

8.14

2.5

2.1

10.73

12.70

nmol/l

11.83

1057

9706

Small fibre neuropathy

169

1073

1.67

8.12

3.0

2.4

13.07

13.36

nmol/l

0.16

150

953

Other viral hepatitis

423

3198

1.38

8.05

2.9

2.5

13.33

14.02

nmol/l

0.86

359

3000

Cluster headache, strict, including avohilmo

262

1822

1.50

8.05

2.5

2.4

13.28

13.32

nmol/l

0.02

246

1695

Urinary track infection

639

2484

1.29

8.03

1.5

1.4

1.38

1.84

nmol/l

3.79

536

2154

Insulin, intermediate and long-acting

2651

28563

0.88

8.02

2.5

2.3

11.77

13.41

nmol/l

20.91

2292

25958

Acute laryngitis and tracheitis

680

5353

1.28

7.99

2.6

2.2

12.73

13.10

nmol/l

0.56

625

4973

Benign neoplasm: Rectum

804

6548

1.25

7.98

2.6

2.3

12.47

13.14

nmol/l

1.13

717

5836

Endometriosis diagnosis and infertility diagnosis occurring together

120

685

1.77

7.98

1.2

1.4

1.14

1.37

nmol/l

1.30

104

577

Viral hepatitis

463

3547

1.36

7.97

2.9

2.5

13.43

13.97

nmol/l

0.65

396

3317

Nausea and vomiting

1007

8152

1.22

7.96

2.3

2.2

11.44

12.04

nmol/l

1.19

867

7372

Type 2 diabetes, strict (exclude DM1)

4925

26295

1.10

7.96

2.7

2.2

9.75

13.67

nmol/l

232.48

4412

24110

Disorders of the thyroid gland

4609

27364

1.10

7.95

2.9

2.2

11.33

12.44

nmol/l

14.68

4119

24674

Nontraumatic intracranial haemmorrhage

542

6929

0.77

7.94

2.3

11.80

12.67

nmol/l

1.38

452

6135

Anosmia

100

523

1.91

7.94

2.9

1.9

12.01

16.48

nmol/l

5.22

493

Type 2 diabetes, definitions combined

4912

26225

1.10

7.93

2.7

2.2

9.75

13.68

nmol/l

232.45

4399

24047

Conjunctivitis

3492

25432

1.11

7.92

2.5

2.3

12.56

12.70

nmol/l

0.40

3168

23347

Radiculopathy

602

4741

1.29

7.88

2.7

2.2

12.68

13.10

nmol/l

0.57

511

4291

Other diseases of intestine

733

5921

1.26

7.85

2.5

2.2

13.12

13.41

nmol/l

0.31

649

5354

Bruxism

341

2.16

7.81

2.9

2.1

9.86

12.20

nmol/l

1.37

322

N06DA Anticholinesterases

799

7560

0.81

7.80

2.1

11.94

11.36

nmol/l

0.95

652

6422

Use of anticholinesterases

799

7560

0.81

7.80

2.1

11.94

11.36

nmol/l

0.95

652

6422

Benign neoplasm: Rectum, anus and anal canal

878

7231

1.24

7.79

2.6

2.3

12.43

13.08

nmol/l

1.17

783

6447

Other systemic involvement of connective tissue

738

5953

1.25

7.72

2.2

11.70

11.63

nmol/l

0.09

646

5260

Biguanides

4927

27342

1.09

7.70

2.7

2.3

9.61

13.66

nmol/l

250.43

4370

25009

Cholelithiasis

2938

22296

0.89

7.70

2.4

2.2

11.30

12.47

nmol/l

11.72

2563

19983

Malignant neoplasm of kidney, except renal pelvis, including Hilmo

424

3207

1.36

7.68

2.4

2.3

12.08

15.19

nmol/l

10.80

369

2888

Peripheral arterial reconstruction

491

6316

0.76

7.66

2.0

2.2

11.08

12.47

nmol/l

3.17

393

5527

Visual field defects

355

2617

1.39

7.64

3.6

2.3

12.49

12.85

nmol/l

0.34

322

2331

Nontoxic goitre/thyroid nodule

524

4056

1.30

7.64

2.3

2.2

11.18

11.42

nmol/l

0.25

459

3543

Complications of internal orthopaedic prosthetic devices, implants and grafts

809

6612

1.24

7.62

2.6

2.2

11.85

12.88

nmol/l

3.17

702

5869

Emotional disorders starting during childhood or adolescence

244

1673

1.50

7.60

2.6

2.1

8.59

9.79

nmol/l

1.15

211

1547

Budesonide

651

5210

1.27

7.57

2.5

2.3

12.77

13.26

nmol/l

0.78

597

4761

Dialysis, with operation codes

478

6135

0.76

7.56

2.3

2.4

12.41

13.70

nmol/l

3.00

435

5552

Flat foot [pes planus] (acquired)

270

1895

1.45

7.56

2.8

2.2

11.04

13.19

nmol/l

4.42

236

1723

Trochanteric bursitis

294

2090

1.42

7.55

2.5

2.1

12.01

12.18

nmol/l

0.13

263

1859

Inflammatory disease of uterus

173

1103

1.58

7.54

1.3

1.4

1.30

1.54

nmol/l

1.00

146

947

Scoliosis

266

1864

1.46

7.54

2.7

2.0

11.29

10.63

nmol/l

0.56

230

1703

Ehlers-Danlos syndrome

126

2.95

7.54

2.6

2.0

5.33

9.14

nmol/l

1.70

121

Disorders of synovium and tendon

2585

19593

1.13

7.53

2.5

2.2

13.07

12.84

nmol/l

0.69

2338

17863

Diseases of inner ear

2176

18425

1.14

7.52

2.4

2.3

12.74

12.78

nmol/l

0.09

1930

16545

Other symptoms and signs involving the circulatory and respiratory systems

311

2251

1.42

7.52

2.9

2.2

12.15

13.34

nmol/l

1.78

279

2053

Other and unspecified effects of external causes

1276

10903

1.19

7.46

2.5

2.3

11.98

12.62

nmol/l

1.62

1152

9961

Torsion of testis

201

1375

1.61

7.44

2.7

2.3

14.85

14.95

nmol/l

0.07

183

1298

Disorders of eyelid, lacrimal system and orbit

4081

27333

1.10

7.42

2.4

2.3

12.70

12.56

nmol/l

0.48

3610

24679

COPD-related respiratory insufficiency

327

4424

0.72

7.42

2.7

2.2

11.79

12.55

nmol/l

0.84

258

3888

Acute alcohol intoxication, ICD10

1024

12110

0.83

7.38

2.4

13.05

13.68

nmol/l

1.53

874

11177

Recurrent aphthous stomatitis , including avohilmo

553

4352

1.29

7.36

2.5

2.3

12.11

12.45

nmol/l

0.40

495

3919

Alzheimer disease, including avohilmo

849

7130

0.82

7.34

2.1

2.2

11.09

11.27

nmol/l

0.23

692

6036

Nonalcoholic fatty liver disease

504

3937

1.32

7.32

3.2

2.4

12.02

14.01

nmol/l

6.65

461

3638

Postmenopausal bleeding

191

2.09

7.31

1.3

1.07

1.04

nmol/l

0.04

157

Hypothyreosis and Thyroxine purchase for inclusion criteria

3988

23846

1.10

7.31

3.0

2.2

11.03

12.14

nmol/l

12.67

3549

21424

Disorder of the sleep-wake schedule

111

651

1.83

7.31

3.0

2.3

11.91

12.88

nmol/l

0.57

104

600

Childhood asthma (age<16)

786

5023

1.25

7.29

2.3

2.1

11.83

12.52

nmol/l

1.38

738

4730

Superficial injury of wrist and hand

1057

8917

1.20

7.28

2.4

2.3

12.78

nmol/l

0.00

959

8196

Asthma-related pneumonia

1530

13224

1.17

7.28

2.6

2.2

11.75

12.59

nmol/l

3.54

1344

11857

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

1995

17399

1.14

7.27

2.5

2.3

12.51

12.76

nmol/l

0.68

1830

16078

Poisoning by medicine

1070

9040

1.20

7.26

2.7

2.3

11.61

12.95

nmol/l

4.83

907

8373

Persons encountering health services for specific procedures, not carried out

468

3626

1.33

7.25

2.4

2.3

12.42

13.72

nmol/l

2.56

397

3328

Hypertensive heart and/or renal disease

985

8567

0.83

7.23

2.4

2.1

11.06

13.96

nmol/l

24.49

824

7679

Asthma, hospital admissions 3, pneumonia

1532

13251

1.16

7.21

2.6

2.2

11.73

12.59

nmol/l

3.61

1346

11881

Asthma-related pneumonia or sepsis

1532

13251

1.16

7.21

2.6

2.2

11.73

12.59

nmol/l

3.61

1346

11881

Procedures for purposes other than remedying health state

323

2.12

7.20

2.1

2.3

12.77

12.07

nmol/l

0.24

299

Lichen planus, including avohilmo

656

5278

1.26

7.19

2.4

2.3

12.58

13.22

nmol/l

1.21

587

4746

Heterophoria

317

2317

1.40

7.18

2.5

2.3

11.65

11.61

nmol/l

0.03

281

2096

All kidney diseases

5017

31034

1.09

7.14

2.5

2.3

11.78

12.83

nmol/l

15.33

4476

28332

Crossbite

333

2261

1.40

7.12

2.8

2.3

11.70

11.50

nmol/l

0.14

301

2093

Other complications of surgical and medical care, not elsewhere classified

366

2738

1.37

7.11

2.5

2.3

11.12

12.69

nmol/l

3.11

329

2482

Childhood asthma (age<16), excluding more controls

786

5036

1.24

7.11

2.3

2.1

11.83

12.53

nmol/l

1.40

738

4743

Unspecified dementia

155

2153

0.64

7.10

1.9

2.1

10.78

10.83

nmol/l

0.02

126

1822

Vasomotor rhinitis (mode)

273

1952

1.44

7.08

2.6

2.3

12.75

12.70

nmol/l

0.03

250

1766

Astigmatism

303

2207

1.42

7.07

2.3

2.4

11.44

12.38

nmol/l

1.10

265

2001

Sequelae of external causes of morbidity and mortality

1108

9405

1.19

7.06

2.7

2.3

11.85

13.03

nmol/l

5.12

989

8455

Postpartum hemorraghe, parous women as controls

299

1794

1.40

7.05

1.3

1.21

1.22

nmol/l

0.12

271

1553

Myopia

568

4514

1.28

7.04

2.3

12.50

12.40

nmol/l

0.09

523

4144

Otitis externa, unspecified

525

4139

1.30

7.02

2.5

2.3

11.39

12.88

nmol/l

4.11

465

3789

Nonsuppurative otitis media, including avohilmo

1581

11909

1.16

7.02

2.5

2.2

11.77

12.19

nmol/l

1.12

1434

10913

Sub-endpoint used in defining T1D endpoints

1230

14071

0.85

6.96

2.3

2.4

14.12

13.25

nmol/l

2.90

1073

12891

Missing teeth due to accident, extraction or parodontitis

2921

23588

1.12

6.96

2.5

2.3

12.52

13.17

nmol/l

3.72

2458

21364

Thyrotoxicosis, other and/or unspecified

540

4257

1.28

6.96

2.3

2.1

11.90

11.93

nmol/l

0.03

481

3841

Other (not insulin) diabetes medications

5033

27297

1.09

6.94

2.7

2.3

9.64

13.61

nmol/l

246.00

4471

25011

Alzheimer disease

703

6174

0.81

6.94

2.1

10.86

11.13

nmol/l

0.32

578

5201

Systemic connective tissue disorders

1014

8537

1.20

6.93

2.2

11.91

11.97

nmol/l

0.07

885

7585

Chronic viral hepatitis

372

2830

1.38

6.93

3.0

2.5

13.55

14.19

nmol/l

0.69

314

2666

Hypertensive Heart Disease

874

7942

0.82

6.92

2.4

2.2

10.92

13.85

nmol/l

23.43

725

7109

Gluteal tendinitis

111

651

1.75

6.92

2.3

2.2

10.74

12.04

nmol/l

0.87

593

Benign neoplasm: Sigmoid colon

837

6950

1.23

6.91

2.5

2.3

12.60

13.16

nmol/l

1.17

742

6193

Kela-code for severe mental illness

1557

17789

0.86

6.88

2.7

2.4

11.23

13.64

nmol/l

26.77

1354

16447

Adhesive capsulitis of shoulder

639

5157

1.26

6.87

2.5

2.2

13.70

13.36

nmol/l

0.48

582

4667

Mental and behavioural disorders due to multiple drug use and use of multiple drugs and use of other psychoactive substances

506

4008

1.31

6.87

3.2

2.5

13.21

14.28

nmol/l

1.80

441

3786

Lesion of ulnar nerve

755

6222

1.24

6.86

2.9

2.3

12.62

13.83

nmol/l

4.53

678

5708

Rash and other nonspecific skin eruption

322

2375

1.38

6.85

2.4

2.3

12.13

12.31

nmol/l

0.14

287

2135

Malignant neoplasm of urinary organs

407

3115

1.34

6.83

2.4

2.3

12.01

15.18

nmol/l

11.04

359

2799

Benign neoplasm of male genital organs

173

1166

1.62

6.82

2.8

2.4

13.19

13.76

nmol/l

0.40

151

1047

Other symptoms and signs involving cognitive functions and awareness

2129

16792

1.13

6.79

2.5

2.2

12.54

12.75

nmol/l

0.52

1858

14990

Specific development disorders of scholastic skills

261

1837

1.45

6.79

3.1

2.3

10.01

12.63

nmol/l

5.81

245

1718

Other disorders of optic [2nd] nerve and visual pathways

268

1928

1.43

6.78

3.2

2.3

11.32

12.53

nmol/l

1.61

243

1747

Benign neoplasm: Skin of eyelid, including canthus

506

3979

1.29

6.78

2.4

2.3

12.25

12.74

nmol/l

0.71

435

3540

Assault by bodily force

545

4361

1.29

6.74

2.7

2.5

13.83

14.05

nmol/l

0.25

487

4105

Benign thyroid growths and nodules

640

4789

1.25

6.72

2.4

2.1

11.26

11.70

nmol/l

0.65

561

4224

Conjunctivitis (acute, non atopic), including avohilmo

5634

31625

1.08

6.72

2.5

2.3

12.83

13.01

nmol/l

0.93

5091

28852

Other specified/unspecified hearing loss

340

2540

1.37

6.71

2.4

2.2

12.04

12.60

nmol/l

0.62

300

2256

Dislocation, sprain and strain of joints and ligaments of lumbar spine and pelvis

179

1200

1.56

6.70

2.8

2.3

13.58

13.28

nmol/l

0.18

167

1111

Chalazion

510

4031

1.29

6.69

2.3

13.05

13.11

nmol/l

0.06

460

3684

L04AD Calcineurin inhibitors

599

4838

1.27

6.69

2.9

2.4

13.70

13.72

nmol/l

0.02

570

4454

Amputation of thigh

750

0.39

6.66

2.1

2.3

11.92

12.10

nmol/l

0.03

645

Other and unspecified injuries of shoulder and upper arm

171

1138

1.57

6.65

2.4

13.01

13.06

nmol/l

0.03

149

1042

Adenocarcinoma and ductal carcinoma of pancreas

835

0.42

6.63

1.8

2.3

12.33

15.01

nmol/l

1.18

754

Amputation of toe

195

2810

0.67

6.63

2.2

2.3

10.87

12.92

nmol/l

3.53

164

2468

Sequelae of injuries of upper limb

525

4180

1.29

6.62

2.9

2.4

13.53

13.94

nmol/l

0.55

485

3856

Disorders of gallbladder, biliary tract and pancreas

4237

28592

0.92

6.59

2.4

2.3

11.90

12.92

nmol/l

12.59

3715

25937

Other and unspecified rosacea

297

2178

1.39

6.57

2.5

2.3

12.17

12.73

nmol/l

0.55

270

1968

Rosacea

402

3081

1.33

6.56

2.5

2.2

12.34

12.30

nmol/l

0.03

364

2770

Malignant neoplasm of kidney, except renal pelvis

378

2883

1.34

6.55

2.4

2.3

12.12

15.17

nmol/l

9.49

331

2596

Amputation of foot

1046

0.48

6.54

2.5

2.4

10.44

13.32

nmol/l

2.15

924

Other specified/unspecified inflammatory spondylopathies

196

1340

1.51

6.54

2.4

2.3

12.95

13.12

nmol/l

0.10

187

1251

Sequelae with surgical and medical care as external cause

824

6868

1.22

6.51

2.7

2.3

11.84

13.02

nmol/l

3.91

730

6155

Other bacterial diseases

5087

31257

1.08

6.50

2.6

2.3

11.53

13.49

nmol/l

50.63

4500

28632

Undefined dementia

155

2169

0.65

6.48

1.9

2.1

10.78

11.05

nmol/l

0.13

126

1840

Thyrotoxicosis

633

5126

1.25

6.47

2.4

2.2

11.63

11.72

nmol/l

0.09

566

4584

Carbimazole or st.post thyroidectomy, condition for graves disease

551

4397

1.27

6.45

2.3

2.2

11.49

11.86

nmol/l

0.42

495

3960

Mixed disorders of conduct and emotions, excluding more controls

118

725

1.71

6.44

2.3

1.9

10.49

12.44

nmol/l

1.21

106

681

Abnormal findings on diagnostic imaging of central nervous system

218

1528

1.47

6.43

2.8

2.3

12.80

12.89

nmol/l

0.05

204

1402

Urethritis and urethral syndrome

580

1.79

6.43

2.6

2.3

12.64

12.99

nmol/l

0.16

531

Malignant neoplasm of thyroid gland, including Hilmo

207

1430

1.48

6.42

2.4

2.3

11.48

13.76

nmol/l

3.05

187

1301

Nontoxic multinodular goitre

299

2193

1.38

6.42

2.4

2.1

11.09

11.51

nmol/l

0.36

259

1914

Adverse effects, not elsewhere classified

727

5990

1.23

6.41

2.4

2.2

10.84

11.94

nmol/l

2.08

649

5425

Chronic lower respiratory diseases

6650

32776

1.07

6.41

2.5

2.3

12.47

12.89

nmol/l

3.86

5979

29946

613

4620

1.25

6.40

2.2

2.1

12.05

11.36

nmol/l

0.96

488

3926

Non-small cell lung cancer, squamous, helper endpoint

1563

0.58

6.35

2.2

10.48

12.08

nmol/l

1.14

1347

Nephropathy related operations

464

5840

0.77

6.33

2.3

2.4

12.64

13.59

nmol/l

1.81

424

5280

Noninfectious colitis NAS

561

4511

1.27

6.32

2.5

2.3

12.45

12.96

nmol/l

0.80

510

4100

Fracture of foot, except ankle

1226

10599

1.17

6.30

2.4

2.3

12.49

13.10

nmol/l

1.85

1114

9742

Disorders of choroid and retina

4095

26418

1.09

6.28

2.4

2.3

13.09

13.22

nmol/l

0.40

3596

23975

Delivery

263

1922

0.72

6.28

1.3

1.5

1.32

2.23

nmol/l

10.26

237

1656

Thyroiditis

176

1182

1.52

6.28

2.6

2.2

10.20

11.07

nmol/l

0.65

160

1069

Congenital malformations and deformations of the musculoskeletal system, including avohilmo

467

3658

1.29

6.27

2.6

2.3

11.38

12.08

nmol/l

0.99

417

3362

Mandibular retrognathia

276

2018

1.40

6.24

2.8

2.3

13.17

11.69

nmol/l

2.07

256

1861

Other diseases of oesophagus

422

3289

1.31

6.24

2.7

2.2

12.97

12.84

nmol/l

0.11

358

2941

Presbycusis

396

3009

1.32

6.23

2.1

11.33

11.05

nmol/l

0.22

305

2556

Car occupant injured in other and unspecified transport accidents

915

7737

1.20

6.23

2.6

2.3

12.40

12.87

nmol/l

0.96

819

7103

Emergency coronary revascularization (for ACS)

4381

24433

1.09

6.23

2.6

2.4

12.86

13.65

nmol/l

9.32

3983

22283

Dermatographic urticaria

207

1440

1.47

6.22

2.6

2.2

11.38

11.57

nmol/l

0.11

180

1311

Stomatitis and related lesions

843

7074

1.21

6.20

2.5

2.3

12.17

12.75

nmol/l

1.19

753

6424

Syncope and collapse

2224

16652

1.12

6.19

2.4

2.2

12.34

12.97

nmol/l

2.45

1924

15086

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

792

6618

1.22

6.18

2.6

2.3

11.63

12.95

nmol/l

3.70

668

6144

Spondylopathies in diseases classified elsewhere

312

2.09

6.17

2.9

2.4

4.09

12.52

nmol/l

14.03

284

Disorders of optic nerve and visual pathways

358

2731

1.34

6.17

3.1

2.3

11.72

12.38

nmol/l

0.75

324

2475

Melanocytic naevi of lower limb, including hip

170

1144

1.53

6.16

2.3

11.63

12.28

nmol/l

0.48

158

1035

Asthma, unspecified (mode), excluding more controls

2555

16501

1.12

6.16

2.6

2.2

11.69

13.09

nmol/l

14.79

2259

15225

Inguinal hernia, bilateral

730

6089

1.24

6.14

2.1

2.3

14.39

13.30

nmol/l

3.08

660

5461

Degeneration of the brain due to alcohol

1092

0.51

6.12

2.0

2.4

14.95

13.50

nmol/l

0.54

982

Other behavioural and emotional disorders with onset usually occurring in childhood and adolescence

291

2119

1.39

6.10

2.5

2.2

11.04

11.70

nmol/l

0.61

264

1982

Other keratitis

553

4469

1.26

6.07

2.5

2.4

13.05

13.21

nmol/l

0.17

500

4123

Inguinal or femoral hernia, bilateral

733

6123

1.23

6.07

2.1

2.3

14.42

13.28

nmol/l

3.30

662

5492

Malignant neoplasm of thyroid gland

187

1282

1.49

6.06

2.3

11.82

13.77

nmol/l

2.12

169

1174

Peritonsillar abscess

1123

9681

1.18

6.06

2.3

12.87

13.20

nmol/l

0.71

1030

8923

Neuralgia and neuritis, unspecified

209

1471

1.46

6.02

2.8

2.2

12.98

13.18

nmol/l

0.11

185

1333

Dizziness and giddiness

3410

24304

1.10

6.01

2.5

2.2

12.44

12.59

nmol/l

0.43

3001

21928

Sequelae of injuries of lower limb

466

3702

1.29

6.00

2.7

2.4

13.56

13.69

nmol/l

0.15

432

3409

Pruritus

323

2432

1.35

5.99

2.5

2.2

11.46

11.33

nmol/l

0.09

295

2161

Benign neoplasm of other and ill-defined parts of digestive system

609

4970

1.24

5.96

2.7

2.3

12.31

12.79

nmol/l

0.50

530

4410

Degeneration of nervous system due to alcohol

1083

0.51

5.96

2.0

2.4

14.95

13.50

nmol/l

0.55

977

Neuromuscular dysfunction of bladder

416

3261

1.31

5.94

2.3

13.98

13.15

nmol/l

1.13

375

2920

Postpartum haemorrhage due to anatomy

177

1201

1.49

5.93

1.2

1.3

1.22

1.24

nmol/l

0.12

161

1051

Mental and behavioural disorders due to use of other stimulants, including caffeine

229

1666

1.46

5.89

3.5

2.5

13.29

14.50

nmol/l

1.03

194

1587

Other and unspecified mononeuropathies of upper limb

152

1015

1.57

5.88

2.7

2.4

14.15

13.57

nmol/l

0.36

139

944

Specific developmental disorder of motor function

501

1.82

5.86

2.8

2.2

10.02

11.56

nmol/l

0.68

463

Asthma, hospital admissions , main diagnosis only

4029

32400

1.09

5.86

2.5

2.3

12.37

12.72

nmol/l

1.87

3623

29470

Other and unspecified acne

502

1.83

5.83

3.0

2.3

11.38

13.55

nmol/l

1.49

474

Elevated blood glucose level

383

2980

1.32

5.81

2.9

2.3

10.86

13.63

nmol/l

9.25

337

2717

Speech and linguistic disorders

479

3671

1.28

5.80

2.8

2.3

11.06

12.88

nmol/l

4.54

445

3384

Early lumbar disc prolapse operation

662

5492

1.24

5.79

2.7

2.5

13.02

13.82

nmol/l

2.03

617

5171

Fentanyl

374

2887

1.32

5.79

2.5

2.1

8.22

13.36

nmol/l

21.32

309

2608

Nonischemic cardiomyopathy

363

4648

0.76

5.78

2.5

2.3

12.00

13.69

nmol/l

3.31

324

4215

Asthma/COPD (KELA code 203)

4556

32722

0.92

5.77

2.5

2.3

12.56

12.89

nmol/l

1.93

4100

29895

Non-invasive ventilation

1215

9104

1.17

5.77

2.4

2.1

11.88

14.27

nmol/l

20.42

1124

8527

Recurrent dislocation of patella

192

1340

1.47

5.76

2.4

2.0

11.06

10.81

nmol/l

0.15

173

1230

Hypertrophic disorders of skin

205

1449

1.45

5.74

2.6

2.2

10.95

11.89

nmol/l

0.81

188

1320

Other diseases of liver

814

6866

1.20

5.74

3.0

2.3

12.32

13.58

nmol/l

4.31

734

6264

Other disorders of the genitourinary system

189

1309

1.46

5.72

2.5

2.2

8.52

10.96

nmol/l

3.49

156

1140

Diabetes medication

5472

29858

1.08

5.72

2.6

2.3

10.27

13.51

nmol/l

161.96

4858

27395

Presence of other devices

915

7658

1.19

5.71

2.2

12.09

12.04

nmol/l

0.05

806

6668

Chronic gastritis

911

7745

1.19

5.71

2.7

2.2

12.58

12.34

nmol/l

0.28

803

6854

Other disorders starting during childhood or adolescence

259

1893

1.40

5.70

2.6

2.2

10.53

11.17

nmol/l

0.53

236

1748

Postprocedural musculoskeletal disorders, not elsewhere classified

257

1893

1.39

5.67

3.0

2.3

12.16

13.16

nmol/l

1.15

226

1699

Retinal detachment with retinal break

626

5167

1.24

5.67

2.4

2.3

13.63

13.29

nmol/l

0.51

559

4648

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

408

3210

1.30

5.65

2.8

2.3

11.47

12.92

nmol/l

2.78

377

2880

Desensitization to allergens

252

1857

1.40

5.62

2.7

2.3

12.69

12.37

nmol/l

0.24

230

1728

Other bursopathies

563

4596

1.25

5.60

2.3

2.2

13.06

13.51

nmol/l

0.63

493

4163

Ascites

165

2379

0.68

5.59

2.1

2.3

11.47

13.12

nmol/l

1.43

135

2153

Spondylopathies (FG)

680

5663

1.22

5.58

2.3

13.56

13.63

nmol/l

0.08

626

5210

Other specified/unspecified bacterial intestinal infections

264

1960

1.38

5.57

2.4

2.3

12.71

13.07

nmol/l

0.26

241

1772

Other and unspecified trigeminal disorders

301

2.02

5.56

2.9

2.2

12.93

12.84

nmol/l

0.02

279

Superficial injury of ankle and foot

621

5130

1.23

5.54

2.2

2.3

11.52

12.74

nmol/l

3.02

573

4712

Other viral diseases, not elsewhere classified

891

7574

1.19

5.53

2.6

2.3

12.63

12.90

nmol/l

0.41

823

6927

Glucagon-like peptide-1 (GLP-1) analogues

1706

15231

1.13

5.51

3.2

2.3

9.40

14.34

nmol/l

172.41

1520

14062

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

1706

15231

1.13

5.51

3.2

2.3

9.40

14.34

nmol/l

172.41

1520

14062

Arthropod-borne viral fevers and viral haemorrhagic fevers, including avohilmo

834

7077

1.20

5.51

2.7

2.3

12.82

13.25

nmol/l

0.77

765

6418

Abnormal findings on diagnostic imaging of other body structures

501

4043

1.26

5.49

2.6

2.3

12.17

13.04

nmol/l

1.50

440

3650

Asthma, unspecified (mode)

2594

17024

1.11

5.45

2.6

2.2

11.64

13.03

nmol/l

14.58

2286

15667

Candidiasis

471

3777

1.27

5.44

2.6

2.2

11.35

12.19

nmol/l

1.15

412

3394

Other and/or unspecified nontoxic goitre

141

932

1.53

5.43

2.2

2.1

10.75

11.70

nmol/l

0.71

128

823

Outcome of delivery

127

1193

0.65

5.39

1.4

1.5

1.18

2.28

nmol/l

10.98

111

1010

Benign neoplasm: Caecum

415

3291

1.29

5.39

2.6

2.3

12.48

12.71

nmol/l

0.20

362

2895

Chondropathies

716

6015

1.21

5.36

2.6

2.3

13.08

13.26

nmol/l

0.24

649

5510

Palmar fascial fibromatosis [Dupuytren]

785

6652

1.20

5.35

2.1

2.2

13.49

12.77

nmol/l

1.45

694

5900

Overexertion and strenuous or repetitive movements

531

4344

1.25

5.34

2.7

2.4

13.66

13.75

nmol/l

0.10

503

4008

Mesial bite

259

2.12

5.33

2.6

2.1

13.35

12.14

nmol/l

0.39

243

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

467

2616

1.27

5.32

2.8

2.0

13.03

14.24

nmol/l

2.60

419

2404

Immunodeficiencies

183

1289

1.46

5.32

3.0

2.4

12.60

12.71

nmol/l

0.07

161

1171

130

860

1.59

5.31

2.9

2.4

13.11

13.70

nmol/l

0.29

118

803

Olecranon bursitis

431

3464

1.29

5.31

2.7

2.2

14.60

14.06

nmol/l

0.46

378

3146

Diseases of tongue

210

1512

1.42

5.30

2.9

2.1

12.63

13.60

nmol/l

0.99

191

1373

Benign neoplasm: Kidney

125

816

1.58

5.29

2.2

2.4

11.46

12.65

nmol/l

0.77

102

717

Small cell lung cancer, helper endpoint

691

0.43

5.28

1.7

2.3

11.41

12.03

nmol/l

0.22

595

Open bite

206

1482

1.43

5.28

2.8

2.1

10.89

10.59

nmol/l

0.17

187

1360

Congenital malformations and deformations of the musculoskeletal system

368

2867

1.30

5.28

2.6

2.3

11.18

11.95

nmol/l

0.90

330

2637

Allergic urticaria

292

2217

1.34

5.26

2.4

2.2

10.52

12.13

nmol/l

2.61

258

2027

Heart failure and antihypertensive medication

976

7350

0.85

5.26

2.7

2.1

11.54

15.14

nmol/l

37.59

848

6846

Crushed, pushed or stepped on by crowd or human stampede

461

3728

1.27

5.23

2.6

2.4

14.71

13.52

nmol/l

2.07

432

3466

Hypertrophic scar

185

1308

1.45

5.22

2.6

2.2

10.64

11.89

nmol/l

1.20

168

1190

Dermatophytosis

710

5982

1.21

5.21

2.4

2.3

13.70

13.38

nmol/l

0.46

656

5406

Care involving dialysis

279

3642

0.75

5.20

2.3

11.92

14.10

nmol/l

4.63

253

3301

Pervasive developmental disorders excl. Autism + Asperger

460

1.81

5.20

2.6

2.4

8.81

12.38

nmol/l

2.31

430

Respiratory insufficiency

200

2745

0.71

5.18

2.8

2.2

11.27

12.49

nmol/l

1.24

169

2447

Diffuse large B-cell lymphoma, helper endpoint

184

1304

1.45

5.18

2.6

2.3

12.65

15.13

nmol/l

3.79

171

1172

Diffuse large B-cell lymphoma

184

1304

1.45

5.18

2.6

2.3

12.65

15.13

nmol/l

3.79

171

1172

Diffuse large B-cell lymphoma, including Hilmo

184

1304

1.45

5.18

2.6

2.3

12.65

15.13

nmol/l

3.79

171

1172

Patellar tendinitis

121

798

1.62

5.17

2.6

2.4

15.12

13.94

nmol/l

0.31

106

754

Other specified/unspecified arthritis

1109

9659

1.16

5.16

2.3

2.2

12.41

12.89

nmol/l

0.94

978

8781

Renal failure

1961

18495

0.89

5.16

2.5

2.3

10.92

13.10

nmol/l

25.48

1698

16472

Thoracic aortic aneurysm

931

8049

1.18

5.14

2.4

2.3

13.06

13.41

nmol/l

0.68

813

7242

Necrosis of pulp, including avohilmo

3179

28980

1.09

5.13

2.5

2.4

12.63

13.20

nmol/l

3.59

2808

26713

Polyarthropathies

3390

20086

1.09

5.12

2.4

2.2

12.22

13.00

nmol/l

6.51

2989

18325

Alzheimer’s disease, strict definition

498

4938

0.81

5.12

2.1

10.94

10.91

nmol/l

0.02

408

4144

Melanocytic naevi, other sites/unspecified

347

2712

1.31

5.11

2.4

13.08

12.77

nmol/l

0.31

322

2466

Collagenous colitis

305

2340

1.33

5.10

2.5

2.3

12.37

12.93

nmol/l

0.50

267

2115

Hidradenitis suppurativa

161

1118

1.49

5.09

2.3

9.41

12.75

nmol/l

4.81

143

1043

Open wound of forearm

535

4403

1.24

5.09

2.3

2.4

13.24

13.44

nmol/l

0.21

463

4040

Open wound of lower leg

718

6062

1.20

5.08

2.4

2.3

13.57

13.27

nmol/l

0.32

644

5510

Intracerebral haemorrhage

324

4156

0.77

5.08

2.4

2.2

11.17

12.54

nmol/l

2.20

268

3647

Diabetic retinopathy, strict definition

545

5852

0.81

5.08

2.3

2.7

13.01

10.31

nmol/l

10.78

458

5208

Viral infections of the central nervous system, including avohilmo

331

2575

1.32

5.08

2.7

2.4

12.75

13.38

nmol/l

0.74

311

2368

Glomerular disorders in diseases classified elsewhere

427

5284

0.79

5.07

2.3

12.66

13.47

nmol/l

1.31

381

4767

Poisoning by narcotics and psychodysleptics [hallucinogens]

120

796

1.62

5.06

3.2

2.4

12.29

14.25

nmol/l

1.53

104

763

Superficial injury of shoulder and upper arm

572

4733

1.23

5.06

2.5

2.3

13.57

13.23

nmol/l

0.43

523

4327

Cramp and spasm

220

1618

1.40

5.05

2.8

2.4

12.34

13.06

nmol/l

0.65

203

1477

Acute bronchitis

1866

16475

1.12

5.05

2.6

2.3

12.11

12.64

nmol/l

2.02

1663

14885

Hyperparathyroidism

393

3074

1.28

5.04

2.5

2.0

11.71

12.88

nmol/l

2.26

350

2718

Fracture of shoulder and upper arm

1597

14243

1.13

5.03

2.4

2.3

13.17

13.24

nmol/l

0.12

1438

13001

Other CVD

761

6453

1.19

5.03

2.4

2.2

11.55

12.30

nmol/l

1.54

645

5655

Other strabismus

902

7729

1.18

5.01

2.5

2.3

12.29

12.47

nmol/l

0.27

812

7050

Other and unspecified erythematous conditions

117

764

1.58

4.97

2.6

2.4

12.55

12.88

nmol/l

0.15

105

695

All influenza

1429

12707

1.14

4.95

2.6

2.3

12.57

13.31

nmol/l

2.88

1303

11582

Triptan medication for migraine, single purchase ok

3518

22050

1.09

4.94

2.6

2.3

12.06

13.14

nmol/l

12.23

3244

20423

Migraine, single triptan purchase ok & required. ICD-code if available is included

3518

22050

1.09

4.94

2.6

2.3

12.06

13.14

nmol/l

12.23

3244

20423

Malignant neoplasm of pancreas

112

1699

0.65

4.92

2.1

2.2

12.15

15.02

nmol/l

3.59

100

1518

Polyarthrosis

475

3462

1.25

4.92

2.7

2.1

11.82

12.82

nmol/l

1.66

405

3092

Congenital malformations of the musculoskeletal system, not elsewhere classified, including avohilmo

278

1.98

4.92

2.7

2.2

5.23

10.17

nmol/l

4.24

264

Schizophrenia or delusion, excluding more controls

1263

14104

0.87

4.91

2.5

2.2

11.54

13.90

nmol/l

18.06

1092

13203

Gout

1519

11628

1.13

4.91

2.5

2.2

11.19

13.39

nmol/l

18.20

1296

10444

Abdominal aortic aneurysm (AAA)

301

3840

0.76

4.90

2.1

2.2

11.13

11.68

nmol/l

0.45

248

3289

Seropositive rheumatoid arthritis, strict definition

274

3580

0.76

4.90

2.1

2.3

12.76

12.67

nmol/l

0.06

249

3198

Delivery, wide proxy

248

1765

0.74

4.89

1.3

1.5

1.33

2.33

nmol/l

10.57

221

1525

conjunctival haemorrhage

289

2219

1.33

4.88

2.5

2.3

12.85

12.96

nmol/l

0.07

256

1981

Other bacterial intestinal infections

722

6115

1.20

4.88

2.4

2.3

11.98

12.89

nmol/l

2.03

641

5468

Hypertrophy of breast

133

887

1.51

4.88

1.6

1.5

1.62

1.46

nmol/l

0.29

115

748

Atrial fibrillation and flutter

1873

10890

1.12

4.88

2.5

2.2

13.50

14.89

nmol/l

12.79

1701

10203

Viral infections of the central nervous system

308

2388

1.32

4.88

2.7

2.4

12.89

13.43

nmol/l

0.58

288

2201

Benign neoplasm of eye and adnexa

372

2949

1.28

4.86

2.5

2.3

12.79

12.89

nmol/l

0.08

328

2640

Crowding of teeth, including avohilmo

392

2586

1.28

4.80

2.5

2.1

10.71

10.07

nmol/l

0.66

362

2369

Acute and transient psychotic disorders

391

4860

0.79

4.80

2.5

2.4

11.46

14.01

nmol/l

7.88

337

4533

Fall on and from ladder

491

4048

1.25

4.80

2.4

13.59

13.69

nmol/l

0.09

442

3658

Hypoplasia of dental enamel , including avohilmo

151

1007

1.49

4.79

2.7

2.2

9.78

9.75

nmol/l

0.01

138

929

Gingival hyperplasia

177

1270

1.45

4.78

2.9

2.4

11.12

12.86

nmol/l

1.91

159

1148

Achalasia of cardia

499

1.73

4.78

2.5

2.3

13.79

13.17

nmol/l

0.30

460

Deep bite

488

3504

1.24

4.77

2.5

2.3

12.37

11.83

nmol/l

0.65

440

3210

Polypectomy (DHB20)

399

3217

1.28

4.77

2.1

2.4

13.94

13.75

nmol/l

0.19

362

2920

Valvular operations

602

7157

0.83

4.76

2.0

2.3

12.98

13.28

nmol/l

0.44

515

6449

Presence of other functional implants

2567

16083

1.10

4.75

2.4

2.3

12.30

13.04

nmol/l

4.29

2209

14370

Nontoxic single thyroid nodule

154

1069

1.46

4.74

2.2

12.62

11.97

nmol/l

0.38

132

951

Sudden idiopathic hearing loss

418

3373

1.26

4.74

2.6

2.3

13.34

13.08

nmol/l

0.27

365

3038

Viral haemorrhagic fevers, not elsewhere classified/unspecified, including avohilmo

714

6063

1.20

4.74

2.7

2.3

12.68

13.14

nmol/l

0.76

656

5506

Drug-induced polyneuropathy

280

2.02

4.72

3.5

2.5

7.80

13.04

nmol/l

4.22

259

Viral warts

448

3646

1.25

4.71

2.7

2.3

13.31

12.80

nmol/l

0.65

417

3322

Viral and other specified intestinal infections

1187

10216

1.15

4.71

2.5

2.3

12.13

12.66

nmol/l

1.29

1089

9438

Suggestive for eosinophilic asthma

430

3488

1.26

4.70

2.5

2.3

13.77

13.49

nmol/l

0.32

385

3168

Bacterial intestinal infections, IBD co-morbidities

722

6136

1.19

4.70

2.4

2.3

11.98

12.90

nmol/l

2.07

641

5486

Suppurative and unspecified otitis media

1955

15691

1.11

4.69

2.3

12.04

12.62

nmol/l

2.36

1782

14477

Presence of cardiac and vascular implants and grafts

1976

16006

0.90

4.69

2.3

12.01

13.32

nmol/l

8.39

1711

14345

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

4979

29521

1.07

4.69

2.4

2.3

12.19

12.76

nmol/l

4.96

4469

26912

Benign neoplasm: Tongue

117

778

1.57

4.67

2.7

2.4

13.25

13.07

nmol/l

0.08

108

700

Motor disorders

547

1.70

4.67

2.8

2.3

10.02

11.01

nmol/l

0.38

509

Strabismus

1111

9728

1.15

4.67

2.5

2.3

12.20

12.52

nmol/l

0.62

998

8832

Benign neoplasm: Colon, unspecified

1086

9528

1.15

4.66

2.4

2.3

11.98

12.95

nmol/l

3.54

929

8476

Event of undetermined intent

375

3007

1.28

4.66

2.6

2.4

13.37

13.73

nmol/l

0.36

345

2781

Oral leukoplakia and other epithelial disorders of tongue and oral cavity , including avohilmo

365

2909

1.28

4.64

2.7

2.4

12.43

13.54

nmol/l

1.66

304

2640

Disorders of calcium metabolism

237

1784

1.36

4.62

2.5

2.2

11.34

13.50

nmol/l

3.41

210

1627

Other erythematous conditions

123

826

1.53

4.61

2.7

2.3

12.49

12.84

nmol/l

0.17

110

752

Other and unspecified injuries of lower leg

327

2573

1.30

4.60

2.3

11.23

12.87

nmol/l

2.86

300

2360

Vulvovaginal ulceration/inflammation in other diseases

559

1.63

4.58

1.4

1.03

1.61

nmol/l

5.54

485

Barrett oesophagus

281

2182

1.33

4.58

2.9

2.3

13.23

13.42

nmol/l

0.15

243

1968

Dementia in other diseases classified elsewhere

1243

0.60

4.57

1.6

2.3

12.37

12.53

nmol/l

0.06

1091

Coxarthrosis [arthrosis of hip](FG)

2615

16515

1.10

4.57

2.5

2.3

12.42

13.42

nmol/l

8.12

2322

14894

Intermittent heterotropia

241

1820

1.35

4.57

2.7

2.2

10.45

11.62

nmol/l

1.30

212

1650

Other female pelvic inflammatory diseases

102

652

1.57

4.56

1.4

1.28

1.57

nmol/l

0.91

546

Cyst of kidney

317

2493

1.30

4.56

2.6

2.3

12.39

13.09

nmol/l

0.84

279

2218

Single delivery by forceps and vacuum extractor

174

1447

0.71

4.56

1.2

1.5

1.28

2.12

nmol/l

9.15

153

1251

Bacterial infection, other or unspecified, including avohilmo

2890

21851

1.09

4.55

2.5

2.3

10.47

13.35

nmol/l

55.08

2465

19783

Hordeolum and other deep inflammation of eyelid

250

1903

1.35

4.55

2.4

12.90

12.79

nmol/l

0.07

224

1748

Pregnancy, childbirth and the puerperium

219

1544

0.74

4.55

1.3

1.5

1.37

2.54

nmol/l

10.72

195

1335

Other maltreatment syndromes

222

1678

1.39

4.54

2.5

13.71

14.45

nmol/l

0.64

201

1579

Other/unspecified soft tissue disorders related to use, overuse and pressure

121

814

1.54

4.54

2.3

2.2

13.50

13.05

nmol/l

0.23

109

739

Intracranial injury

3115

26888

1.09

4.54

2.4

2.3

12.51

12.81

nmol/l

1.12

2748

24508

Abnormal findings on diagnostic imaging of lung

2181

18854

1.10

4.53

2.3

12.35

12.99

nmol/l

3.17

1895

16809

Exclusion endpoint for clefts

105

688

1.60

4.53

2.8

2.3

11.33

12.75

nmol/l

0.87

646

Amputation of ankle bones

840

0.52

4.53

2.8

2.5

12.13

13.28

nmol/l

0.47

752

Other/unspecified seropositive rheumatoid arthritis

512

6179

0.82

4.53

2.2

12.70

12.60

nmol/l

0.09

454

5495

Later onset COPD, excluding more controls

621

5613

0.83

4.51

2.0

2.1

11.14

12.26

nmol/l

2.09

483

4922

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

505

6100

0.82

4.51

2.2

12.72

12.61

nmol/l

0.11

448

5427

Personal history of other diseases and conditions

317

2471

1.29

4.51

2.1

2.0

9.09

9.13

nmol/l

0.03

277

2228

Other disorders of breast

112

734

1.54

4.50

1.3

1.4

1.36

1.45

nmol/l

0.15

625

Papillary adenocarcinoma of thyroid gland

134

918

1.49

4.49

2.4

2.3

12.04

13.64

nmol/l

1.23

121

842

Other maternal disorders predominantly related to pregnancy

554

2859

1.22

4.48

1.4

1.32

1.85

nmol/l

7.60

486

2462

Mental and behavioural disorders due to alcohol

3072

31490

0.92

4.47

2.5

2.3

13.29

13.50

nmol/l

0.67

2646

28936

Other and unspecified noninflammatory disorders of ovary, fallopian tube and broad ligament

2.79

4.46

1.6

1.4

1.06

2.20

nmol/l

1.65

Melanoma in situ

169

1216

1.43

4.44

2.5

2.3

12.57

12.51

nmol/l

0.03

148

1073

Lactose intolerance

117

785

1.54

4.43

2.6

2.2

12.43

12.65

nmol/l

0.10

104

723

Seropositive rheumatoid arthritis, wide

522

6273

0.82

4.42

2.2

12.70

12.59

nmol/l

0.11

463

5582

Early syphilis, including avohilmo

112

760

1.60

4.42

2.5

15.26

14.34

nmol/l

0.57

106

717

Percutaneous Coronary Intervention

4089

23246

1.08

4.40

2.6

2.4

12.97

13.74

nmol/l

8.42

3722

21278

Unspecified urinary incontinence

162

1151

1.42

4.40

1.9

2.1

8.68

11.73

nmol/l

4.03

128

1027

Molar incisor enamel hypoplasia

155

1050

1.45

4.40

2.7

2.2

9.68

nmol/l

0.00

141

969

Spirochaetal infections, other/unspecified

336

2670

1.28

4.38

2.3

13.27

13.11

nmol/l

0.13

296

2396

Malignant neoplasm of digestive organs

1224

10549

0.88

4.38

2.1

2.3

12.10

15.14

nmol/l

27.73

1072

9592

Stenosis and insufficiency of lacrimal passages

241

1829

1.34

4.37

2.6

2.3

13.13

12.12

nmol/l

0.93

210

1636

Erysipelas, including avohilmo

4039

27999

1.07

4.36

2.6

2.3

12.06

13.81

nmol/l

35.04

3587

25651

Other peripheral vertigo

282

2191

1.31

4.35

2.3

11.64

12.62

nmol/l

1.18

241

1959

Hypotension

658

5588

1.19

4.35

2.5

2.2

11.59

12.25

nmol/l

1.13

551

4883

Special screening examination for other diseases and disorders

542

4525

1.21

4.35

2.5

2.1

11.40

13.05

nmol/l

4.96

495

4141

Early syphilis

104

700

1.63

4.33

2.5

15.62

14.58

nmol/l

0.64

661

Type1 diabetes, definitions combined, early onset

246

3164

0.75

4.32

1.8

2.5

15.92

13.28

nmol/l

3.92

216

2969

Salpingitis and oophoritis

512

1.63

4.32

1.2

1.4

0.91

1.30

nmol/l

3.43

423

Atopic conjunctivitis

166

1196

1.42

4.30

2.7

2.3

12.69

12.49

nmol/l

0.10

153

1110

Thyrotoxicosis with diffuse goitre

304

2383

1.29

4.29

2.4

2.1

11.06

11.57

nmol/l

0.40

276

2149

Other/unspecified synovitis and tenosynovitis

435

3562

1.24

4.29

2.4

2.2

12.71

13.18

nmol/l

0.57

395

3234

Superficial injury of thorax

757

6523

1.18

4.28

2.6

2.3

13.44

13.40

nmol/l

0.05

665

5959

Carcinoma in situ of skin of other and unspecified parts of face

250

1916

1.33

4.27

2.3

2.2

11.99

11.65

nmol/l

0.21

206

1634

Varicella [chickenpox]

348

2811

1.29

4.27

2.6

2.4

13.78

14.10

nmol/l

0.36

331

2635

Benign neoplasm of mouth and pharynx

438

3596

1.24

4.26

2.5

2.3

12.87

13.27

nmol/l

0.31

387

3243

Unspecified privation

481

3988

1.23

4.26

2.3

2.4

12.40

13.22

nmol/l

1.26

421

3628

Acute suppurative otitis media

1460

12226

1.12

4.24

2.4

2.3

12.36

12.68

nmol/l

0.75

1331

11341

Fracture of skull and facial bones

1312

11740

1.13

4.24

2.5

2.4

14.07

13.84

nmol/l

0.45

1171

10873

Other otitis externa (chronic)

265

2055

1.32

4.23

2.6

2.3

11.85

12.97

nmol/l

1.22

226

1871

Other and unspecified urticaria

680

5803

1.18

4.23

2.5

2.2

10.98

12.17

nmol/l

3.56

613

5267

Calculus of lower urinary tract

290

2286

1.31

4.22

2.1

2.3

12.23

13.14

nmol/l

0.92

256

2015

Other disorders of skin and subcutaneous tissue

3194

25048

1.08

4.22

2.4

2.3

12.52

12.69

nmol/l

0.50

2866

22479

Other and unspecified coagulation defects

185

1363

1.39

4.20

2.4

2.3

11.18

12.23

nmol/l

1.01

167

1242

Other congenital malformations of skin, including avohilmo

296

2328

1.30

4.20

2.4

2.3

12.53

12.33

nmol/l

0.16

268

2117

Other disorders of conjunctiva

534

4472

1.21

4.20

2.4

2.3

12.73

13.06

nmol/l

0.38

472

3988

Bicipital tendinitis

254

1969

1.33

4.19

3.0

2.2

13.09

14.08

nmol/l

1.36

236

1795

Malignant neoplasm of breast

783

0.62

4.18

1.3

1.4

1.29

1.27

nmol/l

0.02

649

Viral meningitis, including avohilmo

167

1215

1.42

4.17

2.7

2.3

13.15

12.93

nmol/l

0.13

156

1135

Coronary revascularization (ANGIO or CABG)

4088

23261

1.07

4.16

2.6

2.4

12.99

13.74

nmol/l

8.09

3729

21292

Pediculosis, acariasis and other infestations, including avohilmo

864

7536

1.16

4.13

2.4

2.3

12.50

12.79

nmol/l

0.48

770

6932

Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs

284

2229

1.30

4.12

2.4

12.90

13.31

nmol/l

0.22

254

2023

Other abnormal auditory perceptions

254

1.95

4.12

2.2

2.3

14.09

12.47

nmol/l

0.67

239

Sacrococcygeal disorders, not elsewhere classified

539

1.62

4.11

3.0

2.3

10.91

12.24

nmol/l

0.97

501

Abnormal blood-pressure reading, without diagnosis

166

1206

1.41

4.10

2.9

2.2

12.05

13.40

nmol/l

1.32

151

1111

Other acute lower respiratory infections

2764

24383

1.09

4.09

2.6

2.3

12.45

12.85

nmol/l

1.78

2482

22195

Calcific aortic valvular stenosis

961

10512

0.87

4.09

2.1

2.2

11.14

12.41

nmol/l

5.18

810

9142

Calcific aortic valvular stenosis, operated

961

10512

0.87

4.09

2.1

2.2

11.14

12.41

nmol/l

5.18

810

9142

Calcific aortic valvular stenosis, including rheumatic fever

963

10520

0.87

4.08

2.1

2.2

11.20

12.41

nmol/l

4.79

812

9148

Lichen planus

396

3229

1.24

4.06

2.4

2.3

12.71

13.26

nmol/l

0.70

349

2904

Zoster [herpes zoster]

639

5447

1.19

4.06

2.6

2.2

12.33

12.70

nmol/l

0.51

551

4846

Atrophic disorders of skin

317

2516

1.27

4.05

2.6

2.3

11.02

12.06

nmol/l

1.24

287

2271

Exposure to other and unspecified inanimate mechanical forces

430

3554

1.24

4.05

2.4

13.63

13.73

nmol/l

0.08

393

3278

Congenital malformations of the musculoskeletal system, not elsewhere classified

240

1.95

4.04

2.9

2.2

5.87

10.55

nmol/l

3.18

230

Bacterial infection, other or unspecified

2603

20292

1.09

4.04

2.5

2.3

10.26

13.36

nmol/l

56.64

2207

18325

Calcific aortic valvular stenosis, diagnosis (helper)

960

10493

0.87

4.04

2.1

2.2

11.15

12.41

nmol/l

5.11

809

9127

Operations 2 for CAVS

960

10493

0.87

4.04

2.1

2.2

11.15

12.41

nmol/l

5.11

809

9127

Non-allergic asthma (mode)

749

6407

1.17

4.03

2.6

2.1

12.03

12.72

nmol/l

1.48

678

5857

Family history of malignant neoplasm

273

2131

1.30

4.03

2.5

2.2

10.93

11.63

nmol/l

0.61

255

1931

Type 1 diabetes

1206

13464

0.88

4.02

2.3

14.28

14.04

nmol/l

0.41

1052

12454

Secondary malignant neoplasm of other and unspecified sites

413

1.72

4.01

2.4

3.09

15.55

nmol/l

24.98

368

Acute generalized exanthematous pustulosis

153

1102

1.42

4.00

2.3

11.50

12.49

nmol/l

0.73

140

993

Cutaneous abscess, furuncle and carbuncle

1446

13049

1.12

3.98

2.7

2.3

12.15

13.42

nmol/l

5.86

1286

11963

Unspecified mental disorder

1769

19392

0.90

3.97

2.7

2.4

11.32

13.49

nmol/l

24.42

1555

17907

Benign neoplasm: Stomach

284

2237

1.29

3.97

2.7

2.3

12.24

12.72

nmol/l

0.24

251

1983

Acute lymphadenitis

268

2104

1.31

3.96

2.4

2.3

12.70

13.22

nmol/l

0.45

242

1950

Congenital malformations of eye, ear, face and neck

274

2155

1.30

3.96

2.3

2.2

11.92

12.03

nmol/l

0.07

254

1972

Malignant neoplasm of breast, HER2-negative

780

0.63

3.95

1.3

1.4

1.28

1.27

nmol/l

0.01

647

Female genital prolapse

104

376

1.54

3.94

1.6

1.3

1.25

1.41

nmol/l

0.35

307

Other salmonella infections, including avohilmo

183

1365

1.38

3.91

2.5

2.4

13.53

13.25

nmol/l

0.17

162

1243

Viral meningitis

159

1162

1.41

3.90

2.7

2.3

13.38

12.96

nmol/l

0.27

148

1083

Dialysis

124

1740

0.69

3.90

2.2

2.4

11.72

13.90

nmol/l

3.27

116

1585

Motorcycle rider injured in noncollision transport accidents

228

1773

1.35

3.88

2.4

14.74

14.20

nmol/l

0.53

219

1660

Benign neoplasm of urinary organs

159

1159

1.41

3.88

2.1

2.3

11.21

12.61

nmol/l

1.25

131

1028

Hypermobility syndrome

109

739

1.50

3.87

2.5

2.0

8.09

8.23

nmol/l

0.06

677

Benign neoplasm: Liver

494

1.63

3.86

3.7

2.2

12.39

11.95

nmol/l

0.16

447

Acute peritonitis

170

2276

0.73

3.85

2.4

2.3

11.67

13.34

nmol/l

2.14

152

2049

Supervision of normal pregnancy

189

1445

0.74

3.85

1.3

1.5

1.26

2.40

nmol/l

12.85

163

1231

Primary_lymphoid and hematopoietic malignant neoplasms

1054

9360

1.14

3.84

2.6

2.3

12.44

12.87

nmol/l

0.95

954

8317

Malignant neoplasm of breast, including Hilmo

816

0.64

3.84

1.3

1.5

1.28

nmol/l

0.01

681

Autoimmune hepatitis, wide definition

185

1386

1.37

3.83

2.5

2.3

13.28

13.22

nmol/l

0.03

160

1285

Other mycoses, not elsewhere classified/unspecified, including avohilmo

611

1.58

3.82

3.2

2.4

12.20

13.13

nmol/l

0.55

558

Mental retardation, wide definition

113

1596

0.68

3.82

3.2

2.4

10.07

12.88

nmol/l

2.61

1469

Abnormal findings in nipple discharge synovial fluid wound secretions

358

1.75

3.81

2.3

2.4

13.88

13.09

nmol/l

0.27

331

Subacute thyroiditis

541

1.59

3.81

2.6

2.1

10.83

11.39

nmol/l

0.22

487

Sarcoidosis

568

4833

1.19

3.81

2.6

2.4

13.05

13.76

nmol/l

1.53

509

4418

Type of accident

1437

12990

1.12

3.81

2.4

2.3

12.66

13.15

nmol/l

1.27

1291

11856

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

300

2400

1.28

3.79

2.5

2.3

10.76

12.70

nmol/l

3.05

261

2213

Muscle strain

154

1125

1.41

3.79

2.6

2.3

12.65

13.52

nmol/l

0.68

138

1032

Type 1 diabetes, strict (exclude DM2)

404

4847

0.81

3.76

1.9

2.4

16.22

14.01

nmol/l

4.79

357

4550

Type 1 diabetes, definitions combined

407

4879

0.82

3.76

1.9

2.4

16.21

14.05

nmol/l

4.64

360

4579

Extracorporeal dialysis

208

2687

0.75

3.74

2.4

11.76

13.72

nmol/l

2.80

187

2430

Calcific tendinitis of shoulder

190

1432

1.35

3.74

2.6

2.3

12.66

13.43

nmol/l

0.63

179

1299

Contact with sharp glass

235

1837

1.32

3.73

2.5

2.3

13.49

13.69

nmol/l

0.12

211

1705

Other deformities of toe(s)

593

1.55

3.71

2.9

2.2

15.43

12.75

nmol/l

1.48

541

Varicella [chickenpox], including avohilmo

370

3051

1.25

3.71

2.6

2.4

13.43

13.81

nmol/l

0.44

350

2850

Carcinoma in situ of skin

271

2144

1.29

3.71

2.7

2.2

13.25

12.57

nmol/l

0.59

237

1862

Conductive hearing loss, unspecified

322

2603

1.26

3.69

2.5

2.3

13.28

13.06

nmol/l

0.17

291

2362

Malignant neoplasm of breast, HER2-negative, including Hilmo

816

0.65

3.68

1.3

1.5

1.27

1.28

nmol/l

0.00

681

Lactose intolerance, other/unspecified

102

694

1.51

3.68

2.6

2.2

12.61

12.69

nmol/l

0.03

641

Hyperlipidaemia, other/unspecified

1876

15448

1.10

3.68

2.5

2.2

12.07

13.51

nmol/l

11.75

1629

13920

Acquired stenosis of external ear canal

478

1.68

3.68

2.7

2.4

14.77

13.67

nmol/l

0.44

436

Alzheimer’s disease (Late onset)

447

4406

0.83

3.67

2.1

10.63

10.56

nmol/l

0.05

364

3672

Non-allergic asthma (mode), excluding more controls

749

6458

1.16

3.67

2.6

2.1

12.03

12.75

nmol/l

1.57

678

5904

Motor- or nonmotor-vehicle accident, type of vehicle unspecified

662

1.56

3.65

2.5

2.3

13.12

13.77

nmol/l

0.34

625

Macular hole

162

1196

1.38

3.65

2.1

2.2

12.25

12.55

nmol/l

0.16

142

1047

Cardiodefibrillation

1796

16410

1.10

3.64

2.4

2.3

13.03

13.09

nmol/l

0.11

1579

14596

Normotensive glaucoma

220

1698

1.31

3.62

2.0

2.2

12.98

12.06

nmol/l

0.86

185

1471

Other specified congenital malformation syndromes affecting multiple systems

587

1.58

3.61

2.9

2.3

11.34

12.66

nmol/l

0.68

549

Melanocytic naevi of other and unspecified parts of face

190

1440

1.35

3.61

2.6

2.3

11.87

12.26

nmol/l

0.24

182

1307

Benign leiomyoma with endometriosis

343

1.70

3.61

1.3

1.4

0.78

1.22

nmol/l

4.06

280

Acute nasopharyngitis (common cold)

931

8208

1.15

3.61

2.6

2.5

13.92

14.44

nmol/l

1.60

890

7717

Intestinal adhesions without obstruction

312

2519

1.26

3.60

2.5

2.2

12.45

13.09

nmol/l

0.62

277

2268

Superficial injury of forearm

456

3828

1.21

3.59

2.5

2.3

12.43

12.71

nmol/l

0.29

420

3513

Rheumatoid arthritis

822

8291

0.87

3.59

2.2

12.73

12.63

nmol/l

0.13

732

7456

Optic atrophy

547

1.59

3.59

4.4

2.4

12.58

13.05

nmol/l

0.22

496

Disorders of male genital organs in diseases classified elsewhere

439

1.75

3.59

2.9

2.4

13.82

14.40

nmol/l

0.25

410

Sacroiliitis, not elsewhere classified

189

1435

1.35

3.58

2.6

2.3

12.68

12.87

nmol/l

0.12

180

1340

Other vitreous opacities

151

1110

1.40

3.56

2.4

2.3

12.49

12.77

nmol/l

0.15

139

993

Other specified/unspecified dorsopathies

113

789

1.47

3.56

3.0

2.3

12.05

12.98

nmol/l

0.66

101

737

Bacterial Sepsis

2045

18329

0.92

3.55

2.6

2.3

10.88

13.21

nmol/l

28.08

1755

16488

Cytomegalovirus infection, IBD co-morbidity

117

829

1.47

3.55

3.2

2.3

13.63

13.54

nmol/l

0.04

111

757

Subarachnoid haemorrhage

247

3119

0.78

3.55

2.2

2.3

12.48

13.11

nmol/l

0.45

208

2783

Dermatitis due to substances taken internally

197

1507

1.33

3.54

2.2

2.3

11.41

12.42

nmol/l

0.93

180

1358

Other and unspecified nail disorders

595

1.55

3.53

2.6

2.3

10.98

13.07

nmol/l

1.51

541

Pneumonitis due to solids and liquids

244

3079

0.78

3.53

2.6

2.3

12.25

12.90

nmol/l

0.60

202

2732

Combinations of oral blood glucose lowering drugs

1355

14932

0.90

3.53

2.7

2.2

10.37

14.19

nmol/l

78.74

1203

13595

Other disorders of skin and subcutaneous tissue, not elsewhere classified

543

4631

1.19

3.52

2.6

2.2

11.56

12.96

nmol/l

3.65

471

4153

Other infective otitis externa

249

1968

1.29

3.52

2.3

12.24

13.00

nmol/l

0.68

209

1798

Glomerular diseases

710

8122

0.86

3.49

2.3

12.43

13.37

nmol/l

2.45

635

7341

Injuries to unspecified part of trunk, limb or body region

444

3730

1.21

3.49

2.3

11.96

12.95

nmol/l

1.78

402

3385

Gonococcal infection, including avohilmo

157

1168

1.38

3.49

2.2

2.4

15.43

14.34

nmol/l

0.92

151

1096

Pre-existing hypertension complicating pregnancy, childbirth and the puerperium

511

1.56

3.48

1.3

1.4

1.10

1.32

nmol/l

1.23

435

Fall on and from stairs and steps

1089

9747

1.13

3.48

2.4

2.3

12.17

12.96

nmol/l

2.39

977

8834

Separation of retinal layers (serosa)

261

2090

1.29

3.47

2.7

2.4

13.73

14.07

nmol/l

0.32

248

1939

Other disorders of Eustachian tube

115

812

1.46

3.46

3.2

2.3

13.48

12.87

nmol/l

0.29

101

738

Optic atrophy, wide definition

568

1.56

3.45

4.5

2.4

12.81

13.01

nmol/l

0.08

513

Corneal ulcer

895

7932

1.14

3.44

2.5

2.3

13.75

13.43

nmol/l

0.55

815

7276

Other congenital malformations of skin

144

1057

1.40

3.44

2.3

12.76

12.32

nmol/l

0.27

134

970

Supplementary factors related to causes of morbidity and mortality classified elsewhere

1570

14338

1.10

3.43

2.3

12.69

13.12

nmol/l

1.14

1405

13100

Scabies, including avohilmo

733

6414

1.16

3.43

2.4

2.3

12.37

12.77

nmol/l

0.66

652

5921

Perichondritis of external ear

448

1.63

3.42

2.6

2.3

13.02

13.39

nmol/l

0.15

401

Non-small cell lung cancer, adenocarcinoma

187

1426

1.33

3.42

1.9

2.2

9.05

15.23

nmol/l

16.11

154

1264

Ulcer of lower limb, not elsewhere classified

477

5612

0.84

3.40

2.4

2.3

11.30

13.10

nmol/l

5.48

403

4999

Degenerative macular diseases

366

3022

1.23

3.40

2.4

2.2

12.66

12.29

nmol/l

0.35

325

2657

Mental retardation

111

1535

0.70

3.39

3.2

2.4

10.08

12.92

nmol/l

2.63

1413

Intentional self-harm by unspecified means

467

1.62

3.38

2.5

2.4

10.42

13.29

nmol/l

1.92

445

Use of memantine

593

5541

0.85

3.38

2.0

2.1

10.61

10.98

nmol/l

0.41

486

4646

Use of other anti-dementia drugs

593

5541

0.85

3.38

2.0

2.1

10.61

10.98

nmol/l

0.41

486

4646

Ill-defined and unknown causes of mortality

290

3571

0.80

3.38

2.4

2.3

10.21

12.81

nmol/l

6.25

250

3144

Familial hypercholesterolemia, with ischemic heart disease

287

3534

0.80

3.38

2.5

2.2

11.45

12.84

nmol/l

2.26

236

3110

Oral lichen planus or lichen planus, and hypothyroidism or thyroxine medication

613

1.50

3.37

2.7

2.3

10.67

11.45

nmol/l

0.31

541

Hypertension, Pulmonary Arterial

188

0.25

3.37

2.0

2.3

8.21

13.11

nmol/l

—

169

Spondyloarthritis

820

7234

1.15

3.37

2.3

13.41

13.19

nmol/l

0.33

743

6601

Oral lichen planus, including avohilmo , including avohilmo

177

1341

1.34

3.37

2.5

2.3

13.48

12.78

nmol/l

0.59

156

1217

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

316

2576

1.25

3.36

2.8

2.3

11.48

12.75

nmol/l

0.92

274

2340

Pregnancy examination and test

269

1320

1.27

3.34

1.3

1.5

1.38

2.41

nmol/l

8.46

242

1125

Prolonged pregnancy

155

1770

0.74

3.33

1.3

1.5

1.25

1.90

nmol/l

7.65

137

1541

Anomalies of pupillary function

506

1.57

3.32

2.0

2.5

12.78

12.45

nmol/l

0.09

475

Type 1 diabetes, strict definition

341

4100

0.81

3.32

1.7

2.4

16.66

14.04

nmol/l

5.83

300

3870

Other hammer toe(s) (acquired)

337

2507

1.23

3.31

2.4

2.1

13.24

12.82

nmol/l

0.37

286

2237

Ankylosing spondylitis

442

3737

1.21

3.30

2.3

14.21

13.82

nmol/l

0.50

398

3472

Benign neoplasm: Rectosigmoid junction

159

1197

1.36

3.28

2.7

2.4

13.40

13.11

nmol/l

0.17

136

1066

Chondromalacia

117

840

1.44

3.27

2.7

2.3

13.55

13.25

nmol/l

0.16

102

767

Arthropod-borne viral fevers and viral haemorrhagic fevers

480

4094

1.20

3.27

2.5

2.4

13.08

13.71

nmol/l

0.98

437

3735

Cytomegaloviral disease, including avohilmo

124

902

1.43

3.27

3.3

2.4

13.44

13.50

nmol/l

0.03

117

824

Abscess of anal and rectal regions

516

4430

1.19

3.26

2.5

2.3

13.39

14.02

nmol/l

1.09

463

4114

Helminthiases, including avohilmo

147

1093

1.38

3.24

2.6

2.2

11.54

11.53

nmol/l

0.00

138

998

Carpal tunnel syndrome

2526

20388

1.08

3.24

2.7

2.3

12.12

13.07

nmol/l

7.41

2246

18559

Carcinoma in situ of skin of trunk

118

848

1.43

3.24

2.2

2.4

13.92

12.12

nmol/l

0.99

102

727

Phlebitis and thrombophlebitis (not including DVT)

880

7817

1.14

3.23

2.5

2.3

12.09

13.24

nmol/l

4.03

773

7069

Other cataract

1947

13345

1.09

3.23

2.3

12.74

13.10

nmol/l

1.09

1698

12005

Tongue abnormality

181

1387

1.33

3.23

2.7

2.3

12.30

12.79

nmol/l

0.35

164

1243

Dipeptidyl peptidase 4 (DPP-4) inhibitors

2327

19602

0.92

3.22

2.7

2.2

10.07

13.99

nmol/l

111.71

1975

17769

Memory loss

294

2392

1.25

3.21

2.4

2.3

13.78

12.41

nmol/l

1.74

263

2106

Other articular cartilage disorders

108

768

1.46

3.21

2.7

2.3

12.74

13.34

nmol/l

0.41

101

699

Brain glioblastoma and astrocytoma

657

0.55

3.19

1.7

2.5

15.46

15.09

nmol/l

0.10

611

Carcinoma in situ of rectum

484

1.60

3.18

2.3

2.4

12.56

13.45

nmol/l

0.43

429

Implicit Sepsis, including avohilmo

4249

28741

1.06

3.18

2.5

2.3

12.16

13.18

nmol/l

12.26

3718

26228

LeFortI or BSSO operation

158

1193

1.36

3.18

2.7

2.3

12.64

12.68

nmol/l

0.02

147

1114

Preparatory care for dialysis

138

1837

0.73

3.17

2.1

2.4

11.82

13.66

nmol/l

1.82

126

1659

Primary open-angle glaucoma, strict

798

7031

1.14

3.17

2.3

2.2

12.52

12.32

nmol/l

0.25

689

6136

Unspecified behavioural syndromes associated with physiological disturbances and physical factors +Physiological and behavioural factors associated with disorders of diseases classified elsewhere

425

1.62

3.16

3.2

2.2

8.63

11.64

nmol/l

1.73

391

Cellulitis

1179

10673

1.12

3.16

2.7

2.3

12.62

13.52

nmol/l

2.56

1067

9767

Other disorders of pigmentation

140

1037

1.38

3.16

2.5

2.3

13.53

12.61

nmol/l

0.57

124

922

Inflammatory diseases of the central nervous system

362

3019

1.22

3.14

2.6

2.4

12.80

13.45

nmol/l

0.76

325

2771

Causalgia

426

1.61

3.14

3.0

2.3

15.56

13.42

nmol/l

0.72

398

Dementia due to Parkinson's disease

657

0.56

3.12

1.8

2.4

11.92

12.15

nmol/l

0.06

562

Other inflammatory liver diseases

263

2125

1.26

3.12

2.4

2.3

13.65

13.30

nmol/l

0.26

229

1943

Fasciculation

397

1.65

3.11

2.9

2.4

11.57

13.21

nmol/l

0.86

370

Clear cell adenocarcinoma of kidney

201

1576

1.31

3.11

2.3

12.27

15.25

nmol/l

6.03

181

1421

Other peripheral vascular diseases

258

2076

1.26

3.11

2.7

2.3

12.51

12.45

nmol/l

0.04

229

1865

Radial styloid tenosynovitis [de Quervain]

149

1115

1.36

3.11

2.4

2.2

12.64

12.04

nmol/l

0.32

135

1014

All influenza (not pneumonia)

850

7570

1.14

3.11

2.6

2.3

13.17

13.72

nmol/l

1.24

792

6972

Macular cyst

109

779

1.44

3.10

2.1

2.3

12.24

13.15

nmol/l

0.52

694

DVT of lower extremities and pulmonary embolism

1687

15451

1.09

3.10

2.5

2.3

11.20

12.97

nmol/l

15.64

1483

13820

Medial epicondylitis

147

1103

1.37

3.10

2.8

2.3

13.27

13.50

nmol/l

0.11

129

1009

Pilonidal cyst

604

5277

1.17

3.09

2.8

2.4

12.29

14.28

nmol/l

10.08

556

4943

Glaucoma suspect

1200

10860

1.11

3.09

2.2

2.3

12.46

12.72

nmol/l

0.49

1065

9665

Bilateral sagittal split ramus osteotomy operation

127

932

1.40

3.09

2.7

2.3

12.35

12.53

nmol/l

0.08

121

866

Anxious personality disorder

691

1.48

3.08

2.6

2.4

11.04

13.61

nmol/l

2.17

656

Fracture of lower leg, including ankle

2590

23777

1.07

3.07

2.5

2.3

12.39

13.25

nmol/l

6.23

2341

21741

Kyphosis

295

1.73

3.06

2.1

2.4

12.96

13.19

nmol/l

0.07

271

Benign neoplasm of bone and articular cartilage

345

2872

1.22

3.06

2.3

2.4

12.97

13.25

nmol/l

0.26

315

2648

Other specified/unspecified disorders of bone/cartilage

150

1138

1.37

3.05

3.1

2.3

13.42

13.82

nmol/l

0.30

134

1057

Campylobacter enteritis

131

972

1.39

3.04

2.7

2.4

13.60

13.36

nmol/l

0.11

113

890

Cirrhosis of liver, NAS

167

2156

0.76

3.04

2.2

2.4

13.22

13.52

nmol/l

0.16

148

1932

Benign neoplasm: Transverse colon

461

3942

1.19

3.02

2.6

2.3

12.25

13.01

nmol/l

1.16

412

3505

Mixed specific developmental disorders

107

709

1.45

3.02

2.8

2.3

9.61

12.07

nmol/l

1.73

652

Additional codes for the location of defect, injury or illness

224

1785

1.28

3.01

2.7

2.4

12.38

12.98

nmol/l

0.48

208

1621

Anorexia

235

1.80

3.01

1.6

2.0

7.81

10.64

nmol/l

1.10

217

Atopic dermatitis, strict definition with reimbursement

1288

11262

1.11

3.00

2.4

2.2

11.77

11.94

nmol/l

0.29

1175

10387

Other arthritis (FG)

1289

11740

1.11

3.00

2.3

2.2

12.51

12.96

nmol/l

0.97

1142

10655

Contact with machinery

813

7266

1.14

3.00

2.4

14.42

14.10

nmol/l

0.53

749

6648

Nail disorders

367

3081

1.21

2.98

2.7

2.4

12.17

13.64

nmol/l

2.80

335

2858

Erectile dysfunction, exclusion

184

0.30

2.96

2.5

2.3

9.44

14.21

nmol/l

—

174

Atopic dermatitis, strict definition

1216

10803

1.11

2.95

2.4

2.2

11.58

11.75

nmol/l

0.28

1106

9931

Superficial injury of hip and thigh

571

4961

1.16

2.95

2.3

2.2

12.97

12.64

nmol/l

0.36

496

4443

Mandibular retrognathia AND surgery (BSSO)

686

1.46

2.95

2.8

2.3

12.25

12.70

nmol/l

0.21

641

Abnormalities of gait and mobility

476

4086

1.18

2.95

2.4

2.2

12.06

12.62

nmol/l

0.67

386

3606

Other specified/unspecified soft tissue disorders

123

902

1.39

2.95

2.4

2.2

11.50

12.53

nmol/l

0.73

115

812

Asthma mixed form (mode)

181

1406

1.31

2.95

2.6

2.2

11.68

12.30

nmol/l

0.50

158

1274

Benign neoplasm: Skin of other and unspecified parts of face

334

2779

1.22

2.93

2.5

2.3

11.93

12.44

nmol/l

0.58

289

2474

Accidental poisoning by and exposure to other and unspecified chemicals and noxious substances

152

1158

1.35

2.93

2.6

2.3

12.47

12.80

nmol/l

0.19

138

1067

Endometriosis of rectovaginal septum and vagina

198

1.83

2.93

1.4

1.27

1.66

nmol/l

0.66

164

Angina pectoris

2499

17706

0.93

2.92

2.5

2.3

12.25

13.68

nmol/l

16.53

2234

16056

Glaucoma-related operations

162

1242

1.33

2.92

2.3

12.41

12.63

nmol/l

0.09

135

1089

Other dialysis

1328

0.70

2.90

2.2

2.5

11.89

13.61

nmol/l

1.81

1206

Meralgia paraesthetica

133

995

1.37

2.90

2.6

2.3

12.72

13.02

nmol/l

0.16

122

911

Cytomegaloviral disease

120

888

1.40

2.89

3.3

2.3

13.54

13.49

nmol/l

0.02

114

810

Spontaneous rupture of synovium and tendon

315

2614

1.22

2.88

2.5

2.2

13.61

13.45

nmol/l

0.11

279

2370

Immunodeficiency with predominantly antibody defects

104

749

1.43

2.88

3.0

2.4

13.03

12.97

nmol/l

0.03

694

Toxic effect of contact with venomous animals

172

1336

1.32

2.88

2.2

2.4

13.03

13.05

nmol/l

0.01

157

1223

DVT of lower extremities

745

6606

1.14

2.88

2.4

2.3

11.52

13.22

nmol/l

6.70

658

5951

Injury of unspecified body region

305

2525

1.23

2.88

2.3

2.4

11.90

12.89

nmol/l

1.22

270

2293

Carcinoma in situ of other and unspecified digestive organs

196

1551

1.30

2.87

2.2

2.3

11.50

13.26

nmol/l

2.48

166

1386

Other diseases of pleura

1844

17270

0.92

2.86

2.4

2.3

12.19

12.87

nmol/l

2.55

1575

15301

Renal cell carcinoma of kidney

100

714

1.43

2.86

2.6

2.3

11.92

14.91

nmol/l

1.94

638

Biomechanical lesions, not elsewhere classified

179

1397

1.31

2.86

2.5

2.3

11.88

13.00

nmol/l

0.97

155

1253

Dystonia

157

1202

1.33

2.86

2.6

2.3

12.93

12.76

nmol/l

0.09

134

1091

Excessive vomiting in pregnancy

693

1.43

2.86

1.3

1.4

1.23

1.61

nmol/l

2.66

593

Seropositive rheumatoid arthritis

523

6001

0.86

2.86

2.2

12.70

12.80

nmol/l

0.10

464

5384

Hypertrophy of (infrapatellar) fat pad

303

1.71

2.85

2.8

2.2

13.98

13.76

nmol/l

0.08

287

Other osteochondropathies

354

2983

1.21

2.84

2.5

2.4

13.21

13.67

nmol/l

0.55

329

2768

Pedal cyclist injured in transport accident

1145

10413

1.11

2.84

2.3

13.98

13.33

nmol/l

1.72

1040

9558

Lymphoid leukaemia

229

1846

1.27

2.83

2.8

2.3

11.43

12.77

nmol/l

1.56

206

1644

Generalized skin eruption due to drugs and medicaments

129

963

1.37

2.83

2.3

11.25

12.47

nmol/l

0.85

117

865

Lesion of lateral popliteal nerve

236

1912

1.26

2.82

2.5

2.3

12.78

13.80

nmol/l

1.29

213

1742

Other condition

696

6163

1.14

2.82

2.4

2.3

12.91

13.55

nmol/l

1.16

639

5648

Disorders of conjunctiva

3937

28935

1.06

2.81

2.5

2.3

12.57

12.75

nmol/l

0.68

3563

26465

Cardiomyopathy, other and unspecified

270

3271

0.81

2.80

2.4

2.3

13.41

13.59

nmol/l

0.12

237

2985

Foreign body in ear

620

1.47

2.79

2.1

2.2

12.02

12.78

nmol/l

0.36

567

Other disorders of cornea

376

3182

1.20

2.79

2.3

2.4

13.26

13.58

nmol/l

0.36

334

2920

Papilloedema, unspecified

636

1.46

2.78

2.4

9.63

12.38

nmol/l

2.39

582

Respiratory tuberculosis

103

1411

0.72

2.78

2.0

2.3

11.81

12.39

nmol/l

0.28

1238

Hodgkin lymphoma, hilmo

138

1049

1.36

2.78

2.5

12.47

13.42

nmol/l

0.82

132

957

Bronchitis, not specified as acute or chronic

413

3529

1.19

2.77

2.5

2.3

13.28

13.73

nmol/l

0.60

372

3252

Respiratory tuberculosis, confirmed and not-confirmed

103

1410

0.72

2.77

2.0

2.3

11.81

12.40

nmol/l

0.28

1237

Benign neoplasm: Conjunctiva

119

882

1.38

2.77

2.4

2.3

12.48

13.02

nmol/l

0.28

104

796

Sicca syndrome [Sjögren]

128

953

1.36

2.77

2.4

2.2

11.78

11.37

nmol/l

0.21

111

857

Hypertrophy of tongue papillae

376

1.61

2.76

2.3

11.83

13.40

nmol/l

0.58

345

Failed induction of labour

111

809

1.39

2.75

1.2

1.4

1.17

1.66

nmol/l

4.30

690

Other diseases of stomach and duodenum

228

1840

1.26

2.75

2.5

2.2

12.94

13.00

nmol/l

0.04

202

1655

Superficial injury of head

1064

9642

1.11

2.73

2.4

2.3

12.95

13.05

nmol/l

0.14

913

8833

Benign neoplasm: Middle ear, nasal cavity and accessory sinuses

172

1348

1.31

2.73

2.2

2.4

13.13

13.35

nmol/l

0.13

155

1221

Bell's palsy

475

4106

1.17

2.72

2.5

2.3

12.34

13.34

nmol/l

1.80

422

3730

Embolic stroke

103

1401

0.72

2.71

2.2

2.3

10.41

12.27

nmol/l

1.10

1216

Disorders of synovium and tendon in diseases classified elsewhere

109

804

1.41

2.69

2.6

2.3

13.52

13.72

nmol/l

0.10

741

Malignant neoplasm of bladder

225

1815

1.26

2.69

1.9

2.2

10.40

15.27

nmol/l

14.15

193

1592

Mild mental retardation

987

0.67

2.69

3.2

2.3

9.06

13.05

nmol/l

2.90

915

Benign neoplasm of ovary

453

1.51

2.68

1.6

1.3

1.69

1.30

nmol/l

0.34

371

Malignant neoplasm of pancreas, including Hilmo

169

2151

0.78

2.68

2.0

2.3

12.74

15.12

nmol/l

3.35

152

1925

Medical abortion

443

2805

0.85

2.68

1.4

1.15

1.84

nmol/l

12.73

365

2432

Exposure to excessive natural cold

470

0.52

2.67

1.9

2.5

10.29

14.09

nmol/l

2.18

423

Coxarthrosis, primary, with hip surgery

1755

15096

1.08

2.65

2.5

2.2

12.00

12.84

nmol/l

4.29

1553

13327

Asthma mixed form (mode), excluding more controls

181

1428

1.29

2.65

2.6

2.2

11.68

12.38

nmol/l

0.59

158

1289

Chronic kidney disease

1242

13031

0.91

2.63

2.4

2.2

11.00

12.79

nmol/l

12.13

1091

11503

Other and unspecified injuries of ankle and foot

187

1487

1.29

2.63

2.3

12.93

12.68

nmol/l

0.13

166

1372

Misadventures to patients during surgical and medical care

510

4441

1.16

2.63

2.5

2.3

11.64

12.76

nmol/l

2.40

452

3971

Benign neoplasm: Long bones of lower limb

152

1180

1.33

2.62

2.3

2.4

14.04

13.40

nmol/l

0.44

138

1083

Atopic dermatitis

2799

20998

1.07

2.62

2.4

2.3

12.05

12.77

nmol/l

4.68

2541

19381

Tuberculosis

117

1557

0.74

2.62

1.9

2.3

11.55

12.30

nmol/l

0.42

1363

Diseases of arteries, arterioles and capillaries

2949

22880

0.94

2.62

2.3

12.41

13.22

nmol/l

5.84

2544

20663

Panniculitis affecting regions of neck and back

126

950

1.35

2.61

2.6

2.2

11.80

13.11

nmol/l

0.99

116

879

Malignant neoplasm of bronchus and lung, including Hilmo

524

5004

0.87

2.61

2.0

2.2

10.15

15.18

nmol/l

32.38

435

4430

Colorectal cancer, including Hilmo

892

7487

1.12

2.60

2.1

2.2

11.56

15.10

nmol/l

27.41

783

6744

Congenital deformities of feet, including avohilmo

165

1294

1.30

2.60

3.0

2.3

11.38

12.96

nmol/l

2.07

146

1205

Antibody deficiency with near-normal immunoglobulins or with hyperimmunoglobulinaemia

4.98

2.59

6.4

2.3

14.54

13.41

nmol/l

—

Spasmodic torticollis

576

1.45

2.59

2.5

2.2

14.73

12.43

nmol/l

1.47

528

Alzheimer’s disease (Late onset), excluding more controls

353

2710

0.84

2.58

2.2

2.1

11.30

11.19

nmol/l

0.07

291

2343

Ménière disease

259

2132

1.23

2.58

2.3

12.39

12.62

nmol/l

0.16

238

1906

Follicular cysts of skin and subcutaneous tissue

861

7761

1.12

2.58

2.5

2.3

12.68

13.56

nmol/l

1.89

786

7081

Bacterial, viral and other infectious agents, including avohilmo

531

4660

1.16

2.58

2.6

2.4

13.41

13.85

nmol/l

0.71

503

4341

Other and unspecified skin changes due to chronic exposure to nonionizing radiation

271

1.68

2.57

2.9

2.2

13.61

12.99

nmol/l

0.16

233

Chronic hepatitis, not elsewhere classified

124

937

1.36

2.56

2.4

13.88

13.17

nmol/l

0.40

111

855

Benign neoplasm of brain and other parts of central nervous system

241

1976

1.24

2.56

3.1

2.4

12.51

13.15

nmol/l

0.59

216

1790

Dementia due to Parkinsons disease, excluding more controls

621

0.60

2.56

1.8

2.1

11.92

12.12

nmol/l

0.05

528

Focal epilepsy

782

8703

0.89

2.55

2.4

2.3

12.52

13.05

nmol/l

0.96

698

7871

Alcoholic cardiomyopathy

275

0.40

2.54

3.3

2.4

10.93

13.91

nmol/l

0.48

250

Oesophageal varices

132

1709

0.75

2.54

2.0

2.3

14.47

13.76

nmol/l

0.39

109

1549

Other disorders of bone density and structure

101

741

1.40

2.54

2.7

2.4

11.92

13.02

nmol/l

0.73

690

Endovascular or surgical operations to intracerebral aneurysms

133

1728

0.76

2.54

2.8

2.4

14.50

13.49

nmol/l

0.48

116

1564

Use of levodopa decarbox-comt-inhibitor

1001

0.68

2.54

1.9

2.3

12.60

12.82

nmol/l

0.08

880

Persistent delusional disorders

217

2660

0.80

2.54

2.8

2.4

11.61

13.94

nmol/l

3.92

191

2442

Contusion of other and unspecified parts of foot

242

1989

1.24

2.53

2.3

2.2

11.48

12.66

nmol/l

1.42

213

1838

Type 1 diabetes, strict definition, subgroup 1

331

3883

0.84

2.53

1.7

2.4

16.55

14.02

nmol/l

5.31

292

3661

Sequelae of other external causes

220

1789

1.25

2.53

3.1

2.3

11.64

13.15

nmol/l

2.01

201

1629

Thyroiditis, unspecified

210

1.76

2.53

2.3

2.1

9.39

11.98

nmol/l

1.05

192

Nonalcoholic steatohepatitis

298

1.67

2.53

2.7

2.4

13.18

13.90

nmol/l

0.24

275

Eustachian salpingitis and obstruction

413

3562

1.18

2.52

2.7

2.5

13.62

13.70

nmol/l

0.08

386

3338

Reactive arthropathies

364

3104

1.19

2.52

2.4

2.2

13.12

13.62

nmol/l

0.60

332

2849

Benign neoplasm of other and unspecified sites

122

923

1.36

2.52

2.8

2.3

12.84

13.33

nmol/l

0.27

109

834

Malignant neoplasm of bronchus and lung

453

4368

0.86

2.51

1.9

2.2

9.74

15.20

nmol/l

33.12

379

3855

Disorders of lens

3279

19263

1.06

2.50

2.4

2.3

13.17

13.44

nmol/l

0.97

2883

17519

Right hemicolectomy

123

1610

0.75

2.49

2.1

2.3

11.78

12.93

nmol/l

0.70

115

1428

Malignant neoplasm of breast, ER-positive, including Hilmo

558

0.64

2.48

1.4

1.5

1.73

1.28

nmol/l

0.24

456

Visual impairment including blindness (binocular or monocular)

216

1754

1.25

2.48

2.8

2.3

11.71

12.53

nmol/l

0.58

180

1557

Condition for Implicit Sepsis (Organ dysfunction codes)

4425

29266

1.05

2.48

2.5

2.3

12.37

13.20

nmol/l

8.84

3897

26758

Benign neoplasm: Brain, supratentorial

460

1.51

2.48

3.0

2.4

12.67

13.13

nmol/l

0.16

423

Ectopic pregnancy

126

952

1.33

2.47

1.2

1.4

1.15

1.43

nmol/l

1.90

109

812

Otitis media, unspecified

476

3816

1.16

2.47

2.6

2.2

10.70

11.62

nmol/l

1.46

437

3505

Injury of muscle and tendon at forearm level

116

881

1.37

2.46

2.9

2.4

12.62

13.66

nmol/l

0.60

110

820

Mixed disorders of conduct and emotions

118

894

1.36

2.46

2.3

2.0

10.49

12.18

nmol/l

0.99

106

835

Syphilis, including avohilmo

162

1287

1.31

2.45

2.3

2.5

14.65

14.02

nmol/l

0.43

149

1191

Syphilis

162

1287

1.31

2.45

2.3

2.5

14.65

14.02

nmol/l

0.43

149

1191

Impacted maxillary molar

258

2140

1.22

2.45

2.1

2.0

9.81

10.21

nmol/l

0.28

245

1969

Insulin, fast-acting or short human

1744

18684

0.93

2.44

2.4

12.96

13.23

nmol/l

0.66

1513

17036

Implicit bacterial Sepsis

1759

16171

0.93

2.44

2.6

2.2

10.76

13.18

nmol/l

26.08

1502

14484

Polymyalgia rheumatica

371

3172

1.18

2.44

2.1

2.2

12.44

12.42

nmol/l

0.02

317

2747

Malignant neoplasm of breast, HER-positive

556

0.64

2.44

1.4

1.5

1.73

1.28

nmol/l

0.24

454

Other and unspecified disorders of white blood cells

152

1191

1.31

2.43

2.9

2.3

12.06

12.77

nmol/l

0.49

132

1069

Other specified disorders of muscle

138

1070

1.33

2.43

2.7

2.3

13.79

nmol/l

0.00

129

980

Viral haemorrhagic fevers, not elsewhere classified/unspecified

383

3297

1.18

2.43

2.5

2.4

12.98

13.70

nmol/l

1.11

351

3008

Combined immunodeficiencies

237

1.72

2.43

2.9

2.6

11.54

12.76

nmol/l

0.39

215

Dislocation, sprain and strain of joints and ligaments of thorax

162

1282

1.30

2.42

2.5

2.3

11.82

13.32

nmol/l

1.66

146

1177

883

6852

1.11

2.42

2.2

11.66

11.47

nmol/l

0.23

716

5869

Tuberculosis, IBD comorbidity

142

1819

0.77

2.42

1.9

2.3

11.78

12.50

nmol/l

0.46

124

1596

Herpesviral [herpes simplex] infections

395

3399

1.17

2.42

2.8

2.3

12.95

12.56

nmol/l

0.39

350

3079

Trigeminal neuralgia

154

1206

1.29

2.41

2.1

2.3

12.43

nmol/l

0.00

140

1090

Specific development disorders of speech and language

282

2279

1.21

2.41

2.4

2.3

11.83

13.09

nmol/l

1.40

261

2092

Multiple myeloma, including Hilmo

133

1024

1.32

2.40

2.4

2.2

12.40

15.18

nmol/l

2.77

113

911

Alzheimer disease, excluding more controls

483

3580

0.87

2.39

2.1

2.0

11.76

11.93

nmol/l

0.15

398

3157

Benign neoplasm: Parathyroid gland

215

1.74

2.38

3.6

2.5

13.87

13.03

nmol/l

0.30

199

Maltreatment syndromes

267

2234

1.22

2.38

2.2

2.3

12.50

13.43

nmol/l

1.05

239

2086

Other retinal disorders

2950

21216

1.06

2.37

2.4

2.3

12.72

13.03

nmol/l

1.09

2546

19091

Unspecified fall

2425

22432

1.07

2.37

2.4

2.3

12.85

12.81

nmol/l

0.07

2123

20371

Chronic conjunctivitis

698

1.39

2.36

2.6

2.4

12.24

12.61

nmol/l

0.17

640

Mixed hyperlipidaemia

200

1629

1.26

2.36

3.7

2.3

11.75

14.10

nmol/l

4.81

178

1496

Disorders of multiple cranial nerves

4.03

2.36

2.9

1.7

11.83

12.73

nmol/l

—

Other disorders of white blood cells

205

1670

1.25

2.35

2.8

2.3

11.98

12.94

nmol/l

0.96

176

1497

Viral agents as the cause of diseases classified to other chapters, including avohilmo

104

778

1.38

2.35

2.2

2.4

12.36

12.86

nmol/l

0.24

709

Other and unspecified glaucoma

196

1585

1.25

2.35

2.3

2.2

11.81

12.47

nmol/l

0.47

168

1384

Tuberculosis, wide

145

1845

0.78

2.35

1.9

2.3

11.78

12.49

nmol/l

0.46

126

1619

Congenital deformities of feet

111

839

1.36

2.35

3.2

2.4

10.65

13.21

nmol/l

3.26

786

Arterial embolism and thrombosis

144

1829

0.77

2.35

2.1

2.3

12.02

12.75

nmol/l

0.48

122

1626

Insulin, fast-acting

1743

18640

0.93

2.34

2.4

2.3

12.97

13.33

nmol/l

0.98

1512

17019

Mental and behavioural disorders due to cannabinoids

226

1874

1.25

2.34

3.2

2.5

11.96

14.88

nmol/l

6.96

191

1791

Foreign body in respiratory tract

184

1482

1.26

2.33

2.4

2.3

11.08

12.68

nmol/l

1.74

161

1355

Tuberculosis, wide, including avohilmo

148

1877

0.78

2.33

2.1

2.3

11.80

12.47

nmol/l

0.44

129

1648

Vascular dementia

155

1888

0.78

2.32

2.0

2.2

9.98

10.67

nmol/l

0.37

127

1586

Colon adenocarcinoma

360

3085

1.18

2.32

2.2

2.3

11.48

15.13

nmol/l

12.90

317

2743

Personal history of certain other diseases

457

1.48

2.31

2.9

2.1

10.44

10.40

nmol/l

0.02

421

Venous thromboembolism

2215

20061

1.07

2.30

2.6

2.3

11.41

12.94

nmol/l

15.24

1953

17963

Other disorders of thyroid

156

1.84

2.30

2.3

10.35

11.58

nmol/l

0.29

146

Cystitis

2978

18681

0.94

2.30

2.3

2.2

9.87

11.78

nmol/l

23.92

2557

16682

Alcohol use disorder, Swedish definition

3340

31839

0.95

2.30

2.5

2.4

13.33

13.49

nmol/l

0.50

2892

29172

Pleural effusion

505

5727

0.87

2.29

2.2

11.29

12.54

nmol/l

2.43

435

5043

Nonsuppurative otitis media

1131

9007

1.10

2.29

2.4

2.2

11.65

11.97

nmol/l

0.57

1018

8247

Leisure time condition

786

7104

1.12

2.27

2.3

12.34

12.95

nmol/l

1.11

697

6458

Contact with sharp object, undetermined intent

156

1246

1.30

2.27

2.5

2.4

12.63

13.91

nmol/l

1.69

144

1155

Vascular disorders of the intestines

227

1873

1.23

2.27

2.0

2.2

11.26

12.67

nmol/l

1.47

186

1663

Intestinal malabsorption

189

1535

1.26

2.26

2.4

14.22

12.91

nmol/l

1.40

167

1408

Diseases of peritoneum

256

3053

0.83

2.26

2.5

2.3

11.87

13.02

nmol/l

1.53

232

2732

Conotruncal defects

485

0.57

2.26

3.0

2.4

10.96

12.59

nmol/l

0.52

454

Other and unspecified drugs and medicaments

286

2414

1.20

2.26

2.9

2.4

11.15

12.80

nmol/l

1.27

250

2196

Tooth agenesis EXCLUDE clefts and syndromes

146

1148

1.29

2.26

2.2

10.23

10.51

nmol/l

0.13

134

1058

Melanocytic naevi of upper limb, including shoulder

620

1.41

2.25

2.5

2.3

13.58

11.79

nmol/l

0.88

560

Malignant neoplasm of digestive organs, including Hilmo

1433

11354

0.92

2.25

2.2

2.3

12.19

15.13

nmol/l

30.92

1259

10357

Other and unspecified corneal deformities and disorders

129

1002

1.32

2.25

2.1

2.4

13.37

13.34

nmol/l

0.02

115

924

Other acquired deformities of musculoskeletal system and connective tissue

208

1710

1.24

2.25

2.7

2.4

15.07

13.81

nmol/l

1.22

195

1567

Primary open-angle glaucoma

972

8531

1.10

2.24

2.3

2.2

12.46

12.22

nmol/l

0.34

839

7428

Other ill-defined and unspecified causes of mortality

272

3221

0.83

2.24

2.4

2.3

9.92

12.78

nmol/l

7.38

237

2830

Malignant neoplasm of other connective and soft tissue, including Hilmo

137

1071

1.30

2.24

2.5

2.3

11.78

14.70

nmol/l

4.37

120

972

Toxic effects of substances chiefly nonmedicinal as to source

573

5100

1.14

2.24

2.5

2.4

13.06

13.40

nmol/l

0.44

517

4698

Peripheral retinal degeneration

106

801

1.35

2.23

2.5

2.3

12.55

12.82

nmol/l

0.12

721

Other degenerative diseases of the nervous system

876

7030

0.90

2.23

2.1

2.0

12.38

12.67

nmol/l

0.41

741

6301

Pacemaker

1336

13392

0.92

2.22

2.4

2.2

11.85

12.54

nmol/l

1.77

1144

11747

Benign lipomatous neoplasm of other sites/unspecified

284

2400

1.20

2.22

2.6

2.4

13.14

12.97

nmol/l

0.07

252

2155

Other salmonella infections

136

1065

1.30

2.22

2.7

2.4

12.78

13.16

nmol/l

0.23

118

961

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

2128

12598

1.07

2.21

2.5

2.2

12.64

13.98

nmol/l

11.91

1936

11738

Other/unspecified enthesopathies, not elsewhere classified

302

2567

1.19

2.20

2.9

2.2

12.90

13.32

nmol/l

0.36

273

2320

Other congenital malformations, not elsewhere classified

229

1.69

2.20

3.5

2.1

10.71

12.85

nmol/l

0.83

219

3509

32787

0.95

2.19

2.5

2.4

13.26

13.40

nmol/l

0.46

3035

30026

Haemangioma, any site

282

2384

1.20

2.19

2.7

2.3

12.10

12.87

nmol/l

0.86

259

2167

Residual foreign body in soft tissue

282

2393

1.20

2.19

2.5

2.3

13.73

13.90

nmol/l

0.12

253

2202

Benign neoplasm: Skin, unspecified

140

1102

1.30

2.19

2.3

2.4

13.38

12.84

nmol/l

0.33

124

991

Lesion of plantar nerve

113

861

1.33

2.18

2.1

2.3

12.92

12.72

nmol/l

0.09

780

Unknown and unspecified causes of morbidity

260

2185

1.21

2.17

2.9

2.2

12.23

13.16

nmol/l

1.13

242

1993

Mental disorders, not otherwise specified

322

2757

1.18

2.17

3.1

2.3

11.72

12.82

nmol/l

1.63

298

2559

Focal epilepsy, strict definition

724

8008

0.90

2.17

2.3

12.57

13.05

nmol/l

0.78

646

7239

Covid-19 suspected case

880

8018

1.11

2.16

2.3

11.94

12.32

nmol/l

0.67

808

7320

Disorder of thyroid, unspecified

152

1.82

2.16

2.3

2.2

9.92

11.58

nmol/l

0.42

142

Benign neoplasm: Choroid

204

1677

1.23

2.15

2.5

2.3

13.47

12.96

nmol/l

0.35

182

1497

Small cell lung cancer

509

0.60

2.15

1.7

2.2

11.41

15.28

nmol/l

2.59

453

Small cell lung cancer, including Hilmo

509

0.60

2.15

1.7

2.2

11.41

15.28

nmol/l

2.59

453

Primary coxarthrosis, bilateral

987

9041

1.10

2.15

2.6

2.2

11.79

12.85

nmol/l

3.83

872

7999

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

1247

11541

1.09

2.14

2.5

2.3

10.73

12.31

nmol/l

7.98

1057

10636

Autoimmune hyperthyroidism

130

1013

1.30

2.14

1.9

2.2

11.30

11.18

nmol/l

0.05

115

922

Other and unspecified disorders of pigmentation

169

1.80

2.13

2.2

2.3

14.78

13.13

nmol/l

0.32

157

Pedal cyclist injured in collision with motor vehicle

144

1144

1.29

2.13

2.0

2.3

12.91

13.16

nmol/l

0.11

134

1050

Dislocation, sprain and strain of joint and ligaments of hip

135

1062

1.30

2.13

2.4

2.3

12.59

13.04

nmol/l

0.18

115

952

Maxillary retrognathism

620

1.40

2.13

3.2

2.4

10.36

12.68

nmol/l

2.02

582

Other local infections of skin and subcutaneous tissue

463

4080

1.15

2.12

3.0

2.3

12.54

13.38

nmol/l

1.47

417

3694

Mumps

146

1167

1.29

2.12

2.8

2.5

13.76

14.11

nmol/l

0.22

137

1082

Graves disease, strict definition

214

1766

1.22

2.12

2.3

2.2

11.23

11.28

nmol/l

0.03

195

1599

Clefts and syndromes for tooth agenesis exclusion, including avohilmo

144

1142

1.29

2.11

2.8

2.4

12.49

12.73

nmol/l

0.11

135

1065

Paralytic ileus and intestinal obstruction

993

9098

1.10

2.11

2.6

2.2

12.49

12.99

nmol/l

1.09

878

8168

Hypocalcemia

628

1.39

2.11

2.2

2.4

10.14

12.75

nmol/l

1.74

564

Laparoscopic right hemicolectomy

190

1556

1.24

2.10

2.3

11.71

12.95

nmol/l

1.21

167

1374

Antenatal screening

218

1479

0.82

2.10

1.3

1.5

1.38

2.41

nmol/l

8.97

190

1263

Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies

187

1530

1.24

2.10

3.3

2.2

12.79

13.58

nmol/l

0.73

176

1407

Struck by thrown, projected or falling objec

319

2749

1.19

2.10

2.5

2.4

12.72

13.83

nmol/l

2.07

300

2541

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified

159

1280

1.27

2.09

3.0

2.4

12.94

12.41

nmol/l

0.37

149

1196

Malignant neoplasm of oesophagus, including Hilmo

103

1339

0.75

2.09

2.2

12.54

15.16

nmol/l

1.95

1207

Other superficial mycoses

114

883

1.33

2.09

2.6

2.4

13.91

13.57

nmol/l

0.16

104

816

Guillain-Barre syndrome

572

1.42

2.08

2.7

2.4

12.84

13.51

nmol/l

0.33

521

Other and unspecified local infections of skin and subcutaneous tissue

433

3805

1.15

2.08

3.1

2.3

12.36

13.34

nmol/l

1.82

391

3447

Implicit bacterial Sepsis, including avohilmo

1988

17550

0.94

2.08

2.6

2.3

10.97

13.22

nmol/l

25.61

1697

15770

Benign neoplasm: Liver/bile ducts

586

1.39

2.07

3.6

2.3

12.50

12.09

nmol/l

0.15

528

Maternal care for cervical incompetence

222

1.64

2.07

1.2

1.3

1.25

1.59

nmol/l

1.09

193

Cardiac murmurs and other cardiac sounds

307

2596

1.18

2.07

2.4

2.1

11.40

11.48

nmol/l

0.05

275

2354

Benign neoplasm: Pancreas

717

1.36

2.05

2.4

2.3

13.12

12.97

nmol/l

0.06

634

Acute renal failure

883

9647

0.91

2.05

2.5

2.3

10.64

13.17

nmol/l

15.45

756

8599

Fibrosis and cirrhosis of liver

224

2672

0.83

2.05

2.2

2.3

13.41

13.32

nmol/l

0.05

201

2396

Viral agents as the cause of diseases classified to other chapters

658

1.38

2.04

2.1

2.4

12.72

13.05

nmol/l

0.14

598

Asthma and opportunity respiratory infection

128

1005

1.29

2.04

2.5

2.3

13.86

12.75

nmol/l

0.75

107

891

Congenital ptosis, including avohilmo

128

1.94

2.03

1.8

2.2

11.43

13.38

nmol/l

0.38

123

Osteopathy in diseases classified elsewhere

211

1.70

2.03

1.9

2.5

6.77

14.27

nmol/l

4.63

198

Mumps, including avohilmo

147

1183

1.28

2.03

2.8

2.5

13.76

14.11

nmol/l

0.23

137

1098

Postmenopausal atrophic vaginitis

231

1.46

2.03

1.4

1.3

1.01

1.37

nmol/l

0.92

192

Malignant neoplasm of bone and articular cartilage

299

1.57

2.02

2.6

2.4

11.06

15.50

nmol/l

2.98

278

5-aminosalicylic acid

1089

10060

1.09

2.02

2.4

2.3

13.46

13.62

nmol/l

0.27

1009

9258

Artificial joint re-operation

188

1544

1.23

2.01

3.0

2.3

12.04

12.90

nmol/l

0.80

165

1367

Other misadventures during surgical and medical care

703

1.36

2.01

2.4

11.64

12.83

nmol/l

0.75

635

Pulmonary heart disease

1111

10261

1.09

2.01

2.5

2.3

11.05

12.98

nmol/l

12.37

973

9164

Allergic contact dermatitis

352

3050

1.16

2.01

2.2

11.38

11.70

nmol/l

0.29

306

2764

Unattended death

331

0.52

2.00

1.6

2.5

15.52

13.84

nmol/l

0.24

298

Follow-up examination after treatment for conditions other than malignant neoplasms

1608

11443

0.93

2.00

2.4

2.1

11.63

12.81

nmol/l

6.24

1430

10464

Drug-induced cataract

722

1.35

1.99

2.7

2.3

12.63

13.35

nmol/l

0.47

662

Other congenital malformations of face and neck

121

950

1.30

1.99

2.3

2.4

12.37

13.02

nmol/l

0.39

110

875

Scar conditions and fibrosis of skin

113

876

1.31

1.99

2.6

2.3

10.71

12.07

nmol/l

1.01

108

800

Pulmonary embolism

1111

10267

1.09

1.99

2.5

2.3

11.05

12.98

nmol/l

12.44

973

9172

Other specified and unspecified disorders of eye and adnexa

122

957

1.30

1.98

2.4

13.55

12.90

nmol/l

0.40

112

871

Short stature starting before birth

153

1.85

1.96

3.5

2.0

7.93

11.65

nmol/l

1.80

140

Unspecified misadventure during surgical and medical care

213

1780

1.22

1.96

2.7

2.4

11.69

12.97

nmol/l

1.56

193

1596

Unspecified jaundice

137

1707

0.79

1.95

2.0

2.4

13.17

12.88

nmol/l

0.15

124

1541

623

1.36

1.94

2.3

2.2

8.02

8.45

nmol/l

0.15

559

Distal bite

136

1076

1.28

1.94

2.3

11.19

9.96

nmol/l

0.82

123

988

Open wound of abdomen, lower back and pelvis

172

1414

1.25

1.94

2.9

2.4

13.43

13.66

nmol/l

0.13

157

1309

Erythema intertrigo

742

1.34

1.94

2.1

2.3

12.92

13.31

nmol/l

0.19

662

Bitten or stung by nonvenomous insect and other nonvenomous arthropods

129

1024

1.29

1.93

2.7

2.3

11.24

12.67

nmol/l

1.25

117

928

Other disorders involving the immune mechanism, not elsewhere classified

164

1343

1.25

1.92

3.4

2.5

12.36

13.57

nmol/l

1.38

154

1231

Disorders of speech understanding and production

183

1481

1.23

1.92

2.5

2.3

12.18

12.43

nmol/l

0.12

171

1343

Infectious mononucleosis, including avohilmo

418

3689

1.15

1.92

2.7

2.3

12.85

12.17

nmol/l

0.97

390

3433

Infectious mononucleosis

418

3689

1.15

1.92

2.7

2.3

12.85

12.17

nmol/l

0.97

390

3433

Malignant neoplasm of bone and articular cartilage, including Hilmo

536

1.40

1.92

2.8

2.5

11.55

14.90

nmol/l

2.46

496

Haemorrhage in early pregnancy

241

1970

1.19

1.92

1.2

1.4

1.16

1.61

nmol/l

5.20

214

1674

Other/unspecified disorders of vestibular function

124

979

1.29

1.92

2.5

2.3

12.00

12.91

nmol/l

0.57

109

879

Alzheimer’s disease (Early onset)

919

0.72

1.91

2.5

2.3

12.16

12.07

nmol/l

0.04

796

Short Achilles tendon (acquired)

560

1.38

1.91

2.8

2.1

12.78

13.09

nmol/l

0.14

515

Family history of certain disabilities and chronic diseases leading to disablement

181

1492

1.23

1.91

2.2

10.94

12.01

nmol/l

0.93

163

1378

Viral pneumonia (unknown virus, not influenza)

328

2851

1.17

1.90

2.7

2.4

12.11

13.59

nmol/l

2.96

299

2626

Other embolism and thrombosis

475

4223

1.14

1.90

2.5

2.3

11.90

13.06

nmol/l

2.43

407

3809

Sequelae of injuries of neck and trunk

149

1209

1.27

1.90

2.6

2.4

13.37

13.49

nmol/l

0.07

131

1123

Bacterial, viral and other infectious agents

496

4435

1.14

1.90

2.6

2.4

13.48

13.98

nmol/l

0.81

469

4131

Disorders of orbit

124

980

1.28

1.90

2.8

2.3

12.52

12.78

nmol/l

0.12

113

892

Chondrocostal junction syndrome [Tietze]

102

786

1.32

1.89

2.9

2.4

11.58

12.49

nmol/l

0.50

722

Overjet

688

1.35

1.89

2.2

2.3

10.88

10.04

nmol/l

0.34

638

Alcohol abuse, main dg

812

8852

0.91

1.89

2.5

2.4

13.23

13.67

nmol/l

0.78

700

8156

Vascular dementia (multiple infarctions)

250

0.47

1.88

1.3

2.2

7.71

10.86

nmol/l

—

207

Other and unspecified nonorganic psychotic disorders

891

9681

0.91

1.88

2.5

2.4

11.13

13.84

nmol/l

17.17

772

9029

Certain conditions originating in the perinatal period

323

2484

1.17

1.88

2.5

2.1

10.53

10.44

nmol/l

0.06

297

2291

Major anomalies of jaw size

117

924

1.30

1.87

3.0

2.3

12.11

13.24

nmol/l

0.84

106

860

Other disorders of nervous system

277

2380

1.18

1.87

2.7

2.3

12.95

13.43

nmol/l

0.41

246

2147

Amiodarone users

366

4163

0.87

1.86

2.2

2.3

12.84

13.20

nmol/l

0.36

321

3696

Coxarthrosis, primary

2414

19025

1.06

1.86

2.5

2.3

12.34

13.01

nmol/l

3.74

2140

16904

Gestational [pregnancy-induced] oedema and proteinuria without hypertension

391

1.44

1.86

1.3

1.08

1.36

nmol/l

1.52

327

Scleritis and episcleritis

198

1651

1.22

1.85

2.3

2.4

12.41

13.04

nmol/l

0.50

180

1528

Algoneurodystrophy

763

1.32

1.85

3.1

2.3

11.84

12.51

nmol/l

0.32

706

Type 1 diabetes, wide definition

1056

11376

0.92

1.85

2.2

2.3

14.59

14.09

nmol/l

1.07

928

10542

Vestibular neuronitis

326

2835

1.16

1.85

2.6

2.3

13.06

13.28

nmol/l

0.19

284

2570

Congenital malformations of ovaries, fallopian tubes and broad ligaments

392

1.44

1.84

1.4

0.99

1.55

nmol/l

4.02

339

Other and unspecified diseases of blood and blood-forming organs

748

1.33

1.84

3.8

2.4

13.37

13.39

nmol/l

0.01

676

Complications following infusion, transfusion and therapeutic injection

396

1.46

1.84

2.2

2.4

11.98

12.87

nmol/l

0.33

357

Ischemic heart diseases

4169

23844

1.04

1.84

2.6

2.4

13.05

13.72

nmol/l

6.83

3794

21842

Chronic periodontitis, complicated

2802

26055

1.05

1.83

2.4

2.3

12.39

13.48

nmol/l

9.55

2385

23756

Malignant neoplasm of colon

447

3966

1.14

1.83

2.2

11.56

15.01

nmol/l

13.50

396

3545

Papulosquamous disorders

1707

16078

1.07

1.83

2.4

2.3

12.58

13.20

nmol/l

2.59

1508

14652

Sequelae of injuries of head

294

2548

1.18

1.83

2.8

2.4

14.29

13.92

nmol/l

0.29

261

2352

Ventral hernia

895

8236

1.09

1.82

2.7

2.3

11.85

12.96

nmol/l

3.87

807

7405

Noise effects on inner ear

296

2577

1.18

1.82

2.2

2.4

13.97

14.13

nmol/l

0.15

269

2354

Glaucoma, exfoliation

239

2027

1.19

1.81

2.6

2.1

12.08

11.55

nmol/l

0.32

208

1729

Postzoster neuralgia

355

1.47

1.81

2.6

2.3

12.28

12.88

nmol/l

0.15

310

Contact with other sharp object(s)

379

3345

1.15

1.80

2.4

12.82

13.51

nmol/l

0.81

348

3105

Effects of other external causes

174

1446

1.24

1.80

3.0

2.3

13.96

14.17

nmol/l

0.14

164

1349

D07AA Corticosteroids, weak (group I)

586

5282

1.12

1.80

2.5

2.3

11.83

12.10

nmol/l

0.30

524

4814

Other and unspecified injuries of wrist and hand

162

1333

1.24

1.78

2.5

2.3

12.89

12.99

nmol/l

0.05

147

1226

Tic and related disorders

415

1.44

1.78

2.2

2.0

12.91

13.43

nmol/l

0.12

391

Epiphora

397

1.44

1.78

2.6

2.3

12.09

12.60

nmol/l

0.16

355

Amblyopia ex anopsia

153

1251

1.24

1.78

2.5

2.2

11.56

11.71

nmol/l

0.08

144

1136

Haemangioma and lymphangioma, any site

302

2620

1.17

1.77

2.7

2.3

12.14

12.90

nmol/l

0.92

279

2387

Biological medicines for asthma

763

1.32

1.77

3.2

2.4

13.34

13.46

nmol/l

0.05

715

Rubella [German measles], including avohilmo

312

2745

1.18

1.77

2.3

2.5

15.11

14.45

nmol/l

1.03

291

2580

Congenital malformations of posterior segment of eye

181

1.71

1.76

1.9

2.4

12.36

13.01

nmol/l

0.16

173

Carcinoma in situ of skin of upper limb, including shoulder

613

1.35

1.76

2.6

2.3

11.48

12.45

nmol/l

0.45

526

Dermatitis and eczema

5917

33896

1.04

1.75

2.4

2.3

12.60

12.91

nmol/l

2.06

5329

30892

Injury of eye and orbit

889

8212

1.09

1.75

2.4

14.02

13.83

nmol/l

0.30

821

7640

Melanoma in situ of other and unspecified parts of face

251

1.56

1.75

2.3

2.2

14.44

12.29

nmol/l

0.70

215

Other pulmonary heart/vessel disease

1162

0.76

1.74

2.1

2.3

12.54

12.68

nmol/l

0.05

1026

Lichen sclerosus et atrophicus

168

1384

1.22

1.74

2.5

2.3

11.70

12.01

nmol/l

0.15

150

1250

Ulcerative proctitis

269

2321

1.18

1.74

2.5

2.3

12.63

13.10

nmol/l

0.40

247

2126

Other acute viral hepatitis

514

1.40

1.74

2.5

2.4

11.03

13.56

nmol/l

1.79

486

Lung diseases due to external agents

462

5163

0.89

1.74

2.6

2.3

11.76

12.81

nmol/l

2.08

393

4570

Hypothyroidism due to medicaments and other exogenous substances

235

1.58

1.74

2.2

2.3

11.64

12.64

nmol/l

0.36

220

Bursitis of shoulder

693

1.33

1.74

2.9

2.3

13.48

13.31

nmol/l

0.07

634

Other respiratory disorders and diseases

668

7327

0.91

1.74

2.6

2.3

11.89

12.64

nmol/l

1.42

579

6461

Other diseases of the respiratory system

668

7327

0.91

1.74

2.6

2.3

11.89

12.64

nmol/l

1.42

579

6461

Secondary right heart disease

1025

0.75

1.73

2.0

2.3

13.18

12.71

nmol/l

0.20

905

Supervision of high-risk pregnancy

259

1326

1.18

1.72

1.4

1.5

1.33

2.39

nmol/l

9.61

232

1127

Psoriatic arthropathies

413

3670

1.14

1.72

2.2

13.23

13.89

nmol/l

0.97

366

3381

Oesophagitis

229

1954

1.19

1.71

2.5

2.3

13.34

13.21

nmol/l

0.09

208

1769

Corneal degeneration

376

1.45

1.71

2.6

2.4

12.61

12.80

nmol/l

0.06

338

Communicating hydrocephalus

548

0.66

1.71

3.5

2.4

10.49

13.02

nmol/l

1.54

490

Acute and subacute iridocyclitis

795

7310

1.10

1.70

2.3

13.22

13.39

nmol/l

0.24

718

6654

Rubella [German measles]

311

2745

1.17

1.69

2.3

2.5

15.06

14.45

nmol/l

0.92

290

2580

Melanoma in situ of trunk

533

1.38

1.69

2.5

2.3

12.88

13.31

nmol/l

0.16

470

Disorders of acoustic nerve

767

1.31

1.69

2.5

2.4

12.43

13.47

nmol/l

0.61

692

Diabetic maculopathy

438

4620

0.88

1.69

2.2

2.6

12.69

10.23

nmol/l

8.20

375

4125

Other obstetric conditions, not elsewhere classified

496

2795

1.12

1.69

1.4

1.21

1.84

nmol/l

13.40

432

2447

Other and unspecified mononeuropathies of lower limb

608

1.34

1.69

2.9

2.2

12.57

13.40

nmol/l

0.45

554

Rheumatoid arthritis, including avohilmo

961

10373

0.92

1.68

2.1

2.3

12.73

12.51

nmol/l

0.34

857

9294

malignant neoplasm of female genital organs, including Hilmo

324

1.44

1.68

2.0

1.4

1.18

1.39

nmol/l

0.25

278

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified, including avohilmo

293

2505

1.16

1.68

2.6

2.2

12.13

11.55

nmol/l

0.60

274

2299

Implicit fungal Sepsis

144

1179

1.24

1.68

2.8

2.2

12.10

13.22

nmol/l

0.73

127

1061

Schizotypal disorder

1024

0.75

1.67

3.1

2.5

15.06

14.28

nmol/l

0.30

958

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

387

2960

1.14

1.67

1.4

1.24

1.59

nmol/l

5.25

336

2540

Wet age-related macular degeneration

425

3645

1.13

1.67

2.2

2.1

11.09

11.27

nmol/l

0.15

350

3097

Complications of other internal prosthetic devices, implants and grafts

120

962

1.27

1.67

2.4

2.3

12.76

12.41

nmol/l

0.13

105

861

Disorders resulting from impaired renal tubular function

110

1372

0.79

1.67

2.6

2.4

10.38

13.52

nmol/l

5.44

104

1241

Orthopaedic devices associated with adverse incidents

395

1.43

1.67

3.1

2.4

11.70

12.96

nmol/l

0.44

344

Other and unspecified anaemias

1695

15019

1.06

1.67

2.4

2.2

10.45

12.59

nmol/l

20.25

1422

13242

Drug-induced hypoglycaemia without coma

613

0.68

1.67

1.8

2.4

10.42

13.62

nmol/l

2.42

555

Contusion of toe(s) with damage to nail

440

1.42

1.67

2.5

2.4

10.38

13.77

nmol/l

2.04

412

Hypercalcemia

127

1026

1.26

1.66

2.7

2.4

11.51

13.13

nmol/l

1.39

114

914

Focal epilepsy, mode (most common among epilepsy diagnosis)

685

7480

0.91

1.66

2.4

2.3

12.63

13.06

nmol/l

0.67

608

6762

Asthma (diagnoses ohter than nonallergic)

4198

32674

1.04

1.66

2.5

2.3

12.01

12.68

nmol/l

5.94

3762

29656

Pedestrian injured in collision with pedal cycle

131

1065

1.26

1.66

2.5

2.4

13.47

13.63

nmol/l

0.08

120

973

Prepatellar bursitis

294

2574

1.17

1.65

2.9

2.3

14.35

14.20

nmol/l

0.08

272

2355

Ulcerative rectosigmoiditis

389

3458

1.14

1.65

2.3

2.4

13.14

13.53

nmol/l

0.43

356

3172

Normal-pressure hydrocephalus

1119

0.77

1.65

1.9

2.3

11.40

12.33

nmol/l

0.51

957

Other encephalitis

109

868

1.28

1.65

2.3

2.4

12.88

13.06

nmol/l

0.07

800

Diabetic retinopathy, excluding more controls

994

5993

0.92

1.65

2.5

2.7

12.09

10.43

nmol/l

8.64

864

5351

Kidney transplant status

210

2456

0.84

1.65

2.3

2.5

13.51

13.91

nmol/l

0.31

198

2262

Malignant neoplasm of oesophagus

956

0.75

1.64

2.4

2.3

12.48

15.36

nmol/l

2.17

862

Other bursitis of elbow

392

1.45

1.64

2.2

2.3

13.83

14.16

nmol/l

0.10

355

Birth injury to peripheral nervous system

2.01

1.64

3.1

1.9

7.37

11.34

nmol/l

1.01

Open bite that required surgery (Lefort1 or BSSO)

231

1.57

1.64

3.0

2.5

12.73

11.75

nmol/l

0.26

219

Malignant neoplasm of small intestine, including Hilmo

770

1.30

1.64

2.2

2.3

12.97

15.06

nmol/l

1.55

693

Single delivery by caesarean section

232

1552

0.85

1.63

1.3

1.5

1.28

2.14

nmol/l

10.07

201

1345

Herpesviral keratitis and keratoconjunctivitis

159

1320

1.22

1.63

2.8

2.4

13.49

12.90

nmol/l

0.34

146

1204

Insulin, fast-acting (human)

617

6759

0.90

1.62

2.2

2.4

15.15

13.70

nmol/l

3.68

543

6268

Suicide or other Intentional self-harm

1134

10595

1.08

1.62

2.6

2.3

11.67

13.21

nmol/l

7.26

963

9805

Respiratory TBC, ICD-8 codes not specifying whether confirmed bacteriologically or histologically

660

0.70

1.62

2.2

2.3

8.99

12.25

nmol/l

2.16

572

Other orthopaedic follow-up care

212

1806

1.19

1.62

2.4

13.19

14.07

nmol/l

0.91

192

1642

Viral conjunctivitis, including avohilmo

132

1075

1.25

1.62

2.6

2.3

12.31

12.33

nmol/l

0.01

111

995

Embolic stroke with flimmer

682

0.71

1.62

2.3

12.04

12.32

nmol/l

0.07

588

Disorders of breast

363

2815

1.14

1.61

1.4

1.54

1.56

nmol/l

0.05

300

2410

Other and unspecified disorders involving the immune mechanism, not elsewhere classified

154

1281

1.23

1.61

3.4

2.5

12.21

13.56

nmol/l

1.54

146

1174

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Testosterone [Moles/volume] in Serum or Plasma

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS